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The confluence of next generation DNA sequencing and synthesis when combined with the 
application of concepts such as standardization and modular design has led to the genesis of a new 
discipline. The nascent field of Synthetic Biology concerns the rational design and construction of 
genetic circuits, pathways, machines and eventually whole organisms. The immaturity of this field 
dictates that early research efforts, including this Thesis, describe foundational work towards the 
creation of tools which make biology more amenable to being engineered. 
 
The first part of this Thesis describes an attempt to standardize the measurement of transcriptional 
promoter activity in E. coli. A method to measure in vivo promoter activity was developed for E. coli 
and tested in a multi-institution trial. Comparable results were achieved with less than a two-fold 
range for the measured promoters across eight laboratories. A standardized measurement kit was 
created and distributed for use by the teams participating in the 2008 international Genetically 
Engineered Machines competition.  Techniques learned measuring the activity of E. coli promoters 
were applied to a collection of S. cerevisiae strains.  Several promoters were measured in synthetic 
dextrose media and ADH1 was measured in multiple media conditions.  The outcome of these 
experiments is to consider proposing ADH1as the reference promoter in S. cerevisiae.   
 
The second aspect of this Thesis describes the construction of artificial organelles in S. cerevisiae.  
Artificial organelles hold the prospect of being able to insulate synthetic genetic pathways from the 
cell. Two proteins are essential for the biogenesis of the peroxisome organelle in humans and yeast, 
Pex3p and Pex19p. Pex3p functions as a peroxisomal membrane receptor for Pex19p, while Pex19p 
shuttles other peroxisomal proteins to the membrane, including Pex3p, creating a feedback loop. 
Human Pex19p has previously been shown to dock to yeast Pex3p and a version of yeast Pex19p has 
been shown to work with human Pex3p as a high degree of evolutionary conservation exists between 
these proteins. Because of these inter-species protein docking characteristics, there exists the 
possibility of creating bimodality: the ambition of the work was therefore to create a cell strain which 
possessed both synthetic “humanized” and natural yeast peroxisomes.  An S. cerevisiae BY4741a 
derivative strain was engineered with fluorophore tagged versions of human (CFP) and yeast (YFP) 
Pex3p and untagged yeast and human Pex19p proteins.  The results indicated the creation of a single 
population of peroxisomes when a measure of fluorescently imaged CFP and YFP peroxisomes were 
plotted on a scatter plot. A log of the ratio of CFP to YFP peroxisomes was plotted on a histogram 
and a normal distribution was found to best fit the curve, indicating a lack of bimodality. Finally, 
microscopy images of this strain were reviewed and by visual inspection, showed no evidence of 
distinct human or yeast peroxisomes. This experiment therefore produced no evidence of bimodality 
when examining the interactions of human and yeast Pex3p and Pex19p proteins. However, the four 
proteins were shown to interact closely to produce a single population of chimeric human-yeast 
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1 Introduction  
 
 
In 1828, Friedrich Wöhler synthesized urea, an organic chemical compound, from inorganic 
substances (Wöhler 1828).  This act ushered in the dawn of synthetic chemistry and by the 
1850‟s, dyes and pigments were synthesized which led to a revolution in the textile industry as 
toxic natural compounds such as arsenic were no longer used.  By the end of the 19th century, 
many more organic compounds had been created in the lab.  This led to the creation of the 
petrochemical industry when synthetic rubbers and adhesives were produced from crude oil and 
its derivatives.  After the petrochemical industry, came the pharmaceutical industry where more 
and more complex organic molecules and proteins were synthesized to create drugs.  Drugs like 
aspirin, insulin and penicillin were manufactured in large quantities leading to a revolution in 
medicine and healthcare (Gerhardt 1853; Bliss 1982; Pontikis 2010).   
 
The structure of Deoxyribonucleic acid (DNA) was elucidated in 1953 by Watson and Crick 
(Watson and Crick 1953); a discovery that paved the way for genetics and genetic engineering.  
The 1968 discovery of restriction enzymes in Haemophilus influenzae (Smith and Wilcox 1970) 
allowed scientists to cut DNA at specific locations, which introduced the possibility of 
recombinant DNA and the construction of plasmids in vitro (Cohen, Chang et al. 1973).  The 
work of Frederick Sanger in 1975 produced the dideoxy sequencing or chain termination method 
of DNA sequencing (Sanger, Nicklen et al. 1977).  The discovery of Taq polymerase in 1976 led 
Kary Mullis to invent polymerase chain reaction (PCR) technology in the early 1980‟s (Mullis, 
Faloona et al. 1986).  The advent of shotgun sequencing led to H. influenza being the first free 
living organism to have its entire genome sequenced (Fleischmann, Adams et al. 1995).  The 
convergence of these technologies and advances was leading to one of the greatest scientific 
endeavors of the 20th century.   
 
The human genome project is the largest biology project undertaken to date.  It began in 1990 
when James Watson was the head of the National Center for Human Genome Research at the 
National Institutes of Health in the United States.  The USD $3 billion dollar project was 




roughly expected to take an international consortium of researchers from the US, the UK, Japan 
France, Germany and China 15 years to complete a consensus sequence of the haploid genome.  
The human genome was first published in 2001 when a physical map of the largest genome ever 
sequenced was published in nature (McPherson, Marra et al. 2001). The same month in Science, 
Craig Venter and his team published a 2.91 billion base pair consensus sequence of the human 
haploid genome (Venter, Adams et al. 2001).  In 2006, the public consortium project was finally 
finished after 16 years as the annotated sequence of chromosome 1 was published (Gregory, 
Barlow et al. 2006).  In parallel to the International Human Genome Sequencing Consortium 
(IHGSC), Craig Venter was the first person to sequence a diploid human genome of an 
individual (his own) in 2007 (Levy, Sutton et al. 2007).  At the time of publishing, the cost of 
sequencing a human genome ranges from about $5000 USD (Lauerman 2009) to $20,000 USD 
(Karow 2010) and is expected to fall to less than USD $1000 or cheaper (Johnson 2010) within a 
few years.   
 
In 2008, Craig Venter published a protocol on how to synthesize and assemble a 582,970 base 
pair Mycoplasma genitalium genome (Gibson, Benders et al. 2008).  Due to problems 
transforming this DNA into M. genitalium, a 1.08 mega–base pair Mycoplasma mycoides 
genome was constructed using the previously described method.  In 2010, Venter succeeded in 
inserting the artificial M. laboratorium DNA into a DNA-free cell and „booting up” life (Gibson, 
Glass et al. 2010).  However, his project copied the DNA of an existing species with the addition 
of a few watermarks in order to test the method.  He did not design his own organism from 
scratch.  Costs have not fallen in gene sequencing as much as they have in synthesis and the 
biggest problem facing synthesis is still the error rate.   
The industrial revolution was based on several well known innovations, such as the steam 
engine, the mechanization of industrial processes, the discovery and mining of coal in the British 
midlands and one less well known factor: standardization.  Factories produced all the parts they 
needed for their machines, and every factory had a different standard and size for nuts and bolts.  
The standardization of fasteners allowed factories to concentrate on producing their products, 
not each individual component.  Many examples of standardization exist from the beginning of 
the industrial revolution to the emergence of the Internet, from the Ohm allowing trans-Atlantic 




telegraph cables to be laid and repaired to TCP/IP protocols allowing computers to 
communicate.   
 
Biology in its current guise is highly standardized in that four nucleotides form the basis of all 
known living organisms.  With 20 amino acids, the structure of all proteins in the biological 
world can be formed (but protein function is more complex as secondary structures are usually 
needed for the protein to fold correctly and often metal ions are necessary, specifically in the 
case of metalloenzymes).  The field of biology is poised to go through great changes that will 
seek to exploit and capitalize on this underlying standardization as it moves further into the 21st 
century.  The nascent field of Synthetic Biology is about the construction of genetic circuits, 
pathways, machines and eventually whole organisms.  The confluence of next generation DNA 
sequencing, synthesis and the application of engineering concepts such as standardization, 
decoupling and abstraction (Endy 2005) to biology will pave the way for Synthetic Biology, or 
SynBio to likely be the next industrial revolution.   
1.1 What is ‘Synthetic Biology’? 
This question can be answered differently depending on your background and interests.  There 
are several groups and many definitions for this new field.  First the groups: biologists, 
bioinformaticians/systems biologists, chemists, re-writers and engineers (Endy 2005).  
Biologists are interested because they will be able to use new tools and techniques to probe 
current understanding.  They can build systems to test their understanding of the underlying 
phenomena.  Systems biologists and bioinformaticians want to test computer science techniques 
and in-silico models against synthetically constructed biological systems.  With biochemistry 
being an extension of chemistry, Synthetic Biology gives chemists the ability to create new 
molecules and systems to further probe questions from simple biomolecular interactions to the 
origins of life.  „Re-writers‟ seek to optimize biology for human interaction by making biology 
easier for humans to use through projects such as genome refactoring (Kuldell and Lerner 2009).  
Finally, for engineers, biology is technology (Carlson 2010).  Engineers want to build on the last 
four decades of progress in genetic engineering by turning biology into a discipline where new 
functions can be easily created through application of engineering methodologies.  In this 
Thesis, Synthetic Biology will be discussed from the engineering perspective.  It is about the 
creation of tools to make engineering biology easier.  However, engineering and biology are 




vastly different in the ways knowledge can be used to design systems.  Engineering applies 
theories and material properties to design systems to a specification that can be achieved in a 
range of operating conditions.  The same principles can‟t be applied to the design of biological 
systems as the behavior of each individual genetic part can‟t be predicted in the same 
deterministic manner as in engineering.  This doesn‟t mean biology can‟t be engineered, but has 
implications in the design of the project.  A parts based assembly approach is taken in this 
Thesis, as will be discussed later, but there is scope to develop a better method.  In a talk on 
Synthetic Biology at the Singularity University, Andrew Hessel gives the following definition of 
Synthetic Biology: 
“An ultimate dream is to design… , press a button and have the design translated into 
DNA sequences that can synthesized and put to work in living cells (Hessel 2009)” 
This quote reflects the ideal situation in a future where cloning is no longer necessary to 
assemble DNA fragments.   
 
In 1978, the Nobel Prize in physiology or medicine was awarded to Arber, Nathans and Smith 
for the discovery of restriction endonucleases.  In an editorial to the journal Gene, Waclaw 
Szybalski was the first to term this new field: 
“The work on restriction nucleases not only permits us easily to construct recombinant 
DNA molecules and to analyze individual genes, but also has led us into the new era of 
Synthetic Biology where not only existing genes are described and analyzed but also 
new gene arrangements can be constructed and evaluated (Szybalski and Skalka 1978).” 
Szybalski was a little ahead of his time, but restriction enzymes still had a massive impact on the 
field of biology.  The field he called Synthetic Biology became Molecular Biology and the first 
modern reference to “Synthetic (Cell) Biology” in the literature came in 2001: 
“Molecular Biology has entered a stage of maturity that requires its transformation into an 
engineering discipline.  The wealth of data on cellular components and their interactions 
will promote an understanding of cellular behavior that is sufficient for prediction, control 
and redesign (Arkin 2001).” 




As the above quote illustrates, the nascent field of Synthetic Biology is about applying a 
quantitative approach to an often qualitative field.  Most work in Synthetic Biology takes place 
at the transcriptional level.  Transcriptional logic has been well understood and used in 
molecular biology for some years (Casadaban 1975).  The process by which DNA has been 
extracted, copied and written is generally referred to as cloning.  Until very recently and still in 
many labs, building and sharing genetic constructs by cloning was analogous to blacksmithery 
and cannot be performed reliably and repeatedly with a 100% success rate.  The exact restriction 
enzymes that were necessary for the DNA fragment were built into the PCR primers and each set 
of restriction enzymes were specific to each construct.  This was advantageous in that site 
directed mutagenesis was seldom necessary, but problematic in that constructs could not be 
easily shared or reused.  Another aspect of Synthetic Biology uses a new and novel construction 
technique to quickly and easily assemble multiple genetic parts together to produce a device: 
“The field is in a similar situation to mechanical engineering in the 1800s and micro-
electronics in the 1950s, when rapid progress required the adoption of standardized 
interchangeable parts and modular construction methods.” (Haseloff and Ajioka 2009) 
These devices can be assembled together in a modular manner to build systems to “reprogram” 
the host organism for a variety of different tasks.  Although genetic engineering has existed for 
decades, conventional techniques were inflexible to producing larger constructions.  This simple 
but powerful new technique is called the “BioBrick” system.  This format of part exchange is 
supported by the BioBricks foundation in an effort to help mediate the technology and inspire 
students to become involved in the field (Smolke 2009). 
 
The BioBrick system has had a huge impact on Synthetic Biology by allowing laboratories 
across the world to use standard parts to construct devices and systems.  Biological parts can be 
selected from a catalogue and ordered, in the same way an engineer would select fittings or 
components.  Labs across the world are developing new BioBrick parts and beginning to 
characterize existing ones.  Once submitted to the open source Registry of Standard Biological 
Parts (Rettberg 2010), a part could be obtained from the registry by simply ordering the whole 
catalogue and re-hydrating the construct on arrival.  This system draws many parallels to open 
source software engineering.  It is a concept that has the possibility to revolutionize biology.   




1.2 Exemplars in Synthetic Biology 
The field of Synthetic Biology has grown explosively over the last several years and covering all 
of the representative projects would be impossible.  Several illustrative projects or exemplars 
will be briefly presented to show the milestones in the field. 
 
Arguably, the first demonstrated exemplar in Synthetic Biology was the repressilator.  This 
system was composed of three transcriptional repression systems and was designed to oscillate a 
GFP signal in Escherichia coli over time.  The first repressor protein, LacI, inhibits the 
transcription of the second repressor gene, tetR, whose protein product in turn inhibits the 
expression of a third gene, cI from λ phage (Elowitz and Leibler 2000).  They succeeded in 
creating a strain of E. coli that would periodically oscillate, inducing the synthesis of GFP.  As 
the period of oscillation was slower than the generation time of the cells, the state of the 
oscillator was passed from generation to generation.  The period of oscillation of the system 
depends on several parameters: the dependence of the transcription rate on repressor 
concentration, the translation rate and the decay rate of the mRNA.  Strong promoters coupled to 
efficient ribosome binding sites, comparable mRNA and protein degradation rates and 
cooperative repression characteristics were necessary for the system to function.  The period of 
the oscillations was in the order of 160 ± 40 minutes.   
 
Another interesting device is the genetic toggle switch (Gardner, Cantor et al. 2000).  Gardner 
and colleagues built a bi-stable toggle switch using two repressors and two constitutive 
promoters.  They designed and modeled the switch based on the biochemical rate equation for 
gene expression.  A simple Ordinary Differential Equation (ODE) model was constructed in 
Matlab and they then built and demonstrated that their system exhibited bimodality in vivo.  
 
There are exemplars that demonstrate other important functions in biology, such as cellular 
memory (Ajo-Franklin, Drubin et al. 2007).  Ajo-Franklin and co-workers built a set of 
transcriptional activators and quantitatively characterized their effects on gene expression in S. 
cerevisiae.  They correctly predicted the behavior of the memory network based on quantitative 
characterization of the promoter pairs.  Simple memory in single-cell eukaryotes is a powerful 
tool if it can be easily exploited.   





There have been several projects from the international Genetically Engineered Machines 
(iGEM) competition that can also be classified as exemplars.  In 2005, a team from Texas 
produced a strain of bacteria that was light-sensitive, making “bacterial photography” 
(Levskaya, Chevalier et al. 2005).  This was the first truly successful demonstration of an iGEM 
project.  In 2006, the University of Edinburgh team produced a strain of E. coli that could detect 
arsenic to a concentration of 5 ppb or greater than the WHO detection standard of 10 ppb 
(Aleksic, Bizzari et al. 2007).  This project has been championed by the creators of the 
competition and is still mentioned as a model Synthetic Biology project.  From 2006 onwards, 
iGEM projects started to tackle more complex projects involving mammalian cells.  The 2006 
team from Slovenia engineered a method of eliminating sepsis in mammalian cells.  The binding 
of bacterial components to a family of Toll-like receptors activates the immune system, where an 
exaggerated response can lead to systemic inflammation.  Mathematical modeling of the system 
indicated that a feedback loop at the weak spot in the signaling cascade at MyD88 could inhibit 
this response (Ciglič, Fekonja et al. 2007).  In 2008, a team from the same institution tested 
functional „immunobricks‟ by assembling a vaccine to combat acquired immune response to H. 
pylori and tested their system in vivo in mice (Čeh, Kočar et al. 2008). 
 
The first commercialization examples of Synthetic Biology are starting to appear.  Jay Keasling 
and his team engineered a strain of yeast to produce the anti-malarial drug precursor artemisinic 
acid to approximately 50 mg per liter of saturated culture (Ro, Paradise et al. 2006).  Today, they 
have increased that figure to about 120 mg / L of saturated culture.  The project was funded by 
the Bill and Melinda Gates foundation with the aim of producing the drug at much lower cost 
than current processing techniques, effectively allowing developing countries that needed a 
cheap supply to purchase enough treatments to inoculate their population.  An added bonus of 
this project was that the artemisinic acid biosynthesis pathway is very close to a class of organic 
chemicals called terpenoids (isoprenoids), which make Excellent biofuels (Keasling and Chou 
2008).  This discovery led to the formation of Amyris Biofuels with the aim of producing bio-
diesel, bio-jet fuel and bio-gasoline from engineered yeast.  Professor Keasling‟s projects are 
impressive, but the work took 150 man-years and $25 million USD for the artemisinic acid 
biosynthesis pathway alone.  This scale of work is possible with large grants or follow-up 




industrial applications, but not without these huge sources of finance.  Keasling‟s initial work 
involved many years of developing and creating the tools necessary to make his achievements 
possible and he has stated with the experience they now possess, the same feat could be 
reproduced in a much shorter time span with less financial resource.   
1.3 Ethical, Legal and Social Issues surrounding Synthetic Biology (ELSI) 
The field of Synthetic Biology has the potential to make great changes with wide ranging 
impacts on people, communities, economies and even nature itself; issues that reach far beyond 
the confines of the lab.  As the implications of this work can reach so far with major discoveries 
in the field making headlines, discoveries within context become important:   
“Indeed, the „I‟ of ELSI itself implies that once the natural scientists have done their 
work, the social scientists arrive to explore the „implications‟ of the work for society, 
perhaps by drawing analogies with similar technological developments in the past” 
(Calvert and Martin 2009). 
In this quote, Jane Calvert states that the traditional methodology of the social sciences is to 
investigate the implications of natural scientists work after the „fait accompli‟.  In this context, 
the umbrella of social science refers to the Ethical, Legal, and Social Issues (ELSI) surrounding 
the field of Synthetic Biology.  Social scientists usually take the role of external observers and 
report on the implications of discoveries after scientists have finished and published their work.  
The first wave of Synthetic Biology research institutes have incorporated ELSI into the core of 
their work.  The Synthetic Biology Engineering Research Center (SynBERC) has a human 
practices thrust that aims to foster mixed teams of human scientists with other researchers to 
design models of collaboration and inquiry (Endy 2010).   
 
In the UK, the Economic and Social Research Council (ESRC) has established a national 
„Genomics Network‟ of research centers to carry out social science research on the science and 
technology of genomics, with Synthetic Biology being one of the specific areas of investigation 
(Frow 2009).  The Royal Academy of Engineering and the UK Research Councils have 
commissioned reports investigating the scope, applications and implications of Synthetic 
Biology as well as several public dialogues to explore peoples informed and uninformed 




perceptions (Kitney 2009; Paterson, King et al. 2009).  The BBSRC have also published their 
own reports on the findings of these studies with a preliminary indication that the public finds 
Synthetic Biology technologies both exciting and scary (Balmer and Martin 2008; Bhattachary, 
Calitz. et al. 2008).  In this field, the role of social scientist is changing and moving away from 
the traditional impartial observer to a more active role in the development of the field itself.  
Social commentary has become involvement, a new paradigm for the social sciences.  This 
change is likely to lead to closer relations between the social and physical sciences and where 
there is collaboration and understanding, productive and positive interactions are much more 
likely to result.   
 
A prominent ethical issue raised about Synthetic Biology relates to the wider implications of 
trying to engineer DNA as a programming code.  Craig Venter has succeeded in booting up M. 
laboratorium from entirely synthetic man-made DNA (Gibson, Glass et al. 2010).  The question 
that then needs to be asked is:  “Is this creating life?”  In radio interview on the program 
Frontiers – Synthetic Biology, a social scientist and Anglican priest, Robin Gill, said: 
“I think it‟s a metaphor [on the idea of creating life], it‟s not my understanding of 
creating.  For me, creating is creating from nothing.  I think what we‟re doing here is 
modifying life, combining synthetic elements with bio-elements.
1
” 
The issue can be transformed into a question of using a bottom-up or a top-down approach to 
constructing biology.  A top-down approach focuses on modifying existing organisms by 
changing part of the whole genome.  One ongoing effort in this area is Jef Boeke‟s S. Cerevisiae 
2.0, where a large international group of collaborators are trying to re-build a minimal genome 
version of the most widely used experimental yeast (unpublished work).  The bottom up 
approach to Synthetic Biology involves building an organism from component parts.  This 
approach differs as aside from Robin Gill‟s idea on the creation of life stated above, there are 
still ethical issues involved.  Work in this category would include Jack Szostack‟ self replicating 
artificial vesicles (Hanczyc and Szostak 2004).   
 
                                                     
1 August 2009, BBC Radio 2 




An interesting aspect of the field from a legal standpoint is the issue surrounding intellectual 
property.  Parts-based Synthetic Biology functions with the aid of the Registry of Standard 
Biological Parts at MIT (Rettberg 2010).  This DNA repository exists solely due to the academic 
exemption to IP law (known as the Hatch-Waxman exemption in the US), where academic 
institutions can use protected patents without fear of legal pursuit from the patent owners.  Many 
of the parts in the registry are known to be or suspected to be patented including many of the 
green fluorescent proteins (D Grewal, personal communication).  As a consequence, parts-based 
Synthetic Biology could not exist without this exemption.  Questions surrounding the transition 
into commercialization then become more interesting, and more of a debate.  As Synthetic 
Biology grapples with the issues surrounding IP, a landmark ruling was made in the Association 
For Molecular Pathology et al. v. United States Patent and Trademark Office et al. case 
involving a US company.  The plaintiffs‟ in this case posed a unique question: 
“Are isolated human genes and the comparison of their sequences patentable?”  
This question brings attention to the intersection of Molecular Biology and patent law.  Myriad 
Genetics own the patents related to specific sequences implied in breast and ovarian cancer in 
the BRCA1 and BRCA2 genes and hold a monopoly on testing these genes for selected 
mutations.  The defendants won the case when parts of the company‟s patents were ruled invalid 
in the U.S. District Court for the Southern District of New York  (Sweet 2010).  In the context of 
Synthetic Biology, the legality of distributing, using and creating BioBrick parts has remained a 
grey area.  In an attempt to tackle this issue, the BioBrick foundation drafted a public agreement 
pertaining to the use and distribution of BioBrick parts (Endy, Grewal et al. 2010).  This 
framework simply states that you may use the parts, but in the event that a company seeks 
compensation, the BioBricks Foundation is not the legally responsible entity.   
 
From the social standpoint, the field is rapidly evolving new facets with the use of community 
organizing tools.  OpenWetWare is a community based web site that allows synthetic biologists 
to share protocols and useful techniques (Kelly 2010).  It evolved from the use of wikis as the 
main public form of information dissemination for the iGEM competition where producing a 
team wiki is a key element of the competition (Rettberg 2010).  The field has introduced to 




biology a new format of publication from Computer Science – Request For Comments (RFC) 
which will be discussed later in the Thesis.   
 
One of the other aspects of the social science in Synthetic Biology involves the issue of safety, 
especially in the context of public perception.  While the founders of the field are pushing ahead 
with the technical development to allow discoveries to become possible, there are other opinions 
being expressed, including from the security community.  Synthetic Biology aims to makes 
biology easier to engineer which in turn makes biological weapons easier to engineer.  In 2004 
Steve Kurtz was made painfully aware of how the security community can react after being 
arrested on suspicion of bioterrorism.  Paramedics were called to his home when his wife was in 
cardiac arrest.  The art professor was using genetically modified bacteria as part of an art 
installation for the Massachusetts Museum of Contemporary Art but the paramedics became 
suspicions of the biological materials in his home and alerted the FBI (Hirsch 2005).  He was 
eventually cleared of all charges after a four year legal battle (Galarneau 2008).   
 
In 2006, a reporter from the Guardian newspaper in the UK succeeded in ordering an partial 
sequence of the smallpox virus from a company online and had it delivered to his home address 
(Randerson 2006).  The reporter was aiming to write an expose on how lax laws allow new DNA 
synthesis companies to send sequences without verification of the customers or the sequences.  
With the widespread availability of genetic information about most of the worst mass pandemic 
diseases easily found online the idea was that more controls should be in place.  While 
potentially worrying, the 78 base pair sequence ordered represents a tiny fraction of the 185 000 
nt smallpox genome.  Assembly of the approximately 2400 78 nt oligomers in to a functional 
version of the virus is not trivial.  The Synthetic Biology community is aware of potential 
biosecurity threats of large-scale DNA synthesis and is trying to work with governments and 
industry to implement safety procedures (Bugl, Danner et al. 2007).  The do it yourself 
biotechnology (DiyBio) community are also aware of potential threats and have been in 
discussions with the FBI (Weapons of Mass Destruction Directorate) and the UN (Biological 
Weapons Convention Implementation Support Unit) to help address these issues (Personal 
communication M. Cowell, J. Bobe, E. You, P. Millet).   
 




Scientists involved in the field of Synthetic Biology need to be very aware of the implications of 
what they are doing.  Questions pertaining to the release of genetically engineered organisms 
into the environment are still as relevant now as when GM crops first appeared in the media.  
Academic research can often proceed in the confines of academia without attracting the attention 
of the public, but in this case researchers would do well to be aware of broader social context in 
which Synthetic Biology is developing.  The Asilomar conference in 1975 described a set of 
principles to follow for any researcher working on recombinant DNA (Berg, Baltimore et al. 
1975).  These principles state that containment be made an essential consideration in the 
experimental design and that the effectiveness of the containment matches the estimated risk.  
These principles help guide genetic engineering and are still as valid today for Synthetic Biology 
as they were when originally conceived.   
1.4 The International Genetically Engineered Machine Competition 
The main training ground for aspiring Synthetic Biology is an undergraduate competition that 
takes place every year at Massachusetts Institute of Technology (MIT) (Brown 2007).  In 2002, 
three engineering professors chose to break with the MIT traditions of computers, AI, electronics 
and robotics at the Computer Science and Artificial Intelligence Laboratory (CSAIL) department 
to think about how to engineer biology.  In the MIT Independent Activity Period in January 
2003, they decided to give the challenge of building biological machines to improve on the 
repressilator (Elowitz and Leibler 2000).  It became iGEM in 2005 coinciding with the 
participation of the University of Cambridge along with 11 US teams.  In 2006, 13 teams 
became 37 from the UK to India to South America.  In 2009, the competition had 112 
participating teams and it continues to grow year on year.  The competition is structured around 
a team of undergraduates working for a period of 10 – 12 weeks over the summer to design, 
build and test a genetic machine.  The iGEM competition started with the aim of answering a 
question posed by Randy Rettberg:  
“Can simple biological systems be built from standard, interchangeable parts and 
operated in living cells?  Or, is biology simply too complicated to be engineered in this 
way?” 




After a national level competition and two years of international work, the question was 
answered in the affirmative as teams demonstrated working biological devices at the 2006 final 
(Aleksic, Bizzari et al. 2007; Ciglicˇ, Fekonja et al. 2007; Kitney, Freemont et al. 2007).  The 
competition is currently the most well-known forum for the generation of new Synthetic Biology 
project ideas and the focal point of the international research community.  It is also how the 
author became interested in the field.   
1.5 The Registry of Standard Biological Parts and BioBricks 
The Registry of Standard Biological Parts is both a database of parts and a catalog of DNA that 
can be ordered.  It was established in 2003 to provide support for the iGEM competition.  There 
are many categories of parts available, the most common being promoters, ribosome binding 
sites, genes (especially fluorophores) and terminators.  Most of the documentation to build and 
use BioBricks can also be found on the site (Rettberg 2010).  The principal model organism for 
Synthetic Biology is E. coli as nearly all genetic assembly is performed in the bacteria.  The 
assembly of the parts is performed in E. coli and as a consequence, most of the parts in the 
registry are for this organism.  DNA assembly and cloning for most other organisms also takes 
place in E. coli.   
 
The distribution of parts is traditionally available through participation in the iGEM competition 
although it can be ordered by any interested lab.  At the time of writing, about 1200 parts are 
distributed by the registry each year.  The parts are submitted by iGEM teams as a requirement 
of the competition.   They are sequenced by the teams but little characterization work is usually 
performed to determine the characteristics of the parts beyond functionality.  Many of the parts 
described in this Thesis are available in the Registry of Standard Biological parts.  Traditionally, 
the parts are distributed in 384 well plates but in 2008, the registry was spotted onto 
chromatography paper and sent in a three ring binder.  This format was copied for the E. coli 
promoter measurement kit that described in Chapter 4. 
 
The BioBricks Foundation has also implemented a publication system from computer science 
that allows for the open discussion on the setting of standards.  This system draws heavily on the 
MIT origins of software engineering and is called the Request For Comments (RFCs) (Knight 




2007).  This forum is where discussions take place on the setting of standards for the 
community, including the assembly standards and the electronic BioBrick description standards.   
 
The BioBricksTM technology was first described by Tom Knight at MIT (Knight 2003).  The 
technology describes a system of assembling fragments of DNA together from a set of standard 
interchangeable parts.  BioBricks are defined as genetic parts that contain standard restriction 
enzymes flanking a piece of DNA of interest.  The first standard, initially known as assembly 
standard 1.0 (now known as RFC10) contains four standard restriction enzymes: EcoRI, XbaI, 
SpeI and PstI.  EcoRI and XbaI are placed upstream of the part and SpeI and PstI, downstream. 
A Not1 site was placed between the EcoRI and XbaI sites as well as the SpeI and PstI sites to 
allow enough space for the enzymes to bind.  The following diagram explains BioBrick single 
antibiotic standard assembly: 
 
Figure 1.1: BioBrick assembly diagram (Rettberg 
2006) 
 
Figure 1.1 shows BioBrick part assembly in diagrammatic form.  The blue part is inserted 
downstream of the green part when cutting the fragments with the given enzymes.  It is also 
possible to insert the blue part upstream of the green part by cutting it with XbaI and PstI, while 
the green part (vector) would be cut with SpeI and PstI.  A variant of this assembly technique 
can be used to assemble three parts together in one step called three antibiotic assembly.  This 




two part assembly technique was used to assemble all constructs involved in the projects 
discussed in this Thesis.   
 
When the original BioBrick assembly standard was first described, a limitation in the design was 
overlooked.  This original standard is now referred to as BBF RFC assembly standard 10.  Once 
the parts have been assembled together, translation over the mixed assembly site causes a frame-
shift of one nucleotide, preventing the assembly of fusion proteins.  This issue was addressed 
with the creation of new BioBrick assembly standards.  There are currently six BioBrick 
assembly standards in the Registry: 10 (Knight), 12 (Knight 2), 21 (Anderson), 23 (Silver), 25 
(Mueller) and 28 (Peisajovich).  These standards have been created to address a range of issues 
from fusion protein creation to problems with charged residues in the mixed assembly site.  As 
eukaryotic organisms are incompatible with polycistronic expression, a new assembly standard 
was needed to allow eukaryotic Synthetic Biology to proceed.  The Silver-Philips standard was 
developed in Pamela Silver‟s lab to allow the construction of fusion proteins (Phillips and Silver 
2006).  This new standard simply removed a single nucleotide from the RFC10 to allow the 
correct frame to be preserved when translating over the XbaI-SpeI mixed site.  All BioBricks 
used in the yeast work in this Thesis were constructed in accordance with the Silver standard 
(BBF RFC 23).  At the time of publishing, it is the most widely adopted standard for BioBrick 
assembly in yeast.  The assembly standards are maintained by the BioBrick Foundation, but 
implemented by the Registry of Standard Biological Parts (see below).  Further information on 
the assembly standards and compatibilities can be seen on the Registry website (Rettberg 2010).   
 
BioBricks assembly is the accepted and most widely used cloning technique within the 
framework of the iGEM competition, but there are many other cloning techniques.  Before 
BioBricks, Invitrogen had a recombination-based cloning range of products called the Gateway 
system (Hartley, Temple et al. 2000; Sasaki, Sone et al. 2004; Alberti, Gitler et al. 2007).  One 
of the big problems with recombination-based systems is the time-consuming incubation in a 
host to allow the DNA fragments to assemble.  Daniel Gibson and colleagues developed a 
ligation free cloning technique during work on chemical synthesis of the Mycoplasma 
genitalium genome (Gibson, Benders et al. 2008).  Gibson and colleagues ordered synthetic 
oligonucleotide sequences in the region of 5 – 6 kb, but this technique would also work with 




natural sequences.  The overlapping DNA molecules are digested using a 3‟exonuclease to 
expose overlaps.  The complementary overlaps are then annealed and the joins repaired between 
the sequences.  A similar system using a 3‟exonuclease was described in 1990 by Aslanidis and 
de Jong (Aslanidis and de Jong 1990).  A need exists for high throughput, fast DNA assembly 
methods and while BioBricks is a step in the right direction in terms of part composability, faster 
techniques will continue to be developed beyond ligation free cloning.   
1.6 Thesis Outline 
This Thesis is composed of 9 Chapters and as Synthetic Biology is so different from traditional 
engineering disciplines, effort will be made to describe the origins of the field and some of the 
basic ideas, concepts and technologies.  A survey of current literature is conducted on the 
development of the field of Synthetic Biology and the role that engineering plays in an otherwise 
biological discipline.  This is followed by an examination of previous work on measuring 
promoters and a look at the evolution of peroxisome form and function in Chapter 2.   
 
A great deal of diversity exists between labs when it comes to protocols and methods.  To this 
end, the protocols used are presented in as complete a manner as possible in Chapter 3.  Two 
results Chapters will be shown starting with the E. coli promoter characterization, the proposal 
of a standard promoter unit (SPU) and promoter measurement in S. cerevisiae in Chapter 4.  
Chapter 5 presents the peroxisome engineering work.  Chapter 6 presents a numerical analysis of 
the peroxisome engineering work and Chapter 7 will discuss these results.  Finally, Chapter 8 
covers the conclusions and further work. 




2 Review of Current Literature  
 
 
The previous Chapter began at the production of the first organic molecule and continued to the 
revolution in DNA sequencing that led to the completing of the human genome project.  Most of 
the major discoveries have been covered that have allowed Synthetic Biology to evolve as a 
discipline.  Synthetic Biology can be fundamentally viewed as an engineering discipline which 
seeks to construct complex devices from well defined modular parts analogous to other 
engineering disciplines.  As it is so different from traditional engineering disciplines, this review 
will introduce some of the basic concepts and technologies unique to Synthetic Biology.   
 
Two major areas will be covered in this Thesis: relative promoter measurement in E. coli and 
peroxisome engineering in S. cerevisiae.  After covering the basics of Synthetic Biology, 
background on previous efforts to standardize promoter measurement will be examined, 
followed by the body of work on which the peroxisome engineering project is based.   
2.1 Basic Principles of Biological System Design 
One of the key concepts in the field of Synthetic Biology is the abstraction hierarchy.  The 
analogy most often used is that of computers and computer networks (Andrianantoandro, Basu et 
al. 2006).  At the base level, proteins and genes are analogous to the physical layer of 
components on a circuit board such as resistors, transistors, diodes and LEDs.  At the next level, 
biochemical reactions can be compared to logic gates, by which computer systems do almost all 
processing.  Above that, biochemical pathways are like integrated circuits where the whole 
system has been integrated onto a chip.  Cells are analogous to single computers and tissues 
exhibit cell-to-cell communication properties like a computer network.  This analogy works 
well, but does not account for the way biology executes commands.  The genome in a cell stores 
code in the same way that a hard drive in a computer does, but it also assembles the physical 
hardware through transcription and then translation.  The connection between information 
storage and function execution (hardware assembly) is therefore much closer in biology.  This 
analogy is useful in terms of visualizing the levels of complexity within a biological system, but 




is not strictly true on all levels.  The information contained in the genetic code has the ability to 
modify the physical system to a great extent; this is an emergent property of evolution.  Such an 
analogy does not exist in computational terms as there is no feedback loop from software to 
hardware design within any single computer.   
 
This abstraction hierarchy is important as each level can be examined and understood 
independently.  Computers and other electronic devices can be built without knowing all the 
base physical properties of the underlying technology.  Networking and systems administration 
are done without intimate knowledge of integrated circuit design.  These analogies seek to 
illustrate that computers can be used without understanding how they work.  Knowledge of 
Molecular Biology techniques and genetics at the base pair level is necessary to build even the 
simplest devices, limiting the people who can access biology as a technology and what they can 
achieve in a given time.   
 
As there is not currently any way to build synthetic biological devices without a base level of 
genetics knowledge, this section will cover the basic system design principles used in this 
project.  Any genetic construct with the purpose of expressing a protein is composed of a 
minimum of four elements.  In its most simple form this sequence is: promoter – RBS – coding 
sequence – terminator as shown in Figure 2.1: 
   Promoter             RBS/Kozak               Gene                Terminator 
Figure 2.1: Basic genetic construct layout 
2.2 Measurement in Synthetic Biology 
The BioBricks standard and the Registry of Standard Biological Parts has allowed new devices 
and systems to be engineered and in an open-source modular format not seen in biology before.  
Composable parts and a functional hierarchy have allowed scientists to begin to tackle the 
problem of how to engineer biological systems.  Databases of parts and the ability to assemble 
them together form the backbone of Synthetic Biology.  However, accurate and useful 




characteristics of these parts are often not reported.  The value of the ability to accurately 
measure and quantify these parts cannot be understated: 
“A critical early advance at the beginning of the nineteenth century was precise 
measurement and analysis of compounds as they reacted.  For example, by collecting and 
precisely weighing the carbon dioxide and water that formed upon combustion of organic 
molecules, it became possible to determine the atomic compositions of these molecules, 
and therefore their empirical formulas” (Yeh and Lim 2007). 
As was previously discussed, a great deal of work building new systems and devices uses 
transcriptional logic.  However, not all Synthetic Biology projects focus on transcriptional logic 
devices.  Using RNA, Christina Smolke has constructed an RNA-based framework for 
engineering ligand-controlled gene-regulatory systems called riobzyme switches (Win and 
Smolke 2007).  These devices can perform computation and have been configured to for the 
regulation of cell growth and to sense small metabolite production.  Chris Voigt and his group 
have investigated using ribosome binding sites to engineer new genetic function (Salis, Mirsky 
et al. 2009).  They developed a method that allowed for the predictive design of synthetic 
ribosome binding sites, enabling rational control over the protein expression levels in E. coli.  
Durai and colleagues are investigating the creation of zinc finger-based nucleases to enable 
better engineering of specific integration vectors in mammalian and plant cells by gene targeting 
(Durai, Mani et al. 2005).  New devices cannot be built from off-the-shelf parts if there is no 
information on how these parts function.  Two elements of these problems become important: 
Robust measurement of part characteristics and the standardization of these measures.   
 
Standards are important in engineering and one of the easiest ways of transmitting information 
about a part or device and the standards to which it is designed is to use a datasheet.  For 
example, the manufacturer SKF (SKF 2010) includes a datasheet with every part that allows 
designers and engineers to specify the exact bearing for the application.  This datasheet includes 
all dimensions and tolerances, loading characteristics, speed ratings and fatigue load data.  With 
this information, an engineer can specify the correct bearing for the design situation without 
having to resort to lab testing.  The importance of defining the minimum information to 
characterize a part was illustrated in a news and views piece by Adam Arkin: 




„If suitably designed, a standard can also lead to the abstraction of a composite 
element‟s behaviour into a few key functions and requirements, thereby greatly 
simplifying the design and analysis of the engineered system. If the abstractions are 
chosen just so, they may form a complete mathematical framework for design, as 
Boolean logic does in electronic engineering‟ (Arkin 2008). 
As with SKF bearings, this quote highlights the importance of minimizing the information to 
what is necessary from an engineering standpoint.  In biology, this minimum information could 
ideally contain data on the load the construct puts on the cell in terms of cellular resource 
utilization, codon utilization, Polymerase Per Second (PoPS) utilization, possible cytotoxicity, 
protein-protein interaction information, etc…  However, there are currently no standards for all 
of these metrics, nor protocols to reliably measure all the listed properties.  Information in 
biology is much more context specific than engineering.  Although data sheets may eventually 
be important in biology, the context of the information  is difficult to represent in a meaningful 
manner.  For example: the organism, growth conditions, growth phase, single nucleotide 
polymorphisms (SNPS) in the gene of interest and many more parameters define the 
performance characteristics of the genetic element, yet in the most simple definition of a part, 
this contextual information is ignored.   
 
In Synthetic Biology, the best example of part characterization is a datasheet that was created by 
Barry Canton for part BBa_F2620 (Canton, Labno et al. 2008).  The cell-cell communication 
device is a composition of 5 BioBrick parts and is described as a PoPS receiver.  A copy of the 
datasheet can be seen in Appendix 1: BBa_F2620 datasheet.  This work shows an example of the 
parameters that need to be measured to fully characterize a BioBrick part and the utility of 
having the parameters recorded in a single location so that the modular device can be used to 
design a larger system.  This datasheet represents the minimal information necessary to describe 
the function of a BioBrick part.   
 
This part characterization took two graduate students approximately 12 person-months to 
complete (B. Canton, personal communication).  The datasheet they produced is the first and 
possibly the only one of its kind.  Resources currently do not exist to perform the same level of 




work on the almost 10,0002 parts in the Registry of Standard Biological Parts.  To do this, a high 
throughput method of part characterization needs to be employed.  But before starting high 
throughput assays, the standards necessary for each part and category of part need to be 
determined by the community.  This is a „chicken or egg‟ scenario, as people will not use parts 
without characterization information, but characterization information will not be available until 
the community decides what information if needs about each part.   
 
Currently, the easiest parts to standardize are those that are self contained, modular and can 
either be screened using a high throughput technique or using a method that is easily 
reproducible across all labs.  Promoters were therefore selected for standardization.   
2.3 Promoter Standardization in Synthetic Biology 
As previously mentioned in this Thesis, promoters have been used as tools in molecular biology 
since the mid 1970s when the advent of restriction enzymes made recombinant DNA work 
possible.  Researchers discovered that changing the regulation of genes could affect their 
function, through over-expression and under-expression.  Many promoters have since been 
discovered and categorized.  However, there is no measure or unit, no meter, kilo or Ohm by 
which promoters can be compared.   
 
The lac operon allows E. coli to metabolize and transport lactose across the cell membrane 
(Monod and Cohn 1952).  It consists of a promoter, an operator, the genes lacZ, lacY, lacA and a 
terminator.  LacY and lacA encode β-galactosidase permease, a membrane bound transport 
protein that pumps lactose into the cell and β-galactosidase transacetylase, an enzyme that 
transfers acetyl-CoA to β-galactosides.  LacZ encodes the β-galactosidase enzyme, a large 464-
kDa tetrameric protein. 
 
β-galactosidase is a hydrolase enzyme that cleaves lactose into glucose and galactose.  The 
synthetic compound o-nitrophenyl-β-D-galactoside (ONPG) is also recognized as a substrate by 
the enzyme.  It is cleaved to yield galactose and o-nitrophenol (HOC6H4NO2), which has a 
yellow color.  When there is an excess of ONPG relative to the enzyme, the production of o-
                                                     
2 Although there are approximately 10,000 parts in the Registry (before the 2010 iGEM competition), 
many do not work and are not part of the annual parts distribution.   




nitrophenol per unit time is proportional to the concentration of β-galactosidase, therefore the 
yellow color can be quantified to determine the level of β-galactosidase activity.  If the lacZ 
promoter is replaced with a different promoter, its activity can be assayed by the level of yellow 
color.  This ONPG/β-galactosidase assay was first described in a book by Jeffrey Miller (Miller 
1972):   
                   
                      
             
 Equation 1 
Where: 
–        is the absorbance of the yellow o-nitrophenol at 420 nm 
–        is the scatter from cell debris, which when multiplied by 1.75 
approximates the scatter observed at 420 nm 
– t = reaction time in minutes 
– v = volume of culture assays in ml 
–        is the optical density of the culture at 600 nm 
 
While this assay puts a numerical value on promoter activity, it is difficult to determine exactly 
what this number means.  Many variables in the experimental setup can have an effect on the 
result of the Miller assay.  Temperature, pH, the growth media, the way the promoters have been 
constructed and several other factors can affect the assay.  Giacomini, Corlich and colleagues 
examined several of these experimental parameters and discovered that from a quantitative point 
of view, the results are markedly affected by variations these conditions (Giacomini, Corich et 
al. 1992).  There will always be degrees of variation in all of the experimental conditions, 
rendering comparison between experiments, let alone labs, problematic.   
 
In an attempt to create a better Miller assay, Eustice and Feldman used the chromogenic 
substrate chlorophenol red-β-D-galactopyranoside (CPRG) instead of ONPG.  Their results 
showed the assay to be more sensitive than the standard Miller, but no effort was made to 
standardize the results to a common protocol (Eustice, Feldman et al. 1991). 
 
In a review of 80 published papers on β-galactosidase assays, Serebriiskii and Golemis found the 
techniques could discriminate low, medium and high affinity interactions (Serebriiskii and 
Golemis 2000).  They discovered at least six different protocols and researchers were reporting 




Miller assays using either ONPG or CPRG.  In many cases, the values reported in Miller units 
were incomparable as they were not compared against a common reference standard.   
 
While Serebriiskii and Golemis reported problems with comparing the results of Miller assays 
conducted in different labs without a common reference standard, they didn‟t go as far as 
proposing one.  The challenge is therefore deciding how to make an assay that will take into 
account or cancel out all factors external to the result of the test.   
2.4 Organelle Engineering 
Engineering new cells, cell free chassis and molecular pathways have been attempted in 
molecular biology for several years.  Much of the focus of organelle creation has been focused 
on the self replicating aspect of the cellular compartments (Walde, Wick et al. 1994).  Some 
groups have been looking at the creation of artificial vesicles, not from the point of view of 
organelle engineering, but as an analogy for primitive cell growth and division (Hanczyc and 
Szostak 2004).  There are also groups looking to recreate the function of the Golgi apparatus in 
vitro using microfluidics, magnetic particles and recombinant enzymes (Martin, Gupta et al. 
2009).  Scientific American called this work the first synthetic organelle in a recent edition (Choi 
2009).  Another group created artificial organelles using polymers that were internalized and 
remained stable in macrophage cells for up to 48 hours (Ben-Haim, Broz et al. 2008).  There 
have also been several recent reviews on artificial cells, reproducing vesicles and protocells 
(Roodbeen and van Hest 2009; Stano and Luisi 2010).   
 
Several iGEM teams have also investigated building organelles.  In 2009, the University of 
Lethbridge iGEM team aimed to create synthetic organelles in cyanobacteria by introducing 
micro-compartments with the purpose of creating a bio-battery (Wieden, Fischer et al. 2009). 
Also in 2009, the University of Toronto set out to design, model and construct a bacterial micro-
organelle based system for metabolic engineering to co-localize selected enzymes (Parkinson, 
Cromar et al. 2009).  By far the most successful organelle engineering project was from the 2007 
the UCSF team.  They set out to make an artificial organelle by expressing a higher eukaryote 
lipid phosphatase MTM in S. cerevisiae.  They were successful in their attempts and produced 
fluorescence images of GFP tagged synthetic organelles in yeast (Chen 2007).   However, none 
of the groups mentioned have looked at using peroxisomes as a base for organelle engineering.   




2.5 Yeast (Saccharomyces cerevisiae) Synthetic Biology  
The most common experimental organism to be used in Synthetic Biology is the gram negative 
bacteria: E. coli.  This bacterium is used to assemble and copy DNA due to its high growth rate 
and ease of transformation.  However, it is a prokaryote and cannot be used to study some 
aspects of biology that require more complex protein formation and folding.  S. cerevisiae, or 
budding yeast, is the most well known and understood eukaryotic model organism and has been 
used in recombinant DNA work for some time.  It is also the most used eukaryote in Synthetic 
Biology and as a consequence, a database of parts is being built up to support work in the area.  
BioBrick constructs are still assembled in E. coli, but yeast parts are made by taking sequences 
from the genome of S. cerevisiae and building them into BioBrick parts through PCR 
amplification.   
 
Yeast was chosen as an experimental organism for this project as it has common ancestral roots 
with humans.  There has been a considerable degree of evolutionary divergence between the two 
organisms, but the two genes that are used in the peroxisome project, PEX3 and PEX19, have the 
same functions in humans and yeast.  Later in the Thesis, the homology of the two protein pairs 
will be examined and compared  
2.6 Peroxisome Engineering in S. cerevisiae  
Before discussing peroxisomes, it is important to define an organelle: a specialized subunit 
within a cell, usually but not always surrounded by its own lipid bilayer.  This membrane 
surrounds proteins specific to the organelle in order to allow specialized functions to proceed 
away from the cytoplasm.  There are generally thought to be two types of organelles: 
autonomous and endomembrane compartment derived.  The first group multiplies by growth and 
division and is inherited in much the same way as the nucleus.  It includes mitochondria, 
Endoplasmic Reticulum (ER) and chloroplasts.  If these organelles are lost, they cannot be 
produced de novo by the cell.  The second group is derived from the ER and cannot reproduce 
autonomously.  This group includes the Golgi apparatus, lysosomes/vacuoles, endosomes and 
plasma membrane.   Peroxisomes are unique in that they exhibit characteristics from both groups 
and have not firmly been categorized as one of the other.   
 




Peroxisomes are small, inducible organelles that can be found in almost all eukaryotic cells.  
They were first described as microbodies when imaged using electron microscopy in mouse 
kidney tissue sections (Rhodin 1954).  They are in a sub-category of organelles classified as 
microbodies which also includes glyoxysomes and glycosomes.  As they have no genome, all 
proteins must be imported across the membrane.  The term „peroxisome‟ was first used in 1966 
after biochemical analysis showed that most hydrogen peroxide in the cells is degraded in 
peroxisomes (De Duve and Baudhuin 1966).  Some of the functions of the organelle have a high 
degree of evolutionary conservation, lending them well to interspecies investigations (Gould, 
Keller et al. 1990; Tabak, Hoepfner et al. 2006).  Figure 1.1 shows an electron micrograph of the 
yeast Yarrowia lipolytica containing peroxisomes.   
 
Figure 2.2: Electron micrograph of 
peroxisomes in Y. Lipolytica. Key: ER, 
endoplasmic reticulum, L, lipid droplet, N, 
nucleus, M, mitochondrion, P, peroxisome 
(Titorenko and Rachubinski 2001) 
2.7 Peroxisome Chemistry and Cellular Function 
Several essential chemical reactions take place in peroxisomes.  As per their name, they contain 
produce, use and regulate hydrogen peroxide through various enzymes and pathways.  Equation 
2 shows the oxidative reaction where various enzymes use molecular oxygen to remove 
hydrogen from specific organic substrates (R), resulting in the production of hydrogen peroxide.  
 




              Equation 2 
 
Catalase uses the hydrogen peroxide generated from other enzymes to oxidize other substrates 
such as phenols, formaldehyde and alcohols.  The peroxidative reaction is given in Equation 3. 
 
      
     
       Equation 3 
 
Hydrogen peroxide is highly reactive oxygen species that is toxic to cells.  It is toxic due to its 
ability to form reactive oxygen species (ROS) and because it is lipid soluble and can cross cell 
membranes.  Hydrogen peroxide based oxidative stress initially results in DNA and 
mitochondrial damage.  When cells are subject to greater oxidative stress they can repair, it can 
eventually lead to ATP depletion and cell death.  For this reason there is a close regulation of the 
concentration of hydrogen peroxide.  Equation 4 shows the reaction where catalase converts 
accumulated hydrogen peroxide to water and oxygen. 
 
              Equation 4 
 
Peroxisomes range in size from 0.1 – 1 µm and depending on cell type, can take on a spherical, 
tubular or cubic shape (Kurbatova, Dutova et al. 2005).  Their size, number and protein content 
will also vary based on the metabolic need of the cell.  Various biological routes of investigation 
have identified 32 proteins, called peroxins, which have been shown to be involved in 
peroxisome biogenesis (Heiland and Erdmann 2005).  Using mass spectrometry, 45 peroxisomal 
membrane proteins have been identified in S. cerevisiae, suggesting that there may still be other 
PMPs with an unknown function (Schafer, Nau et al. 2001).  When grown in the yeast media 
YEPD (Yeast Extract, Peptone and Dextrose/glucose) and its variants, peroxisomes are not 
essential organelles in S. cerevisiae hence they are well suited to genetic manipulation.   
 
Peroxisomes are responsible for several important biochemical functions.  They use hydrogen 
peroxide to carry out oxidative reactions, destroying any excess with the enzyme catalase.  They 
also have a role in synthesizing specialized phospholipids in humans as well as degrading excess 
amino acids. They are discrete but contain no DNA or ribosomes.  All proteins involved in their 




biogenesis and maturation are imported from the cytosol (Alberts, Johnson et al. 2002).  
Peroxisomes also contribute to the β and alpha oxidation of fatty acids and the oxidation of bile 
acids and cholesterol (Hogenboom, Romeijn et al. 2002; Kovacs, Olivier et al. 2002; Kovacs and 
Krisans 2003; Wanders 2004).  For a review on human peroxisome chemistry and disorders, see 
(Wanders and Waterham 2006).  In humans, a lack of functional peroxisomes leads to disorders 
such as Zellweger syndrome, neonatal adrenoleukodystrophy, pipercolic acidemia and Refsums 
disease (Ghaedi, Honsho et al. 2000; Muntau, Mayerhofer et al. 2000; Weller, Gould et al. 
2003).   
2.8 Peroxisome Biogenesis 
Since their discovery, the mechanism behind the creation of peroxisomes has been controversial.  
During cell growth, peroxisomes double in number and are segregated between the mother and 
daughter cells in a process termed „peroxisome replication‟.  During normal cell growth, 
peroxisomes are scattered throughout the cells but when division begins, they migrate towards 
the bud in a Myo2 dependent manner.  Peroxisomes are segregated from mother and bud along 
the actin cytoskeleton using the class V myosins (Myo2 and Myo4) in preparation for cell 
division (Hoepfner, van den Berg et al. 2001).  Myo2 attaches to the peroxisome through its 
interaction with the protein Inp2 and carries them to the bud along actin tracks (Fagarasanu, 
Mast et al. 2010).  In order to diffuse these organelles back into the mother cell from the bud, 
Myo2 is not immediately released after reaching its destination and only a few peroxisomes in 
the cell are transferred to the bud during division.   Later, peroxisomes are transferred from 
Myo2 to other devices that anchor the organelles in the bud region (Fagarasanu, Fagarasanu et 
al. 2006).  Peroxisome replication is separate to peroxisome proliferation, which is an increase in 
peroxisome number in response to environmental or intracellular conditions (Fagarasanu, 
Fagarasanu et al. 2007).  Peroxisome multiplication or biogenesis describes any increase in the 
number of peroxisomes in a cell.   
 
The view of the community on peroxisome biogenesis has switched many times between two 
competing theories.  Each side can produce evidence to support their model.  The first supports 
peroxisomes being autonomous organelles that multiply by growth and division (Kim, Mullen et 
al. 2006; Motley and Hettema 2007).  The second states that peroxisomes bud de novo from the 
ER (Geuze, Murk et al. 2003; Kunau 2005; Tabak, Hoepfner et al. 2006).   





Initially, the ER was not thought to play a role in the formation of peroxisomal proteins and 
peroxisomes were observed to form by division in yeast (Lazarow and Fujiki 1985).  The 
opinion then shifted so that every membrane must originate from a pre-existing membrane 
(Borst 1989).  The changing viewpoint often came when new techniques become available.  
During the 1990s, the debate continued with the addition of peroxisome deficient strains of S. 
cerevisiae that were made by deleting the pex genes, but it was not resolved with papers 
continuing to support both models.   
 
In S. cerevisiae, the best data set for the de novo synthesis model appears in the paper: 
„Contribution of the endoplasmic reticulum to peroxisome function‟ (Hoepfner, Schildknegt et 
al. 2005).  Hoepfner and colleagues used real time fluorescence microscopy to track the two key 
peroxins involved in peroxisome biogenesis, Pex3p and Pex19p, from the ER until they formed 
fully functional peroxisomes.  They followed the intercellular route of newly made YFP-tagged 
Pex3p and Pex19p using real time fluorescence microscopy in pex3Δ and pex19Δ S. cerevisiae 
strains.  Pex3p was first observed concentrated in foci in the ER.  These Pex3p focal points bud 
off in a Pex19p dependent manner before developing into fully functional peroxisomes.  Pex19p 
was first enriched at the Pex3p foci on the ER and then further enriched on maturing 
peroxisomes.  When looking at the deletion strains, without Pex19p, Pex3p was stuck in the ER 
and no vesicles were formed.  Without Pex3p, Pex19p failed to localize to the ER membrane and 
no peroxisomal precompartment was formed.   
 
Hoepfner and colleagues highlighted the key role performed by these two peroxins.  In 
summary, Pex3p and Pex19p were shown to be essential to the import of PMPs.  Pex3p was first 
observed on the ER where it recruits Pex19p in foci.  The Pex3p-Pex19p membrane complex 
would then allow for the import of other PMPs (Kunau 2005).  Once the membrane complexes 
were functional, they would enable the import of the matrix proteins (such as catalayse) to 
produce functional peroxisomes.   
 
In mammalian cells, the community has still not reached a consensus as to the exact mechanism 
of peroxisome biogenesis.  The prevailing view of the community has been that of growth and 




division of existing peroxisomes (Lazarow and Fujiki 1985; Purdue and Lazarow 2001).  This 
model categorizes peroxisomes as autonomous organelles that are not reproduced from scratch.  
While Pex3p and Pex19 are essential for peroxisome multiplication in yeast, Pex16p is also 
essential in mammalian cells (Kim, Mullen et al. 2006).  S. cerevisiae lacks a copy of Pex16p 
and although the yeast Yarrowia Lipolytica has a 24% amino acid identity with human Pex16p, 
function is not conserved across the two species (South and Gould 1999).  As the work in this 
Thesis will be conducted in S. cerevisiae, Pex16p will not be considered.   
 
Even today, the question of peroxisome biogenesis has not been finally resolved as S. cerevisiae 
can produce new peroxisomes by both de novo synthesis and by peroxisome growth and division 
(Hettema and Motley 2009).   
2.9 Peroxisome Membrane Import 
As peroxisomes contain no DNA or ribosomes, all proteins must be imported across the 
membrane to form a functional organelle.  Most proteins are synthesized on free ribosomes and 
imported post-translationally (Lazarow and Fujiki 1985).  The matrix protein import is 
dependent on two peroxisome targeting signals, PTS1 and PTS2 and their cytosolic receptors, 
Pex5p and Pex7p respectively (Mukai, Ghaedi et al. 2002; Miyata and Fujiki 2005).  These 
peroxisome targeting signals (PTS) correspond with the two classes of PMPs.   Class I PMPs are 
targeted by from the cytoplasm directly to the peroxisomal membrane by the chaperone protein 
Pex19p at the C-terminus (Fang, Morrell et al. 2004).  The class I peroxisomal membrane import 
process is shown in Figure 2.3.  Class II PMPs are sorted to peroxisomes via the ER in a non-
Pex19p dependent manner (Fang, Morrell et al. 2004; Jones, Morrell et al. 2004).  The class II 
peroxisome import pathway has been hypothesized to use Pex16 as the anchoring site 
(Matsuzaki and Fujiki 2008).  There are about 20 other PMPs involved in making the import 
complex functional.   
 





Figure 2.3: Peroxisome membrane biogenesis showing Pex19p 
dependent shuttling of class I PMPs to Pex3p dock.  PMPs include Pex16p 
but exclude Pex3p in mammalian cells (Fujiki, Matsuzono et al. 2006) 
 
Most PMPs are directed to the peroxisome by the PTS1 import tag which consists of 3 amino 
acids, SER-LYS-LEU, and its shuttling receptor, Pex5p.  The hypothesis of shuttling receptors 
suggests that the import receptors Pex5p (and Pex7p) bind their cargo in the cytosol, dock to the 
peroxisome membrane, enter the peroxisome, release their cargo and subsequently exit the 
peroxisome (Marzioch, Erdmann et al. 1994).  A RFP-PTS1 fusion protein will be used as a 
positive control to test for presence of peroxisome functionality in this Thesis.   
2.10 Pex3p and Pex19p in S. cerevisiae 
Pex3p (initially called PAS3) was found and recognized to be essential to peroxisome formation 
by Hohfeld and co-workers (Hohfeld, Veenhuis et al. 1991).  This discovery was made by 
isolation of PEX3 mutants and the cloning of the PEX3 gene by functional complementation.   
 
As with most of the results in the peroxisome community, there are two camps with regard to the 
function of Pex3p.  The first suggests that the docking domain of Pex19p binds to Pex3p (Fang, 
Morrell et al. 2004; Hoepfner, Schildknegt et al. 2005).  The second supports Pex3p being 
targeted to the peroxisome independent of Pex19p (Heiland and Erdmann 2005; Fujiki, 
Matsuzono et al. 2006).  This Thesis is based on the work of Fang, Morrell and co-workers and 
Hoepfner, Schildknegt and colleagues with the assumption that Pex19p has a docking domain 




for Pex3p.  They also state that Pex19p mediates the transport of cytosolic Pex3p to 
peroxisomal/ER bound Pex3p via Pex19p.   
 
Pex19p was also discovered to be essential to peroxisome formation along with its human analog 
(Gotte, Girzalsky et al. 1998).  Gotte and colleagues tested the human analog (gene product 
HK33) and although an initial variant of the protein didn‟t rescue peroxisomes in yeast, a 
chimeric version was successful in rescuing peroxisome function, suggesting the possibility of 
human-yeast peroxisome interaction.   
 
Pex19p interacts with all class I PMPs through a consensus motif that is found at least once in 
each membrane peroxin (Sacksteder, Jones et al. 2000; Rottensteiner, Kramer et al. 2004).  
Pex19p has two key domains that are of interest in this project.  It has a docking domain for 
Pex3p in the 56 amino acids proceeding the NH2-terminal.  It also has a binding domain for class 
I PMPs from amino acids 57 – 299 (Fang, Morrell et al. 2004).  It functions as a targeting 
sequence receptor for peroxisomal membrane proteins.   
 
Peroxisome formation from a pre-peroxisome compartment requires Pex19p in S. cerevisiae 
(Hoepfner, Schildknegt et al. 2005).  Without Pex19p, Pex3p can not leave the ER (Tam, 
Fagarasanu et al. 2005).  However, the nature of this Pex19p mediated Pex3p release is currently 
unknown.   
2.11 Pex3p and Pex19p in Mammalian Cells 
In mammalian cells, the interactions of Pex3p and Pex19p are slightly different to yeast.  
Mammalian cells have an extra essential peroxisomal protein, Pex16p, whose function and 
mechanism of action do not appear to be completely known.  The difference between yeast and 
humans may lie in the existence of a specialized ER subdomain that is not present in yeast cells 
(Geuze, Murk et al. 2003).  The lack of this subdomain may have an effect on the formation of 
human peroxisomes in yeast.   
 
Pex3p is anchored in the peroxisome membrane within a 33 amino acid N-terminal sequence.  
This region is sufficient to target Pex3p to the peroxisomes (Soukupova, Sprenger et al. 1999).  
Interactions with Pex19p are mediated by the cytosolic protein binding domain (Fujiki, 




Matsuzono et al. 2006).  Pex3p is imported into the peroxisome in a Pex19p independent 
manner, making it separate to the class I PSTI import system.  This finding is supported by the 
observation that in mammalian cells, a transient inhibition of Pex19p has no effect on the import 
of Pex3p into pre-existing peroxisomes (Jones, Morrell et al. 2004).   
 
Pex19p is a protein that shows a broad binding specificity for peroxisomal membrane proteins 
and is hydrophilic in nature (Gotte, Girzalsky et al. 1998; Sacksteder, Jones et al. 2000).  Pex19p 
is mostly found in the cytosol, yet a small but significant proportion is also to be found on the 
peroxisomal membrane (Matsuzono, Kinoshita et al. 1999).  Pex19p contains a farnesylation 
consensus motif at the C-terminus that provides structural integrity to the protein, but principally 
serves to target the protein to the peroxisome (Banerjee, Kessler et al. 2005).  Pex19p is 
currently thought to have several functions.   
 
Fransen and colleagues investigated the interactions of Pex3p and Pex19p in mammalian cells in 
a paper entitled: „Analysis of Human Pex19p‟s Domain Structure by Pentapeptide Scanning 
Mutagenesis‟ (Fransen, Vastiau et al. 2005).  In summary, they used transposon mutagenesis to 
build a library of human Pex19 alleles that coded for random in-frame pentapeptide insertions.  
Their work revealed the presence of a tripartite domain structure in Pex19p with an amino 
terminal domain that binds to Pex3p, essential for docking to the peroxisome membrane.  
Pex19p was also shown to contain a central domain that competes with Pex5p and Pex13p for 
Pex14p binding and a carboxy-terminal domain that interacts with multiple PMPs.  They were 
unable to determine if the protein functioned as a chaperone or not.  Finally, they discovered that 
Pex19p contains two distinct binding sites for Pex3p, indicating that it may bind PMPs in several 
places for several purposes.   
2.12 Human Pex3p and Pex19p Protein Structures 
Human Pex3p and Pex19p have only recently had their structures resolved by X-ray diffraction.  
Figure 2.4 A shows the resolved structure of the protein complex where the group have reported 
that PEX3 adopts a novel fold best described as „a large helical bundle‟ (Schmidt, Treiber et al. 
2010).  Figure 2.4 B shows the structure of the folded C-terminal part of the receptor reveals a 
globular domain that displays a bundle of three anti-parallel long helices (Schueller, Holton et al. 




2010).  With the resolution of these structures now complete, the possibly of re-engineering the 




Figure 2.4: A) Pex3p in complex with Pex19p, B) Pex19p.  The structure of Pex3p in 
complex with Pex19p was resolved using X-ray diffraction (Schmidt, Treiber et al. 
2010). Pex19p was also resolved using X-ray diffraction (Schueller, Holton et al. 
2010) 
 
2.13 Peroxisome Engineering Summary 
This section has summarized the function of peroxisomes and highlighted the difference between 
yeast and mammalian peroxisome function.  Peroxisome morphology and chemistry has been 
discussed.  The targeting of peroxisomes with the class I PMP system has been described.  The 
essential peroxisome biogenesis proteins in humans and yeast, Pex3p and Pex19p, have been 
described.   
 
Human Pex19p has previously been shown to bind to yeast Pex3p (Fransen, Wylin et al. 2001; 
Fransen, Brees et al. 2002).  A chimeric yeast Pex19p has been shown to work with human 
Pex3p (HK33) (Gotte, Girzalsky et al. 1998).  However, the focus of the community has been on 




the investigation of the function of Pex3p and Pex19p in multiple organisms, sometimes using 
mutant versions of the proteins.  Interactions of wild-type recombinant human Pex3p with wild-
type Pex19p have been reported using pull-down assays and surface plasmon resonance analysis.  
Wild type and two recombinant mutants of Pex3p showed KD values of 3.4 nm, 1080 nm and 
66.2 nm respectively (Sato, Shibata et al. 2008).  Information of the kinetic binding affinities for 
S. cerevisiae Pex3p and Pex19p has not been reported in the literature.   
 
The interest in the project lies in the binding domains for Pex3p on Pex19p and vice versa.  With 
the interspecies binding specificities for Pex3p and Pex19p being lower than the species specific 
binding affinities, there is a possibility of observing bimodality in the biogenesis of peroxisomes.  
So far in the literature, putting both proteins from yeast and mammalian cells in the same 
organism with the aim of observing the resulting organelle formation has not been attempted.  
This Thesis fits into the peroxisome community by building on accumulated knowledge of the 
peroxins Pex3p and Pex19p.  This project has combined fluorophore tagged versions of yeast 
and human Pex3p and untagged yeast and human Pex19p proteins in an attempt to build 
artificial peroxisomes.   
 
Finally, Bimodality and bistability are interesting in this context as engineering dual 
functionality can produce interesting effects and emergent behaviors.  The first example of 
engineered bistability is Gardner‟s toggle switch in E. coli (Gardner, Cantor et al. 2000).  The 
introduction of two modes of operation for their switch allows for the introduction of elementary 
DNA processing in the cell, without the difficulty of having to engineer protein-protein 
interactions.  This type of switch can then be used to build networks with more complex 
functions (Ellis, Wang et al. 2009).  In the context of this project, bimodality would allow for the 
creation of two populations of peroxisomes.  If these populations could be selectively targeted, 
novel biochemistry could be created and targeted while maintaining endogenous peroxisomes.  
Each population of peroxisomes could allow for different chemical environments to be created, 
depending on the desired reactions.  Bimodality is therefore important in biology as a tool to 
engineer novel functions and interactions. 




2.14 Yeast and Peroxisomes Image Analysis Techniques  
Image analysis and automated image analysis is necessary in this Thesis to identify yeast cells 
and the peroxisomes they contain.  Scripts will be written to automate the process where possible 
in an attempt to remove the human element from quantitative processing.  Previous work has 
examined the development of image processing techniques for yeast cell morphology (Ohtani, 
Saka et al. 2004).  They developed a script that detects the cells from the background using an 
edge detection and thresholding system.  Ohtani and colleagues focused on measuring 
parameters associated with yeast morphology to categorize cells into cells cycle phases.  Beyond 
yeast morphology, systems have been designed to automatically identify subcellular features and 
organelles based on pattern recognition from fluorescence images of mammalian cells (Murphy, 
Boland et al. 2000).    
 
Image analysis has been applied to peroxisomes in the past.  Techniques have been described for 
the quantitative evaluation of peroxisome morphology in rat livers, using a combination of 
automated image analysis and immunocytochemistry (Beier and Fahimi 1987; Beier 1992; Beier 
and Fahimi 1992).  This system is designed to work principally with tissue samples when 
investigating changes to the peroxisome enzyme proteins.  Automated scripts have also been 
described to determine the number of peroxisomes per cell in S. cerevisiae using a composition 
of out-of-focus brightfield images and single channel fluorescence images of GFP peroxisomes.  
A script was written to identify peroxisomes from a fluorescent image and select them within a 
region from a brightfield image (Niemisto, Selinummi et al. 2006).  This technique was 
interesting as it used an algorithm to separate the mother from the bud during processing, but 
their identification of the peroxisomes was poor in general.  Incorrect thresholding and a lack of 
sufficient filtering led to non-peroxisome areas in the GFP images being falsely tagged as 
peroxisomes.   
2.15 Aims and Objectives 
This Chapter has examined the basic concepts of the field of Synthetic Biology, from an 
engineering point of view.  The background literature for promoter measurement in E. coli and 
organelle engineering in S. cerevisiae has been covered.  This Thesis will aim to investigate the 




development of two foundational technologies in Synthetic Biology: standardized promoter 
measurement and the creation of an artificial organelle. 
This aim will be accomplished through the following objectives: 
 Measure E. coli promoters and compare results to those of other labs using an in vivo 
reference standard; 
 Measure a collection of S. cerevisiae promoters by applying techniques from the E. coli 
promoter measurement work; 
 Develop and build a set yeast strains capable of expressing human and yeast 
peroxisomes; 
 Image these yeast strains; 
 Validate the nature of the peroxisome population through numerical analysis; 
 Determine if artificial peroxisomes have been created. 
 
 




3 Materials and Methods 
 
 
3.1 Growth Conditions and Media 
Luria-Bertani (LB) (Sambrook, Fritsch et al. 1989) was prepared using 10 g of bacto-tryptone, 5 
g of yeast extract and 10 g of NaCL in a total volume of 1 l of double distilled water.    YEPD 
medium contained 2% dextrose (Fluka, ≥99% molecular biology grade), 1 % yeast extract 
(Fisher Scientific, Molecular genetics grade) and 2% bacto-peptone (Oxoid, molecular biology 
grade).  YPDA medium contained 2% dextrose, 1% yeast extract, 2% bacto-peptone and 0.1% 
adenine (Sigma, minimum 99%). SD medium contained 2% dextrose, 0.67% yeast nitrogen base 
without amino acids (Fluka) and 0.2 % synthetic complete amino acid powder, without YNB 
(US biological).  YNO medium contained 0.1% oleic acid (VWR, extra pure grade), 0.5% 
Tween 40, 0.1% yeast extract and 0.67% yeast nitrogen base without amino acids.  YPGO 
medium contained 0.1% oleic acid, 0.5% Tween 40, 3% glycerol (Fischer Scientific, analytical 
reagent grade) 1% yeast extract and 2% yeast nitrogen base without amino acids.  STYO 
medium contained 0.1% Tergitol NP-40 () 0.005% yeast extract, 0.67% yeast nitrogen base 
without amino acids, 0.2% synthetic complete amino acid powder without YNB and 0.1% 
adenine.  S-KAc medium contained 0.67% yeast nitrogen base, 0.2 % synthetic complete amino 
acid powder, without YNB, 0.2% potassium acetate (Fischer Scientific, analytical reagent 
grade).   
 
E. coli strains were grown from – 80 oC stocks onto solid media agarose LB plates.  For 
experiments, strains were transferred from solid media to liquid LB cultures and grown at 37 oC 
for 12 – 1 hours at 200 rpm.  Unless otherwise stated, S. cerevisiae strains were grown from – 80 
oC stocks for 16 hours at 200 rpm and 30 oC.  Antibiotics were prepared, filter sterilized, stored 
at – 20 oC and used at predefined concentrations (Table 3.1) unless otherwise stated.  Yeast and 
bacterial stocks were stored long term at – 80 oC in 30% v/v glycerol solution (yeast) and 20 % 
v/v glycerol solution (bacteria).   
 





3.2 Antibiotics used in this study 
Antibiotic Final concentration (µg ml
-1
) Solvent 
E. coli S. cerevisiae 
Ampicillin 50 - Water 
Kanamycin 50 - Water 
Genetecin - 200 Water 
Phleomycin - 25 Water 
Table 3.1: Antibiotics and working concentrations used in the study 
 
Antibiotics were prepared, filter sterilized and stored at – 20 oC. All antibiotics were purchased 
from Sigma.   
3.3 Molecular techniques 
3.3.1 Plasmid purification 
5 ml overnight stationary phase E. coli cultures grown in LB medium were harvested by 
centrifugation using a microfuge (Beckman and Coulter) at 13 000 x g for 5 minutes.  The 
plasmids were isolated using a QIAprep Spin Miniprep Kit (Qiagen) and the above microfuge.  
Plasmid DNA was eluted using 30 µl of the elution buffer (EB) contained in the kit.  Once 
eluted, the sample DNA concentration was measured using a UV visualization Nanodrop 
(Thermo Scientific).  Samples were then adjusted to a concentration of 100 ng/µl using EB.  The 
plasmid DNA was stored at -20 oC.   
3.3.2  Transformation of DNA into Bacterial Cells 
Plasmid DNA was transformed into Top 10 or DH5α cells (both Invitrogen) using the enclosed 
protocols.  DNA was incubated with cells on ice for 10 minutes and then heat shocked at 42 oC 
for 30 seconds then placed back on ice for 5 minutes.  The cells were then incubated with SOC 
media (2% w/v tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgSO4 and 20 mM glucose) at 37 oC for 1 hour with shaking before being plated onto LB plates 
with the appropriate antibiotic selection.   




3.3.3 Restriction Digests 
Restriction digests were performed during BioBrick part assembly when two parts and during 
colony PCR to check for insertion success.  The EcoRI, XbaI, Spe1, PstI, BsteII and NotI 
Fastdigest enzymes were used (Fermentas).  Reactions were performed according the 
manufacturer‟s specifications using 1 µl of each restriction enzyme (1 unit), 1 µl of 10x 
Fastdigest buffer (Fermentas), up to 1 µg of plasmid DNA and the reaction volume was 
completed to 20 µl using ddH2O.  The reactions were incubated at 37 
oC for 5 minutes, run on an 
agarose gel to verify fragment size and purified to remove remaining enzymes.   
3.3.4 Agarose Gel Electrophoresis 
Purified DNA was analyzed using 0.8 – 1.2 % (w/v) agarose gels and ethidium bromide (0.5 µg 
ml-1) in 1 x TAE buffer (per litre at 50 x concentration: 242 g tris base, 57.1 ml glacial acetic 
acid, 100 ml 0.5 M EDTA adjusted to 1 l using ddH2O).  Eight parts DNA were typically added 
to one part loading buffer (30% v/v glycerol, 0.25% w/v bromophenol blue and 0.25% w/v 
xylene cyanol) prior to loading the gel.  A 1 kb or 2 log DNA ladder (both New England 
Biolabs) were used according to the manufacturers specifications to size DNA products.  Gels 
were run at V until sufficient migration had occurred, determined by the position of the leading 
dye front.  Gels were visualized using a UV transilluminator and Chemidoc gel documentation 
system (Bio-Rad).  When required, DNA was excised from gels and purified using a QIAquick 
Gel Extraction Kit (Qiagen) and purified using a microfuge according to the manufacturer‟s 
instructions.   
3.3.5 Lithium Acetate Transformation (LiOAc) of S. cerevisiae Cells 
Cells were transformed using a variant of the Ito and colleagues LiOAc protocol (Ito, Fukuda et 
al. 1983). Cells were grown in 10 ml YEPD cultures overnight to a density of 1-2 x107 cells/ml.  
They were harvested by centrifugation at 4000 x g for 4 minutes.   Cells were washed in 10 ml 
of ddH20 and harvested at 4000 x g for 5 minutes.  After resuspension in 1 ml of ddH20, the cells 
were harvested in a microfuge at 13000 x g for 10 seconds.  The cells were washed with 1 ml of 
LiOAc/TE (100 mM Tris-HCl, 10 mM EDTA, 0.1 M LiOAc), harvested by centrifugation at 
13000 x g for 10 seconds and ressuspended in 50 µl of LiOAc/TE.  Salmon sperm DNA (10 
mg/ml) was prepared by boiling for 4 minutes at 100 oC.  2 μl of Salmon sperm was added to 4 
μl of the requisite plasmid at a concentration of 250 ng/ μl and 300 μl of 50% w/v PEG 3350 




g/mol (Sigma, molecular biology grade) in LiOAc.  The mixture was vortexed for 60 seconds 
and incubated at 30 oC on a roller shaker for 30 minutes.  After incubation, 35 μl of DMSO 
(Sigma, molecular biology grade, 99.9%) was added and the tubes were vortexed for 60 seconds.  
After a 15 minute heat shock at 42 oC, the cells were harvested by centrifugation at 2000 x g for 
5 minutes and the supernatant removed using a vacuum aspirator.  The cells were resuspended in 
100 μl of ddH2O and plated on selective plates and incubated overnight at 30 
oC.    
3.4 LoxP Flippase Removal Protocol  
Phleomycin is a glycopeptide antibiotic from the bleomycin family.  To remove a gene using the 
LoxP protocol, page-purified primers with 40 nt base-pair regions of overlap with the region of 
were designed and ordered (Invitrogen).  Knockout cassettes were constructed using PCR 
amplification of the selected EUROSCARF vector (pUG66 – ampicillin resistance in E. coli, 
phleomycin resistance in yeast) with the Pex3 and Pex19 knockout primers shown in Table 3.2.  
Cells were transformed with the PCR knockout cassette using the previously described LiOAc 
transformation protocol onto auxotrophic selective medium plates.  A single colony was selected 
and grown in 5 ml of liquid YEPD medium to mid-log phase (1-2 x 107 cells/ml).  The cells 
were transformed with the flippase plasmid, pPS-3098, using the previously described LiOAc 
protocol and grown on phleomycin selective medium plates for 48 hours.  A single colony was 
selected and inoculated into 1 ml of YEP-GAL, incubated a 30 oC for 2 hours and added to 9 ml 
of YEDP and incubated overnight.  10 µl of this culture was plated onto YEPD plates and 
incubated overnight at 30 oC.  From this plate, 20 colonies were selected and incubated on 
YEDP plates overnight at 30 oC.  Using the same velvet, the YEDP plates were replica plated 
onto the original auxotrophic selective medium.  Colonies that grow on the YEDP but not the 
auxotrophic plates have had the gene in question successfully deleted and have lost the 
phleomycin resistance cassette.  This protocol can be repeated several times to produce a strain 
with multiple knockouts without using selectable markers.   




3.5 Pex3 and Pex19 knockout primers 









Table 3.2: Pex3 and Pex19 Knockout primer sequences. The capital sequence shows the 40 nt 
region of homology with the chromosome integration site.  The lower case bold sequences 
represent a 25 nt homology with the EUROSCARF cassettes to allow for PCR construction of 
knockout cassettes.   
3.6 BioBrick Standard Assembly 
BioBrick parts were received on a plasmid in backbone vectors pSB1A2, pSB1A3 or pSB3K3.  
When BioBrick parts were assembled, the insert was cut from the backbone by performing a 
restriction digest as explained previously using either restriction enzyme pairs EcoRI and SpeI or 
XbaI and PstI (Fermentas).  The vector was cut using the complement restriction enzyme pairs 
EcoRI and XbaI or SpeI and PstI (Fermentas).  The insert reaction was comprised of 17.0 µl of 
plasmid vector DNA (500 ng/ µl or 8.5 µg), 2.0 µl of 10 x FastDigest buffer (Fermentas) and 0.5 
µl (0.5 units) of both restriction enzymes (Fermentas).  The vector digest reaction contained 14.5 
µl of ddH20, 20 µl of vector (500 ng/ µl or 10 µg of DNA), 4.0 µl of 10 x FastDigest buffer, 0.5 
µl of calf intestinal alkaline phosphatase (NEB) and 0.5 µl (0.5 units) of both restriction 
enzymes (Fermentas).   
 
Once digested, the vector was purified using a QIAprep Spin Miniprep Kit (Qiagen).  The DNA 
concentration was measured using a Nanodrop (Thermo-Scientific) and normalized to 100 ng/µl.  
The insert was run on a gel and after the correct sized fragment excised, purified using a 
QIAquick Gel Extraction Kit (Qiagen) and again measured using the Nanodrop.  The excision 
and purification can lower the concentration of DNA to below 20 ng/µl so it is important to start 
with a high concentration.  After the insert and vector were restriction digested and purified, they 




were ligated together using a Rapid DNA Ligation Kit (Roche).  Once transformed and selected, 
the E. coli strains were stored long term in 20% w/v glycerol at -80 oC.   
3.7 GFP Paraformaldehyde Fixation 
Cells were cultured according to previously described protocols and media.  Paraformaldehyde 
fixation was performed by centrifuging cells at 13,000 x g for 30 seconds and removing the 
supernatant using a vacuum aspirator.  100 µl of diluent paraformaldehyde mix (10% v/v 37% 
paraformaldehyde (Sigma, molecular biology grade), 0.143 M NaCl (Fisher, analytical reagent 
grade), adjust to pH 7.5 using KOH), 1.43 M EDTA (Sigma, molecular biology grade 99+%), 
71.41 mM HEPES (Fischer, 99+%)) was added and the cells were vortexed for 30 seconds.  
Cultures were incubated at room temp for 2-5 minutes followed by centrifugation at 13,000 x g 
for 30 seconds and removal of the supernatant using a vacuum aspirator.  Cells were washed 
once in 0.5 – 1 ml of KPO4/sorbitol (21.8% w/v sorbitol (Fisher, 98+%), 1.4% w/v K2HPO4 
(Fisher, 99%), .23% w/v KH2PO4 (Fisher, 99%)).  This cell sorbitol mix was resuspend in 30-50 
µl of KPO4/sorbitol and stored for up to four weeks.  Prior to microscopy, the cells were 
resuspended by vortexing for 30 seconds.   Paraformaldehyde fixation can reduce fluorescence 
signal, but in the case of peroxisomes in live yeast cells, fixation resulted in a greater signal as 
the peroxisomes could be immobilized in the cells and longer acquisitions used without loss of 
resolution.   
3.8 Mounting Media Protocol for All Strains 
Strains grown in oleate and surfactant based media were suspended for microscopy in mounting 
media of same composition without amino acids, glycerol or yeast extract.  YNO mounting 
medium contained 0.1% oleic acid, and 0.5% Tween 40.  YPGO mounting medium contained 
0.1% oleic acid and 0.5% Tween 40.  STYO mounting medium contained 0.1% Tergitol NP-40 
and 0.1% oleic acid.  For strains that had been grown in sugar based media, the KPO4/sorbitol 
from 3.7 was used to mount cells.   
  




4 Measuring Promoter Activity Using an In vivo Reference 
Standard in E. coli and S. cerevisiae 
 
 
The foundations of modern engineering, since the industrial revolution, have been built on 
standardization, decoupling and abstraction.  Systems biology has evolved further with 
standardized programming languages for models such as CellML and SBML, but implementing 
standards in silico will generally remain easier than in vivo.  The first widespread standard in 
Synthetic Biology is for the functional compositional of DNA parts: BioBricksTM.  These parts 
are available to order in a catalog from the Registry of Standard Biological Parts at MIT.  
However, this standard only relates to DNA part assembly.  There are few standards yet in 
Synthetic Biology relating to the quantification of DNA function.    
4.1 Contributions to this Chapter 
This Chapter discusses the creation of a standard measure for promoter activity in E. coli.  It is 
based on the author‟s contribution to the paper: Measuring the activity of BioBrick promoters 
using an in vivo reference standard (Kelly, Rubin et al. 2009).  Jason R Kelly built the E. coli 
strains, established the theory behind the relative measurement system.  The other authors on the 
paper (Adam J Rubin, Joseph H Davis, Caroline M Ajo-Franklin, John Cumbers, Michael J 
Czar, Aaron L Glieberman, Dileep D Monie and Drew Endy) participated in the multi-institution 
experiments.  In the yeast promoter measurements section, Jake Wintermute constructed the 
promoter constructs and transformed them into the yeast strains.  The author had assistance with 
the flow cytometry experiments from Bruno Afonso.  All data analysis in the yeast promoter 
experiments was conducted by the author.   
4.2 E. coli Promoter Measurement Introduction  
Promoter expression levels have been previously measured in E. coli and experiments to 
describe the strength of these promoters have been created (Chapter 2.3).  One problem with 
using Miller units is that there no precise way of measuring promoter activity with repeatable 
accuracy; different days, under different conditions or between labs (Giacomini, Corich et al. 




1992).  There is a great degree of variation in methodologies and reagents used to measure 
promoter expression in Miller units and the technique is sensitive to these variations.  This 
section describes a method to measure the activity of BioBrick promoters using an in vivo 
reference standard.   
 
As previously stated, there are many promoters in the Registry of Standard Biological Parts and 
the number grows every year.  Some of these promoters have been characterized but no single 
characterization protocol has been followed to allow their performance to be compared.  A 
reference standard was created called the Relative Promoter Unit (RPU) and a basic 
measurement protocol to make measurements under standardized conditions was suggested. 
4.3 Measurement Kit Background 
A major concern with measuring any biological variable is the effects of the environment on that 
variable.  The effect of environmental parameters such as growth rates, agitation, temperature, 
humidity and oxygenation levels need to be considered when concerning fluorophores.  
Maturation rates of green fluorescent protein molecules are affected by all of the previously 
listed factors, so controlling or normalizing is necessary to ensure consistent fluorescence.    
4.3.1 Assumptions  
One way to address the environmental variables is to test the promoter activity using a relative 
standard for each measurement.  Most of the environmental variables can be eliminated as the 
samples will be grown under the same conditions using the same equipment.  One area where 
the samples may differ is if a 96 well plate is used and sealed using a plastic film that does not 
allow oxygen into the well.  This may result in a difference in oxygenation levels across the 
wells in the plate, so a breathable membrane was chosen.  Alternately, experiments could be 
conducted using a small volume of mineral oil in each well on top of the growth media and cells 
to reduce evaporation in the wells and allow oxygenation of the samples.   
 
Along with the environmental variables, promoter elements need to be standardized to make 
validating assumptions.  The reference promoter (BBa_J23101) was originally derived from a 
promoter collection constructed by the 2006 Berkeley iGEM team.  They constructed a family of 
constitutive promoters by isolated sequences from a small combinatorial library.  They then 




measured the promoter activity using relative RFP fluorescence measurements.  The reference 
promoter was assembled to GFP and the measured promoter expressed in the same background 
strain on the same plasmid (in different wells) so that the GFP maturation rate can be assumed to 
be constant.  Both promoters are also on the same backbone plasmid so the plasmid copy 
number is also constant.  Both promoters have been standardized to have the same transcription 
initiation sites and identical downstream sequences so the rate of mRNA degradation may be 
assumed identical.  A final assumption is that the immature GFP is stable so that protein 
degradation is negligible compared to dilution due to cell growth.  The half-life of GFP has 
previously been reported at approximately 26 hours (Corish and Tyler-Smith 1999).   
 
The above assumptions allow comparisons to be made between promoters based solely on the 
difference between promoter activity levels.  This is the basis for the comparative promoter 
measurement experiments in E. coli.  A further numerical explanation can found with derived 
equations in Appendix 4.  In any biological system, a degree of noise will affect behavior of 
individuals and the population as a whole.  Noise can be broken down into two main categories 
intrinsic and extrinsic.  Intrinsic noise creates a difference between two reporters in the same cell 
and extrinsic is where two reporters are affected equally in the same cell, but differences are 
observed from cell to cell in a population (Swain, Elowitz et al. 2002).  In the case of this 
system, sources of noise exist, but the results reported by Kelly are none the less comparable 
between experiments conducted on different days and even using different media conditions 
(changes in carbon sources).     
4.3.2 Strains and Promoters 
In order to use a relative measurement, several elements in the testing protocol were 
standardized.  Invitrogen TOP10 was selected as the E. coli strain for the project as it is easy to 
work with, freely available and in common usage among iGEM teams.  A selection of 
constitutive promoters from the Registry of Standard Biological parts was chosen.   





Strain Construct name Promoter 
TOP10 - - 
TOP10 BBa_I20259 BBa_J23113 
TOP10 BBa_I20269 BBa_J23150 
TOP10 BBa_I20270 BBa_J23151 
TOP10 BBa_I20268 BBa_J23102 
TOP10 BBa_I20260 BBa_J23101 
Table 4.1: Promoters and constructs used in the multi-
institution experiments.  Note BBa_J23101 is the 
reference promoter. 
 
All promoters came from the J. Chris Anderson promoter collection that was developed by the 
2007 UCSF iGEM team.  The collection is from a family of constitutive parts that were isolated 
from a combinatorial library.  Five promoters and the TOP10 control were chosen from this 
collection for the experiment:  BBa_ J23113, BBa_J23150, BBa_J23151, BBa_J23102 and 
BBa_J23101 (the reference promoter).  They were chosen to represent a good cross-section of 
expression levels and they had already performed some basic characterization to assess activity 
levels.  The experimental strains and a TOP10 control as shown in Table 4.1 were distributed by 
Jason Kelly to the institutions taking measurements in an agar stab.  The backbone plasmid for 
the strain collection is shown in Figure 4.1.  





Figure 4.1: Plasmid map showing backbone used in 
collection construction (Anderson 2006). 
 
4.3.3 BD LSR-II Flow Cytometry 
Measurements were taken for the multi-institution experiments using flow cytometry.  A BD 
LSR-II with a 488 nm laser was used for the experiments in the case of this Chapter.  No attempt 
was made to standardize flow cytometry equipment across institutions.  Seven parameters were 
recorded: forward scatter height, area, side scatter height, area, GFP height, area and time.  
Forward and side scatter were used to calibrate the detector voltages.  These voltages were 
adjusted to the correct particle size, which in this case is E. coli.  The particle size is a function 
of the detector voltage, so adjustments to the voltage are made by measuring the minimum 
number of detection events, (10 000) and calibrating the voltage relative to the forward vs. side 
scatter plots.  The GFP area data were used for promoter analysis.   





Figure 4.2: Example gating used during flow cytometry analysis of E. 
coli promoter collection.  This gating was created based on the 
TOP10 background strain, the BBa_I20260 reference promoter 
 
Three colonies for each promoter had been grown and prepared as described in the methods 
section earlier in this Chapter.  They were used to calculate the level of promoter activity based 
on the relative difference between the TOP10 base strain and the BBa_I20260 reference 
promoter.  A gating was applied to the samples based on the forward and side scatter channels 
and the negative control. An example of this gating can be seen in Figure 4.2.  Finally, the mean 
of fluorescence intensity per cell was calculated for each culture. 
4.3.4 Flow Cytometry Data Analysis 
The author participated in the development of the multi-institution measurement protocol and 
acquired data for publication, but was not involved in the analysis.  This section will briefly 
describe the analysis for completeness.  Three colonies were grown and measured in the flow 
cytometer for each promoter.  The average GFP area measurement was calculated using the flow 
cytometry software and this value input into an Excel spreadsheet.  The mean and standard 
deviation were calculated for each promoter using the average from each well.   




4.4    Multi-Institution Measurement Results 
The reference promoter was measured using a variety of carbon sources in the media, on 
different days and using a plate reader and a flow cytometer.  The only data shown here will be 
the multi-institution results.   
 
Figure 4.3: Multi-institution flow cytometer results where the error bars represent the 95% CI 
of three replicates. Note: the authors’ results are displayed under “Harvard” 
 
The institutions involved in the survey were: Johns Hopkins University (JHU), Massachusetts 
Institute of Technology (MIT), Virginia Institute of Technology (Vtech), UC Berkeley, 
Lawrence Berkeley National Laboratory (LBL) and Harvard.  Six strains containing five 
promoters and the TOP10 control were measured.  The error bars are larger than expected due to 
the use of only three replicates.   BBa_23113 is shown as zero because the promoter is not strong 
enough to be differentiated from the control.  This represents one of the limits of the technique, 
promoters can only be measured if they can detected by flow cytometry when GFP is being 
expressed.  The reference promoter is used to normalize the samples (to 1 RPU) so it is also not 
shown.  There is less than a two-fold range across the other three promoters measured by the 
labs (BBa_J23150: 0.14 – 0.23; BBa_J23150: 0.38 – 0.606; BBa_J23103: 0.77 – 0.96) (Kelly, 








































4.5    E. coli Promoter Measurement Kit 
After the reference standard was created, it needed to be publicized and distributed to the 
community.  History is littered with examples of multiple standards being introduced 
simultaneously, from the creation of wide gauge railways in the 19th Century through to the 
competing formats of Blue-ray and HD-DVDs.  In order to create a standard that would be 
accepted and maintained, it was decided to follow the example of the standard Ohm resistor that 
was introduced in the 1850‟s to solve the problem of finding breaks in the transatlantic telegraph 
cable.  The Ohm kit contained a one Ohm resistor made of solid brass and all the necessary 
instructions on how to use the kit.  This kit was so successful in introducing a standard to a wide 
audience, that it was deemed the best model to follow for a promoter measurement kit.  This kit 
was created containing all the instructions and the physical DNA spotted onto chromatography 
paper to allow users to measure their own promoters relative to the reference standard.  The 
reference kit was distributed to all the teams in time for the 2008 iGEM competition.  A 
description of the standard reference kit can be found on pages 191 and 196.  Feedback was 
obtained on the kit from the Harvard team.  They transformed the test constructs from the 
measurement kit into DH5α E. coli cells and obtained similar values to the test promoter activity 
levels when measured using a fluorescence plate reader.   
4.6 Measuring the Activity of Promoters in S. cerevisiae  
In the previous sections, a technique was devised to measure the strength of promoters in E. coli.  
When this work was completed, it was sought to apply these techniques to other situations.  The 
technique was adapted to a collection of yeast promoter strains and the results were collected 
using a similar measurement protocol.  The GFP collection was made by constructing an 
insertion cassette containing a GFP fusion and a selectable marker (Huh, Falvo et al. 2003).  The 
GFP was fused to the gene by using the PCR constructed homologous recombination cassette.  
The promoter strength can be approximately measured by the level of the fluorescence, but this 
is also a measure of the fused protein.  This approximation was the reason why a collection of 
strains was constructed to more accurately test the strength of various S. cerevisiae promoters.   
4.7 Introduction to Promoter Measurement in S. cerevisiae  
After developing a technique to measure promoter activity in E. coli, investigations were 
conducted to apply similar techniques to a collection of yeast strains constructed to measure the 




promoter expression levels.  This strain collection is constructed in a different way to the E. coli 
project as each strain contains two fluorophores, RFP and YFP.  The aim was to compare the 
expression level of a constitutive ADH1 driving RFP to the promoter of interest driving YFP.   
 
The experiments in this section represent a preliminary investigation into the possibility of 
measuring yeast promoter expression levels with the aim of creating a reference standard.   Data 
is presented to illustrate the technique and the strains but; further experimentation is necessary 
before a protocol giving complete characterization of the promoter is achieved.   
4.7.1 S. cerevisiae Promoter Strain Construction 
The background strain for this project is 580a or FY23 and is known as B1 in the context of this 
project.  It has the following genotype: URA3Δ52, TRP1Δ63, LEU2Δ1, GAL+.  Each strain has 
an ADH1 promoter with a human Kozak sequence expressing a fusion of two mCherry RFP 
proteins.  Each strain (other than the RFP control) also contained a fusion of two mVenus 
fluorescent proteins expressed by a combination of either human or yeast Kozak sequence and 
the promoter of interest.   
4.8 Yeast Promoter Collection Methods  
The growth protocols were copied as closely as possible to the E. coli experiments, so that the 
same assumptions could be made when showing the relative promoter strengths.  Changes were 
made so the technique could be performed using the high throughput sampler on the flow 
cytometer.  Supplemental protocols can be found in the appendices on page 167. 
4.8.1 96 well format work 
The strain collection was assembled in triplicate in three 96 well plates.  Deep well plates were 
inoculated with 500 µl of YEPD media and shaken at 1000 rpm at 30 0C overnight in an 
Appropriate Technical Resources (ATR) Multitron 2, with a 3 mm orbit.  When the cultures 
were grown to saturation, 500 µl of 50% w/v glycerol was added to each well and after shaking, 
the plates were frozen at – 80 oC for long term storage.  Three plates were used in case any 
single well or plate became contaminated or in case nine replicates were needed.  A V&P 
Scientific Inc. 384/96 well floating head pin tool was used to inoculate the plates.  The tool was 




configured for 96 well operation.  An automated machine technologies (AMT) MicroPlate plate 
filling machine was used to correctly dose 96 well plates with the required media volumes.   
4.8.2 Flow Cytometry (FACS) 
A BD Biosciences LSR-II with a High Throughput Sampler module (HTS) was used to acquire 
the FACS data.  Two Lasers were used: 
1. 633 nm JDS Uniphase HeNe laser (Red).  
2. 488 nm solid-state laser (Green).   
The forward and side scatter channels were used to calibrate the settings on the flow cytometer 
using cells from the 580a control wells.  The detector voltage was calibrated using the ADH1 
promoter for RFP and the THD3 promoter for YFP.  The number of detection events on the flow 
cytometer was set to 10 000 and once all the settings were correctly adjusted, the automated high 
throughput sampler measured all wells in sequence.   
4.8.3 Media conditions 
The promoter collection experiment was initially grown in YPDA for the overnight step in the 
protocol.  For the re-inoculation step the following day, the growth medium was changed to 
either synthetic dextrose or synthetic potassium acetate medium.  The media were made using 
synthetic amino acid compositions, yeast nitrogen base and either glucose or potassium acetate 
as the carbon source.  Synthetic media were chosen to minimize background signal and avoid 
unintended autofluorescence on the YFP channel that can be introduced with standard yeast 
media (YEDP/YPDA).  The media compositions can be found in Chapter 3, page 37.   
4.9 Strain details 
The promoter collection was designed to test a variety of promoters and Kozak sequences, which 
define the translation initiation codon in eukaryotes.  Each strain contains the control ADH1 
promoter, human Kozak sequence and a fusion protein consisting of two mCherry RFPs.  The 
ADH1 promoter is known to be constitutive in S. cerevisiae during growth on glucose, although 
not when glucose in the media becomes depleted (Denis, Ferguson et al. 1983).  It controls 
expression of the alcohol dehydrogenase 1 enzyme in yeast.  Acetaldehyde is reduced to ethanol 
by ADH1 to regenerate NAD+ allowing continuation of the glycolytic cycle.  The collection was 




split into two major groups with each promoter driving constructs that had either the human or 
yeast Kozak.  Within these two groups, there are a variety of promoters.   
 
Strain 
name Promoter Kozak Fluorophore Strain name Promoter Kozak Fluorophore 
B1 - - - B2 - - - 
Y1 pADH1 hsKozak 2xRFP.m         
Y2 pADH1 hsKozak 2xYFP.v Y18 pADH1 scKozak 2xYFP.v 
Y4 pGAL1 hsKozak 2xYFP.v Y20 pTDH3 scKozak 2xYFP.v 
Y5 pTDH3 hsKozak 2xYFP.v Y21 pTEF1 scKozak 2xYFP.v 
Y6 pTEF1 hsKozak 2xYFP.v Y22 pPGK1 scKozak 2xYFP.v 
Y7 pPGK1 hsKozak 2xYFP.v Y23 pMDH3 scKozak 2xYFP.v 
Y8 pMDH3 hsKozak 2xYFP.v Y24 pPEX3 scKozak 2xYFP.v 
Y10 pPEX8 hsKozak 2xYFP.v Y25 pPEX8 scKozak 2xYFP.v 
Y11 pPEX11 hsKozak 2xYFP.v Y26 pPEX11 scKozak 2xYFP.v 
Y12 pPEX19 hsKozak 2xYFP.v Y27 pPEX19 scKozak 2xYFP.v 
Y13 pPEX25 hsKozak 2xYFP.v Y28 pPEX25 scKozak 2xYFP.v 
Y14 pHIS3 hsKozak 2xYFP.v Y29 pHIS3 scKozak 2xYFP.v 
Y15 pCTA1 hsKozak 2xYFP.v Y30 pCTA1 scKozak 2xYFP.v 
Y16 pCUP1 hsKozak 2xYFP.v Y31 pCUP1 scKozak 2xYFP.v 
Table 4.2: Promoter strain collection details.  This table shows the YFP promoters.  All strains 
except the controls B1 and B2 contain pADH1-RFP. Note the left side of the table contains 
strains with the human Kozak sequence and the right, the yeast Kozak sequence. 
 
Table 4.2 shows a graphical representation of the strain collection.  The pGAL1 strain is only 
present with the human Kozak sequence and the pPEX3, with the yeast Kozak sequence.  As 
much of the work in the rest of this Thesis involves peroxisomes, there are four peroxisomal 
promoters: PEX8, PEX11, PEX19 and PEX25.  The remaining promoters were chosen as they 
had previously been assembled into BioBrick form.   
4.10 Yeast Promoter Collection Analysis 
Once data were acquired using the flow cytometer, the first stage in the analysis was to setup the 
correct gating.  Software from the manufacturer of the flow cytometer called BD FACS-Diva 
was used to analyze the FCS 3.0 files.  The P3 region in Figure 4.4 shows an example of the 
gating used to select the correct population of yeast cells.  This gating was selected based on the 
forward and side scatter data encompassing 95% of the cells for three representative strains from 
the collection: ADH1-RFP control, pTDH3 and pGAL1.  Once the gating had been setup, the 




RFP and YFP mean and standard deviation was generated in an automated manner for each test 
well on the 96-well plate.  These data will be used in the analysis to show the difference between 
promoter expression levels.   
 
Figure 4.4: Example gating showing data from the control pADH1-RFP 
strain.  This gating was created to capture most cells in three strains: 
the pADH1-RFP control, pTDH3 and pGAL1 
4.11 Characterization of the transcriptional activity of the yeast 
promoters in the ADH1-RFP collection 
The results of this experiment are presented in two sections.  The first describes the ADH1 
promoter – 2x RFP for each strain on a media to media basis and the second, the SD results for 
the promoter – 2xYFP strains.  All constructs were integrated into the yeast chromosome.  All 
RFP constructs were integrated into the TRP1 loci while the YFP constructs were integrated into 
the LEU1 loci using the Sikorski vectors (Sikorski and Hieter 1989).  The ADH1 – 2X RFP 
experiment was repeated several times with SD media to fine tune the protocols and equipment 
(data not shown). When the procedure was performed and verified, it was conducted using the 
previously described media.  




4.11.1 ADH1 Promoter - RFP Control Results 
As previously described, all strains have a constitutive ADH1 promoter expressing a double RFP 
fusion protein.  This section describes the RFP strain to strain variation and assesses using the 
RFP to normalize the collection.  All strains in this section have the same construct: AHD1 
promoter - 2x RFP.  The promoter names refer to the promoter driving the YFP protein, but in 
this section are only used to differentiate the strains.  Figure 4.5 and Figure 4.6 show two groups 
of promoters, roughly dividing the plot in half.  The first half contain YFP strains with the yeast 
Kozak sequence and the second half, the human Kozak sequence.  Finally, the last three columns 
represent the ADH1 promoter - 2x RFP with no YFP construct, the background strain and the 
media with no yeast cells.  A scaling factor was set based on the SD medium average to allow 
comparisons with the S-YNB samples.  The units of the Y-axis are shown in this relative scale.  
The YFP promoter results were also been adjusted using the same scaling factor.   The strain 
collection was grown in two media conditions to assess the effect of changing the medium 
conditions on the promoter expression levels.  S-KAc data were normalized to the SD average.  
Error bars in the plots show the range. 
4.11.2 Constitutive ADH1 Promoter – 2x RFP Average in SD Media 
 
Figure 4.5: S. cerevisiae ADH1 promoter strain collection expressing RFP (mCherry).  The 
strains were grown in YEDP overnight and induced in SD medium for 6 hours.  The collection 
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cytometry machine.  The error bars show the range of three replicates for each strain and 
dashed line, the average of the collection.   
 
Figure 4.5 shows the strain collection grown in SD medium.  There is little deviation from the 
population average and only a small range between the three replicates.   The first promoter, the 
yeast ADH1 is clearly different to the rest of the population.  This was likely due to a double 
integration of the construct or a form of fluorescent contamination.  This promoter was excluded 
for the numerical analysis.     
 
Media:  SD 
Min 2200.33 
Max 3081.67 
Range (Min – Max) 881.33 
Average 2570.83 
Residuals squared: 2.21E+06 
Error – residuals squared: 2.81E+05 
Error + residuals squared: 3.69E+05 
Scaling factor 1.00 
Table 4.3: SD medium numerical parameter 
summary table.   
 
Table 4.3 shows the numerical properties of the promoter collection in SD.  The range for the 
SD collection was smallest of all media conditions due to the ADH1 promoter being tightly 
regulated by glucose.  The residuals squared were calculated from the square of the difference of 
the strain from the collection average.  The error – is the square of the difference between the 
lowest replicate and the average.  Error + is the same for the highest replicate.  The scaling factor 
for SD is 1.00 as it is used as the datum to compare data with the potassium acetate medium.   




4.11.3 Constitutive ADH1 Promoter – 2x RFP Average in S-KAc Media 
 
Figure 4.6: S. cerevisiae ADH1 promoter strain collection expressing RFP (mCherry).  The 
strains were grown in YEDP overnight and induced in S-KAc medium for 6 hours.  The 
collection was grown suspended in TE buffer and placed on ice until measured by the BD LSR-
II flow cytometry machine.  The error bars show the range of three replicates for each strain 
and dashed line, the average of the collection.   
 
Figure 4.6 shows the AHD1 promoter – double RFP fusion protein average in S-KAc media.  
There is a clear difference between the transcriptional behavior shown by the average of the 
relative units in this plot when compared to SD medium in Figure 4.5.  The strains exhibits a 
much greater range between replicates when grown in potassium acetate medium.  The error 
indicates that the carbon source does not have a consistent regulatory effect on the ADH1 
promoter in each replicate.  ADH1 is induced by glucose, but mRNA levels have been shown to 
decrease when grown on a non-fermentable carbon source (Denis, Ferguson et al. 1983).  This 
repression is not very tight when compared to induction on glucose, as demonstrated by the large 
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Media:  SKAC 
Min 553.92 
Max 8986.01 
Range (Min – Max) 8432.09 
Average 2570.83 
Residuals squared: 1.46E+08 
Error – residuals squared: 1.88E+08 
Error + residuals squared: 3.09E+08 
Scaling factor 1.13 
Table 4.4: S-KAc medium numerical 
parameter  summary table. 
 
Table 4.4 shows numerical data for yeast strains grown in S-KAc medium expressing RFP under 
control of the ADH1 promoter.  In this case, the minimum, maximum and range are very 
different to those seen with SD medium.  The residuals are also two orders of magnitude higher.   
4.11.4 Constitutive ADH1 Promoter Analysis 
Figure 4.5 to Figure 4.6 shows the normalized constitutively expressed ADH1-RFP in the 
promoter collection.  Table 4.5 shows a summary of the numerical parameters that we calculated 
based on ADH1-RFP expression data in different media conditions.  The minimum and 
maximum represent the weakest and strongest RFP signal of all strains and the range is the 
difference between the two.  The residuals were calculated by squaring the difference between 
the RFP value and the RFP population average. The +/- residuals were calculated by squaring 
the error.   





Media:  SD S-KAC 
Min 2200.33 553.92 
Max 3081.67 8986.01 
Range (Min – Max) 881.33 8432.09 
Average 2570.83 2570.83 
Residuals squared: 2.21E+06 1.46E+08 
Error – residuals squared: 2.81E+05 1.88E+08 
Error + residuals squared: 3.69E+05 3.09E+08 
Scaling factor 1.00 1.13 
Table 4.5: pADH1-RFP summary table. 
 
Strains grown in SD medium have residual values that are two orders of magnitude lower than 
S-KAc.  This section presented results acquired by measuring promoter collection in two media 
conditions.  When grown in glucose, the ADH1 promoter is tightly regulated.  In potassium 
acetate media, this regulation is almost non-existent.  The aim of this experiment was to use the 
ADH1 promoter as a reference to normalize the other promoters.  The data in Table 4.5 show 
that assumption can be applied in the case of SD media, but not with potassium acetate media.  
Based on the above analysis of ADH1, the definition of „constitutive‟ should be updated to 
encompass media conditions.  Observations were made that indicate the difference between 
ADH1 regulation on glucose media and on potassium acetate media.  Although there is a clear 
indication that the ADH1 promoter behaves differently when grown on a fermentative carbon 
source compared to a non-fermentative carbon source, stochasticity is likely to play a role in the 
regulation of this promoter.   
4.12 YFP Promoter collection results  
While RFP data was collected for the ADH1 promoter, the YFP channel was used to acquire 
data on the different promoters in the collection.  YFP data from the promoter collection activity 
is shown for SD medium.   




4.12.1 Promoter, Human and Yeast Kozak Sequence Comparison in SD Medium 
 
Figure 4.7: Human and yeast Kozak sequence comparison in SD media.  Promoters ordered 
from human weakest to strongest.  S. cerevisiae promoter strain collection expressing YFP 
(mVenus).  The strains were grown in YEDP overnight and induced in SD medium for 6 
hours.  The collection was grown suspended in TE buffer and placed on ice until measured 
by the BD LSR-II flow cytometry machine.  The error bars show the range of three 
replicates for each strain and dashed line, the average of the collection.   
 
Figure 4.7 shows the results of the promoter collection in SD ordered by the relative strength of 
the yeast Kozak sequence.  The promoters show approximately the same expression levels with 
each Kozak sequence with the exception of the HIS3 promoter. As explained previously, error 
bars display the range of the three replicates while the solid bars represent the average.  The 
TEF1 and TDH3 promoters are among the strongest, but show a great variability in the 
replicates.  The PGK1 promoter is the strongest with a small variation in the replicates.  The 
other promoters are not induced at a very high level relative to the three highest.  
4.13 Promoter Measurement Discussion 
A method to measure the promoter activity in E. coli across multiple labs using a standardized 
























was chosen as the constitutive E. coli reference promoter.  Results from the multi institution 
experiments were shown, indicating that using a relative standard and measurement protocol can 
produce close results across labs with non-standard equipment.  A measurement kit was 
developed and distributed to the iGEM teams during the 2008 competition and discussions with 
teams who used the kit reported that it worked well.   
 
The aims of the yeast promoter experiments were to assess the promoter activity of a strain 
collection in different media compositions by applying knowledge gained from the E. coli 
measurement experiments and to investigate a yeast reference promoter.  This work provided an 
indication that the ADH1 promoter could be used as a reference promoter.  However, several 
other promoters such as the HXT1, HXT2, HIS3 and potentially PGK1 should also be 
investigated.  The protocol used to test these promoters should specify glucose as the carbon 
source in the media as the experiments using multiple media conditions were ultimately not 
successful.  Further work is required to be conducted to measure the promoter collection strains 
with single constructs.  The YFP measurements were ultimately not reported in conditions other 
than SD.  Using the Kelly method with only the YFP fluorophores could result in a more robust, 
reliable comparative measure for yeast promoters if a yeast measurement kit in the form of 
BioBrick parts could be implemented and distributed with the iGEM part collection.    
 




5 Peroxisome Engineering in S. cerevisiae  
 
 
Two terms will be defined and referenced throughout this Thesis.  “Image-set” refers to a series 
of images taken under identical conditions for the purpose of data analysis and the generation of 
color composite images.  “Data-set” refers to the quantified information produced from the 
“image-set” after image processing.  Two imaging setups were used with different imaging 
characteristics.  The initial work was conducted on a Nikon microscope at Harvard and will be 
referred to as the Nikon microscope/setup/system.  The second setup was a DeltaVision 
microscope at the Centre Optical Instrumentation Laboratory (COIL) facility and will be referred 
to as the DeltaVision microscope/setup/system.  These microscopy setups are described in 
greater detail later in the Thesis.   
5.1 Contributions to this Chapter 
The individual BioBrick parts involved in this project were all constructed by Jake Wintermute 
and Caroline Ajo-Franklin.  Simple part combinations, such as RBS-promoter and gene-
terminator assemblies were also constructed by Jake Wintermute.  The author assembled all 
BioBrick constructs from simple part combinations into yeast transformation-ready vectors.  The 
author performed all yeast transformations into YPH500α while Keiji Nishida transformed all 
constructs into BY4741a.  All microscopy in the Chapter was performed by the author.   
5.2 Peroxisome Project Background 
Peroxisome biogenesis and organelle engineering was covered in detail in sections 2.4 to 2.13 in 
Chapter 2.  This section gives a brief recapitulation of the project theory and motivation.  The 
current theory on how peroxisomes are formed is that Pex3p is expressed at a minimum level 
when the cell is growing under normal (YPDA/YEPD glucose carbon source medium) 
conditions and is then transported by Pex19p to the ER.  The Pex19p shuttle protein has a 
domain-recognition sequence for the membrane-bound Pex3p and a transport domain for other 
peroxins (including Pex3p).  Pex3p targets to discrete ER-localized punctae, forming an ER 
subcompartment en route to the peroxisome (Hoepfner, Schildknegt et al. 2005; Tam, 




Fagarasanu et al. 2005).  This feedback system allows for the transport of cytosolic Pex3p to ER 
bound Pex3p, increasing the local concentration of the protein.  One assumption for this project 
is that the human Pex3p can bind to the docking domain of the yeast Pex19p, but with a lower 
binding affinity.  The other assumption is that the human Pex19p also docks to the yeast Pex3p 
with a lower binding affinity.   
 
The combination of these characteristics led to the possibility of a system that could potentially 
demonstrate bimodal behavior.  In this case, bimodal is defined as the creation of two 
populations of peroxisomes, where one is entirely (or mostly) human and the second, yeast.  The 
“human” peroxisomes would not be entirely human as all peroxins other than Pex3p and Pex19p 
would be the yeast variants.  The motivation is hence to create a new organelle that would allow 
the compartmentalization of harmful or useful chemical reactions away from the cytosol while 
maintaining a population of the endogenous organelles.  Figure 5.1 shows a cartoon of the two 
possibilities where in A) yellow shows human peroxisomes, blue yeast and in B) hybrid human 
yeast peroxisomes.   
 
Figure 5.1: A) illustrates the outcome of the principal experiment if bimodality is observed 
while B) represents a homogenous population of peroxisomes.  
5.2.1 Pex3p and Pex19p sequence analysis 
Human Pex3p and Pex19p are known to work with each other and the binding affinities of these 
two proteins have been discussed in Chapter 2.  Yeast Pex3p and Pex19p are also known to 
interact, but binding affinities have yet to be measured and reported in the literature.  The two 
protein pairs (yeast Pex3p with human Pex19p and human Pex19p with yeast Pex19p) are 
known to bind to each other, but the binding affinities have also yet to be measured and reported 
in the literature.  Bimolecular fluorescence complementation (BiFC) could be used as an 




indication of the binding strength (Kerppola 2006).  The Pex3p-Pex19p interaction would be 
well suited to characterization using this method as the human interaction strength could be 
verified and compared with reported values in the literature, before moving on to the yeast-yeast 
and human-yeast interactions.  The sequences used in the project were aligned using AlignX and 
then analyzed for sequence homology.   
 
Sequence analysis of the protein coding regions of human and yeast Pex3p revealed a 40.3% 
identity.  Figure 5.2 shows a plot of the sequence homology mapped using AlignX (Invitrogen 
Vector NTI).  The identity was mapped with a 5 amino acid moving average showing the 
difference in the height of the peaks.  The absolute complexity is the pairwise alignment score 
between the two sequences.  Human and yeast Pex19p were also analyzed and showed a 43.6% 
identity (data not shown).   
 
 
Figure 5.2: Human and yeast Pex3p sequence analysis.  The plot shows a 40.3% identity.  This 
figure was generated by aligning and comparing human and yeast PEX3 nucleotide 
sequences. 
 
At the time of inception of this project, the structures of human Pex3p and Pex19p had not been 
resolved.  They have since been described, as shown in Chapter 2.12, Page 32.  The structures of 
yeast Pex3p and Pex19p have yet to be resolved using X-ray crystallography or other techniques.   
5.2.2 Yeast Strain Selection 
Two background strains were selected for this project.  The first was: YPH500α (MATα ura3-52 
lys2-801_amber ade2-101_ochre trp1-Δ63 his3-Δ200 leu2-Δ1) (Sikorski and Hieter 1989).  The 




second was: BY4741a (MATa, ura3-Δ0, leu2-Δ0, met15-Δ0, his3-Δ1) (Paciello, de Alteriis et al. 
2009).  The Sikorski vector compatibility was necessary as the project was originally designed 
with five constructs in mind.  The corresponding Sikorski chromosomal integration vectors were 
used: URA3 - pRS306, TRP1 - pRS304, LEU2 - pRS305 and HIS3 - pRS303.  ADE2 is involved 
in the adenine synthesis pathway in S. cerevisiae and when the yeast is grown in absence of the 
amino acid, it turns a bright shade of red that is easily detectable by eye (Sharma, Kaur et al. 
2003).   
5.2.3 Project Methodology and Progression 
BioBrick parts were assembled into the Sikorski vectors for transformation into yeast.  In 
compliance with BioBrick assembly techniques, all parts had forbidden restriction sites EcoRI, 
XbaI, SpeI and PstI removed by site-directed mutagenesis.   All plasmid maps were constructed 
using Invitrogen Vector NTI 10.  This software was also used for all other genetic analysis 
including sequence trace analysis and restriction site searches.  A PEX3 and PEX19 double 
knockout was necessary to avoid having any untagged copies of the membrane protein in the 
cell.   
 
Sikorski vectors are yeast integration vectors that function via the homologous recombination 
DNA repair system (Sikorski and Hieter 1989).  They were linearized in order to integrate into 
the genome.  The HIS3, TRP1 and URA3 vectors are BioBrick compatible and can be linearized 
using the standard 4 enzymes (EcoRI, XbaI, SpeI & PstI).  However, the LEU2 vector is not, so 
BstEII site was chosen for linearization.  The constructs were searched for any other occurrences 
of this site and none were found, implying no further site directed mutagenesis was necessary.  
Up to five constructs were planned per strain.  Initially the yeast PEX3 promoter was to be used 
in the project to direct the transcription of human and yeast pex3.  Unfortunately, several 
attempts to clone the PEX3 promoter constructs using E. coli strains DH5α and TOP10 were 
unsuccessful.  Several attempts were made to clone the construct using E. coli strains DH5α and 
TOP10 without success.  This is the only time an E. coli cytotoxic part was observed in the 
duration of the project.  A promoter with similar expression levels under Raffinose/oleic acid 
media was needed so the PEX8 promoter was chosen.   




5.3 BioBrick Part, Construct and Strain Assembly 
Many parts were used to construct the DNA assemblies for this project.  This section shows 
progression from individual parts to completed Sikorski vector constructs.  The general 
assembly structure was as follows:   
 
Part  BioBrick assembly  Sikorski vector assembly  Strain 
 
Individual parts were made by designing PCR primers containing the BioBrick-compatible 
restriction sites and amplifying a region of DNA of interest, as explained in the introduction.  
Individual parts have a single letter and number designator, such as T1 (terminator 1) or P6 
(promoter 6) as shown in Table 5.1.  Once parts were assembled, their designation was changed 
to kZ plus an assembly number.  The kZ designation represented parts composed together and 
selected for cloning into a Sikorski vector.  When the Sikorski vector was correctly assembled, it 
was linearized to allow it to integrate into the genome when transformed.  Completed yeast 
strains were designated KDY followed by a number.  Each subsequent transformation 
incremented the number following the KDY yeast designation.   




5.3.1 BioBrick individual parts  
  
Table 5.1: Individual BioBrick parts used in the project.  Parts with BioBrick names are in the 
registry of standard biological parts, while parts with no BioBrick names were used in the 
project and not submitted. 
 




5.3.2 BioBrick kZ part to assembly summary  
 
Figure 5.3: Schematic of constructs assembled during the cloning phase of the project.   
 
Figure 5.3 shows a schematic of the BioBrick constructs assembled from individual parts shown 
in Table 5.1.  These constructs were designed to be used in the YPH500α and BY4741a 
background strains.  Two strategies needed to be developed for this part of the assembly.  The 
first involved using three constructs, kZ7, kZ10 and kZ11.  This strategy was based around 
having two constructs on the kZ10 and kZ11 assemblies:  Pex3p-fluorophore and Pex19p.  This 
would have limited the number of serial transformations to three for the main experimental 
strain; the RFP-PTS assembly, the CFP and YFP constructs.  However, it was not known if 
having a single terminator would produce plasmid instability (during cloning) or read-through 
problems, so a secondary strategy was also devised.  This strategy called for using kZ3, kZ4, 
kZ5, kZ7 and a version of kZ6 that was planned to be constructed using genetecin selection.  
This strategy would have used all four Sikorski vectors and a geneticin selection for the final 




strain.  A cloning strategy involving 5 sequential transformations was not ideal so the first 
strategy was employed.   
5.3.3 Strain construction in the YPH500α and BY4741a backgrounds 
 
Table 5.2: KDY strain construction details. Strains KDY1 – KDY3 were constructed to test the 
PEX3Δ, PEX19 Δ and PEX3 Δ, PEX19 Δ knockouts.  *The main experimental strain (KDY19) was 
constructed without the LEU2::pHIS3-RFP-PTS1 construct. 
 
Table 5.2 shows the progression of the yeast strains.  Strains KDY1 – KDY3 are the knockout 
strains.  The KDY4 – KDY6 strains were built to find the best promoter to use with the RFP-
PTS1 construct between HIS3, PEX8 and PEX19.  KDY7 was planned as a control to test that 
PEX3 had been successfully knocked out.  KDY8 tests the successful rescue of peroxisome 
import function using human yeast Pex3p can rescue the knockout.  It was also to be used to test 
the performance of CFP as a fluorophore and whether the PEX3 promoter is a strong enough 
promoter to see any activity.  KDY9 has a similar function with the yeast PEX3 rescue and the 
YFP fluorophore.  KDY10 was designed to verify the deletion of PEX19.   
 





Table 5.3: KJY strain construction details. Strains KDY1 – KDY3 were constructed to test the 
PEX3Δ, PEX19 Δ and PEX3 Δ, PEX19 Δ knockouts.   
 
 
Table 5.3 shows the genotypes for the KJY strain collection.  As the BY4741 background was 
capable of importing proteins into the peroxisome using the PTS1 import tag, it was used for the 
majority of experiments discussed later in the chapter.  The KJY10 strain is the main 
experimental strain.  It used the PEX3 and PEX19 double knockout background and possesses 
the RFP-PTS1 import tag, the human Pex3p-CFP and yeast Pex3p-YFP constructs.   
5.3.4 Media Formulation  
Peroxisomes are known to be repressed (although cells maintain a minimum number of the 
organelles) when grown on glucose and induced when grown on fatty acids and raffinose as a 
carbon source.  To this end, several media were researched and developed using glucose, 
raffinose, potassium acetate, glycerol and oleic acid as carbon sources.  SA and YNO did not 
meet with much success due to the high background fluorescence and consequent low signal to 
noise ratio.  YEDP/YPDA and SD often showed high background fluorescence, producing low 
quality images that made automated image analysis difficult.  YPGO and its variants, with the 
exception of STYO/STYO-2, produced better results.   
 




   
A) B) C) 
Figure 5.4: (YPH500α MATα ade2-101_ochre leu2-Δ1 ura3-52 pex3-Δ pex19-Δ TRP1::pPEX3-
scPEX3-CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) A) 
yeast cells imaged using differential interference contrast microscopy (DIC), B) cells imaged 
using the YFP channel (mVenus) C) yeast cells imaged using the CFP channel (Cerulean). This 
figure shows an example of insufficient fluorescence signal.  The strain was grown in SD 
media for 24h then imaged while live. The strain contains human and yeast Pex3-YFP and 
yeast-CFP peroxisomes.   
 
Figure 5.4, shows yeast grown and imaged live in SD media.  Figure 5.4 A shows a DIC image 
of the strain while B and C show the YFP and CFP fluorescence.  The graining effect seen in 
these images indicates a very weak fluorescence signal.  Greater induction of the peroxisomes 
was necessary and would be achieved though changes in the composition of the growth media.  
However, B and C show vacuoles that appear fluorescent from an accumulation of a purine 
intermediary in the adenine biosynthesis pathway in the ADE2 deletion strain, not peroxisomes.   
 
A number of yeast growth media were formulated and tested during the media exploration phase 
of the project.  Often, the results were either a minor incremental change in the quality of the 
images, or no change at all.  All media recipes have been given, but only successful tests will be 
shown in the results section.   
5.3.5 Mounting Cells for Microscopy 
Initially, strains grown in SD/YEPD/YPDA were mounted in double distilled water (ddH20) on 
glass slides for microscopy.  When strains grown in YPGO or SCGO media were mounted using 




ddH20, cell lysis was often observed as illustrated in Figure 5.5 A.  Oleic acid media contains a 





Figure 5.5: (YPH500α wt: MATα ura3-52 lys2-801_amber ade2-101_ochre trp1-Δ63 his3-Δ200 
leu2-Δ1) A) Lysed cells subject to Osmotic shock due to incorrect mounting media. B) Cells 
grown in SCGO and imaged live with correct osmotic pressure osmolarity during live 
imaging. 
 
To prevent lysis, a mounting media was formulated to mimic the osmolarity of the surfactants 
used in the oleate growth media.  The mounting media consisted of the same concentrations of 
oleic acid and surfactant as found in the growth media, without any amino acids or yeast 
nitrogen base.  Cells mounted using this new formulated media can be seen in B Figure 5.5.  
Once created, this media was used in all subsequent live cell imaging for cells grown in oleic 
acid media. Cells that were paraformaldehyde fixed were imaged in a solution of ddH20 
containing 1.2 M sorbitol and 0.2 M potassium phosphate.    
 
There were several problems with imaging live cells.  The peroxisomes do not have a strong 
fluorescence signal when tagged with CFP and require long acquisition times (up to 2 seconds) 
when an electron-multiplying charge coupled device (EMCCD) camera is not employed.  
Imaging a single focal plane for two seconds can result in unclear images as the peroxisomes can 
move in and out-of-focus.  As the peroxisomes are not fixed within the cell, acquiring multiple 
images in a z-stack does not solve the problem.  A solution was to crosslink the cells using a 




paraformaldehyde fixation protocol prior to imaging as described in Chapter 3.  The cells could 
now be fixed and imaged at a later date, instead of a two hour window and the peroxisomes no 
longer travel across the focal plane.  The cells were then mounted in the KPO4/sorbitol mounting 
media.  This process yielded much brighter and clearer images at the expense of killing the cells.   
5.3.6 Initial Fluorescence Imaging Experiments 
The strain construction was separated into two major sections.  The PEX3-PEX19 double 
knockouts were constructed in parallel to the RFP-PTS1 test strains.  Once the RFP-PTS1 
construct was transformed into the PEX3-PEX19 double knockout, the other constructs could be 
inserted and there would always be a positive control that the peroxisomes were functional.  
However, the imaging results influenced the design and first the correct promoter was selected to 
drive the RFP fluorophore at an appropriate expression level.   
 
   
A) B) C) 
Figure 5.6: A) HIS3 promoter RFP (mCherry)(YPH500 MATα ade2-101_ochre trp1-Δ63 his3-
Δ200 ura3-52, LEU2::pHIS3-RFP-RFP-PTS1) B) PEX8 promoter RFP (mCherry)(YPH500 MATα 
ade2-101_ochre trp1-Δ63 his3-Δ200 ura3-52, LEU2::pPEX8-RFP-RFP-PTS1) C) PEX19 promoter 
RFP (mCherry)(YPH500 MATα ade2-101_ochre trp1-Δ63 his3-Δ200 ura3-52, LEU2::pPEX19-
RFP-RFP-PTS1).  The strains were grown in YEPD media for 24h and the microscopy was 
performed while the cells were live. 
 
Figure 5.6 shows micrographs of the strains hosting the HIS3, PEX8 and PEX19 promoter 
constructs expressing RFP.  Figure 5.6 A (HIS3 promoter) shows some highly fluorescent circles 
thought to be vacuolar localization of RFP with some smaller regions that appear to show 
peroxisomal localization.  B (PEX8 promoter) shows only vacuolar localization and (PEX19 




promoter) shows only cytoplasmic localization.  Based on these preliminary images, the decision 
was made to use the HIS3 promoter to express RFP-PTS1.  The images in Figure 5.6 appear to 
show a different localization of the RFP based on the promoter.  The observation was made, but 
not investigated as this stage in the project was purely about strain construction.   
 
 
Figure 5.7: (YPH500 MATα ade2-101_ochre trp1-Δ63 his3-Δ200 ura3-
52 , LEU2::pHIS3-RFP-RFP-PTS1) RFP-PTS1 with cytoplasmic RFP 
(mCherry).  The cells were grown in YPDA medium for 24 hours and 
the cells were imaged live. 
 
Once HIS3 was selected, the construct was imaged again using the YPGO media to fully induce 
the peroxisomes.  Figure 5.7 is from this experiment and shows cytoplasmically located RFP.  
The RFP was characterized as cytoplasmic as there the vacuoles do not appear to have 
fluorescence, nor do any of the other subcellular organelles.  The RFP appears brighter in the 
daughter cells, but the resolution does not allow for identification of subcellular compartments.   
This experiment led to a shift in focus to construction of the double knockout strain and the 
Pex3p-fluorophore expression cassettes.   
5.3.7  PEX3-PEX19 Double Knockout Strain Construction 
In parallel to the RFP-PTS1 promoter selection and the BioBrick part assembly, the double 
knockouts were constructed.  This process involved designing oligonucleotide primers 
containing a 50-75 base pair region of DNA for homologous recombination of a selection 
cassette in the loci of the gene to be removed.  Constructs were assembled by PCR of the 




selection cassette with the homologous recombination primers.  Both PEX3Δ and PEX19Δ single 
knockout strains were made at the same time.  The knockouts were made using the LoxP 
flippase system so that the phleomycin-resistance selectable marker could be subsequently 
removed and re-used; the protocol is given in Chapter 3.4.  Both knockouts were made without 
using two selectable markers, as it was necessary to keep up to five markers available.  This was 
necessary incase assembling Pex3 and Pex19 into the same vector failed.  The PUG72 (URA3) 
& PUG73 (LEU2) EUROSCARF vectors were used initially, but several attempts failed.  The 
PUG66 phleomycin resistance vector was eventually chosen as it had previously been used with 








Figure 5.8: (YPH500 MATα ade2-101_ochre leu2-Δ1 ura3-52 pex3-Δ pex19-Δ 
trp1::ppex3-scpex3-cfp-adh1t-ppex19-scpex19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-
pPEX19-hsPEX19) A) CFP imaging - KDY13 grown in YFGP (Cerulean) B) KDY12 YFP 
peroxisomes and vacuolar localization (mVenus).  The cells were grown in YPDA 
medium for 24 hours, peroxisomes were induced for 24 hours in YPGO medium 
and the cells were imaged live. 
 
Figure 5.8 shows the first images taken with the CFP and YFP yeast Pex3p tagged constructs.  
Figure 5.8 A shows extremely bright, single circles in each cell.  Figure 5.8 B has the same 
circles at a lower intensity but also has smaller dots in each cell.  B shows the first observation of 
peroxisomes.  It was assumed that the same observations couldn‟t be made in A as the circles 
were much brighter than the peroxisomes consequently obscuring them from view.  These 
circles were vacuolar localization from the ADE2 deletion (Weisman, Bacallao et al. 1987).  




Mutations in ADE2 lead to the accumulation of purine precursors in the vacuole, which produces 
the red pigmentation and fluorescence (Zonneveld and van der Zanden 1995).  Fluorescence was 






Figure 5.9: (YPH500 MATα ade2-101_ochre leu2-Δ1 ura3-52 pex3-Δ pex19-Δ 
trp1::ppex3-scpex3-cfp-adh1t-ppex19-scpex19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-
pPEX19-hsPEX19) A) yeast expressing yeast Pex3p-YFP with peroxisomal and 
cytoplasmic localization (mVenus) B) human Pex3p-CFP with cytoplasmic localization 
(Cerulean). The cells were grown in YPDA medium for 24 hours, peroxisomes were 
induced for 24 hours in YPGO medium and the cells were imaged live. 
 
Figure 5.9 shows a yeast strain grown in YEPD for 24 h then transferred into YPGO for a further 
24 h and imaged while live.  Figure 5.9 A shows YFP-human peroxisomes and vacuolar 
localization while Figure 5.9 B shows only vacuolar localization.  The vacuolar problem 
continued to occur, so a solution needed to be found.  However, a new observation could now be 
made.  The vacuolar fluorescence was approximately the same intensity in both images, so it 
was apparent that B did not contain any peroxisomes in the cells.  Two problems now needed 
solutions, the vacuolar fluorescence and the absence of yeast CFP peroxisomes.   
 





Figure 5.10: Pex3p-GFP from the GFP collection using Aequorea 
victoria GFP (Tsien 1998). The cells were grown in YPDA medium 
for 24 hours, peroxisomes were induced for 24 hours in YPGO 
medium and the cells were imaged live. 
 
Figure 5.10 shows a fluorescence control with known GFP tagged peroxisomes. This figure 
shows Pex3p-GFP strain from the GFP collection created by Erin O‟Shea (Huh, Falvo et al. 
2003).  When compared to Figure 5.10, the images in Figure 5.6 appear to all show vacuolar 
localization to some degree.  The Pex3p-GFP construct was used in the GFP collection work as a 
co-stain to identify other peroxins.  In this work, it was used it as a control to show an example 
of clear, discrete, membrane tagged peroxisomes.  In Figure 5.10, an observation can be made 
that there is no vacuolar localization and the peroxisomes can be clearly seen as discrete white 
objects.  The background strain phenotype includes an ADE2 deletion.  This deletion causes an 
interruption of the adenine synthesis pathway producing a pigment that is red in color.  It was 
postulated that this otherwise useful phenotype was interfering with the microscopy. 
 












Figure 5.11: (YPH500 MATα ade2-101_ochre leu2-Δ1 ura3-52 pex3-Δ pex19-Δ trp1::ppex3-
scpex3-cfp-adh1t-ppex19-scpex19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) A) FITC 
(mVenus) B) YFP (mVenus) C) CFP (no fluorophore) D) RFP (no fluorophore).  Images show the 
KDY3-KX9-KX10 strain grown overnight in YEPD, induced for 7 hours in SD media and imaged 
live. 
 
Figure 5.11 shows a strain containing human-YFP and yeast-CFP peroxisomes.  In an attempt to 
visualize any interference, all four fluorescence channels were imaged after the yeast had been 
grown in synthetic dextrose (SD) media.  The SD media lacks certain fluorescent elements found 
in yeast extract, eliminating fluorescence from the media itself.  All images show vacuolar 
localization, but Figure 5.11 A is the only image showing peroxisomes.  This highlighted 
interference from the media lacking adenine and also a lack of CFP-fluorophores despite the 
presence of the KX10 (yeast Pex3p-CFP) construct.  These images illustrate the choice to select 
FITC instead of the YFP channel.  The YFP peroxisomes can clearly be seen in Figure 5.11 A 
(FITC), but not in B (YFP).  An unfortunate and common phenotype is the pigmentation with 
fluorescence in most of the visible spectrum, causing the vacuole to appear as an intensely 
fluorescing object under microscopy (Sharma, Kaur et al. 2003).   
 
Vacuolar fluorescence was noted during most of the previous experiments but the cause was 
assumed to be interference from the YEPD medium.  Yeast extract used in the medium is known 
to have fluorescent elements that can interfere with microscopy.  To reduce this effect, synthetic 
medium was used where possible.  When the cause of this effect was attributed to the ADE2 
deletion in the strain itself, adenine was added to the media in a successful attempt to reduce 
background interference.   




5.3.8 CFP – YFP Strain Re-construction 
When both Pex3p tagging constructs had been transformed into the strain, they were verified by 








Figure 5.12: (YPH500 MATα ade2-101_ochre leu2-Δ1 ura3-52 pex3-Δ pex19-Δ 
trp1::ppex3-scpex3-cfp-adh1t-ppex19-scpex19, HIS1::pPEX3-hsPEX3-YFP-
ADH1t-pPEX19-hsPEX19) A) DIC, B) YFP-human peroxisomes (mVenus) C) CFP 
channel without peroxisomes (no fluorophore).  The strain was grown in SD 
media for 24h then transferred to YGPO for peroxisome induction for 24 
hours.  The cells were imaged live. 
 
Figure 5.12 shows the strain expressing only YFP peroxisomes.  When several digests and 
analytical gels were run on the assemblies in question, one of the constructs was 200 bp smaller 
than expected.  Subsequent analysis showed the kZ3 construct was missing the promoter driving 
expression of Pex3p-CFP, hereby explaining the lack of CFP yeast peroxisomes.  
 
Once the discrepancy had been discovered, the construct was rebuilt and transformed into the 
working YFP strain, creating the new KDY3-KX9-KX10-KX9_URA3 strain.  This long 
designation is explained by the strain having two copies of the KX9 construct.  The original 
malfunctioning KX9 was supplemented with a new working copy using a different Sikorski 
vector.  The strain contained functional copies of CFP-hsPEX3 and YFP-scPEX3, but possessed 
two functional copies of the yeast PEX19.   
 










Figure 5.13: (YPH500 MATα ade2-101_ochre leu2-Δ1 ura3-52 pex3-Δ pex19-Δ TRP1::pPEX3-
scPEX3-CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) A) 
DIC, B) CFP-human peroxisomes (Cerulean) C) YFP-yeast peroxisomes (mVenus).   These 
images represent the first successful CFP peroxisome images.  Strain: KDY3-KX9-KX10-
KX9_URA3.  The cells were grown in SD medium overnight to stationary phase, induced in 
YPGO for 24 h and imaged live. 
 
Figure 5.13 shows the human and yeast peroxisomes in the same strain.  The cells were imaged 
live and show a low but visible peroxisome signal on both the CFP and YFP channels.  Adenine 
was used in the media so the cells show no trace of vacuolar fluorescence.   
5.4 Z-stacks and Automated Image Processing using 3d deconvolution 
DeltaVision uses its own proprietary acquisition software, but a choice of suites was available 
for image analysis.  Initially, MetaMorph was used due to familiarity.  However, poor scripting 
support led to the eventual use of Image Pro for post processing and AutoQuant X for 3d 
deconvolutions.    
5.4.1 Z-stack details 
Once the exposure times and transmitted light percentages were set, the Z-stack depth was set.  
For consistency, this value is was always 10.20 µm.  A Z-step of 0.20 µm was as close as 
possible to the XY camera pixel size of 0.12760 µm.  The voxels (3 dimensional pixels) are 
effectively rectangular in shape when looked at from the 3d perspective, but 0.20 µm is the 
minimum accurate resolution of the microscope stage.  Once all the acquisition parameters were 




verified and re-verified and the experimental settings were saved, the microscope automatically 
imaged the ~50 Z-slices over four wavelengths.  This process was repeated up to ten more times 
without changing any settings other than the XY position on the microscope slide.  Once a 
sufficient number of images were acquired, the process was repeated a last time on a region of 
the slide with no cells to produce the blank.    This image acquisition protocol was repeated with 
all samples and controls.  Experiments were conducted using fewer z-slices, but problems were 
encountered when there weren‟t enough images above and below the regions of interest to 
successfully apply the point spread function (PSF) during deconvolution.  This resulted in the 
entire stack of images being lost for processing purposes.  This technique was developed as once 
the first z-stack was acquired, the imaging protocol was not changed from region to region on 
the slide as a greater number of z-slices would account for any potential variations in thickness.   









Figure 5.14: (YPH500 MATα ade2-101_ochre leu2-Δ1 ura3-52 pex3-Δ pex19-Δ 
TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-
pPEX19-hsPEX19) A) False color CFP-YFP (cerulean & mVenus) overlay, B) False color CFP-
YFP (cerulean & mVenus) overlay 2. The strain shown is KDY3-KX9-KX10-KX9_URA3.  
These false color images were acquired using a strain that was grown to saturation in 
YPDA, induced in YPGO for 24 h and paraformaldehyde fixed.  CFP is colored green and 
the YFP, red to improve contrast. 
 
Figure 5.14 shows false color images of the working CFP (green) and YFP (red) strain.  To 
produce the image, CFP and YFP channels were imaged in a Z-stack and a 3d deconvolution 
was performed.  These deconvolved Z-stacks were compressed into one image and then both 
channels were added together.  Figure 5.14 A shows red peroxisomes in the top left hand corner 
of the image and green ones in the bottom left.  Figure 5.14 B shows more red and green 
peroxisomes with an added cell containing yellow peroxisomes.  This could indicate that the 
cells have entirely CFP, YFP or mixed peroxisomes.  This is a rough observation as a bright-
field image was not taken in this image-set so cell delineation is difficult.  However, both images 
show some degree of bimodality in the peroxisome populations.   




5.5.1 RFP-cell Outline Images 
 
 
Figure 5.15: (BY4741 MATa LEU2::pHIS3-RFP-RFP-PTS1) RFP 
peroxisomes (mCherry) with cell outlines after image 
processing. Cells were grown in YPDA overnight, induced in 
YPGO for 24 hours and imaged fixed. 
 
The bright-field out-of-focus imaging was developed to produce a protocol to delineate cell 
outlines.  Figure 5.15 shows cell separation based on the out-of-focus bright-field image with a 
strain containing RFP-PTS1 peroxisomes.  This cell delineation analysis technique was 
incorporated into the first module in the Image Pro script.   
 




5.5.2 CFP-YFP cell outline 
 
Figure 5.16: (YPH500 MATα ade2-101_ochre leu2-Δ1 pex3-Δ pex19-Δ TRP1::pPEX3-scPEX3-
CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) False color 
composite image of CFP (Cerulean) and YFP (mVenus) peroxisomes with blue cell outlines.  
Cells were grown in YPDA overnight, induced in YPGO for 24 hours and imaged fixed. 
 
The best image produced in the microscopy evolution using the KDY19 (YPH500 MATα ade2-
101_ochre leu2-Δ1 pex3-Δ pex19-Δ TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-scPEX19, 
HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) strain is shown in Figure 5.16.  This 
image is made from three channels: CFP, YFP and out-of-focus bright-field.  As in earlier 
images, the CFP channel is colored green and the YFP channel, red to enhance contrast.  The 




image shows entirely green peroxisomes and entirely red peroxisomes, indicating some degree 
of bimodality.  However, upon closer examination the green peroxisomes appear predominantly 
in the centre of the image while the red ones appear towards the outer edges.   At the very 
extreme edges of the image, no peroxisomes are present in the cells.  To further investigate this 
effect, an intensity plot was made from one diametrically opposite corner to the other where each 
point was assigned a numerical value.  The average of this value appeared to increase in the 
centre and decrease towards the edges on both the CFP and YFP plots.  The microscope is set up 
so that the illumination in the field of view is as consistent as possible to avoid introducing this 
kind of bias.  Various components of the microscope were examined and the xenon illumination 
bulb was determined to be faulty.  The silver coating had partially burning off, likely due to 
insufficient cooling, and produced an uneven illumination and a halo effect on the image.  This 
effect explained the bimodality and unfortunately invalidated the quantitative analysis due to the 
illumination bias.   
5.6 Construction and Development of the Control and Main 
Experimental Strains 
This section describes work with the BY4741a control strains, which were analyzed because 
they contained a functional RFP-PTS1 construct that was used as a positive control for 
peroxisome identification during the algorithmic processing.  Each control strain has genotype 
information, images of that strain and explanation of the images.  The construction of the project 
was structured to show the endogenous peroxisomes functioning correctly in the wild-type 
background strain.  From this starting point, the experimental strains are shown not to have 
functioning peroxisomes when PEX3 and PEX19 were individually knocked out.  These genes 
were removed so that no copies of PEX19 or untagged copies of PEX3 exist in the genome.  
Subsequently, function of PEX3 and PEX19 was rescued with the human or yeast tagged 
equivalent peroxin.   
 
The rescues were demonstrated in the double PEX3 and PEX19 knockout, first with the yeast 
construct and then with the human construct.  The experiments were designed so that both PEX3 
and PEX19 genes are on the same plasmid, to allow for only one transformation per species 
rescue.  In the current constructs, the human Pex3p membrane protein was tagged with a cyan 
fluorescent protein and the yeast Pex3p, a yellow one.  Once these species specific rescues were 




demonstrated, they are combined in the same strain.  In order to prove that this expected bimodal 
effect is more than just an artifact of the imaging, numerical results are demonstrated showing 
CFP/YFP scatter plots and corresponding bimodal histogram in the next Chapter.   
5.6.1 Control Strain Information Layout 
The control strains are separated into two categories: the rescue controls and the CFP/YFP 
controls.  The rescue controls show successful construction of the single and double knockouts 
while the CFP/YFP controls will show the interactions of all three fluorophores.  Note that 
human has been abbreviated to hs and yeast to sc.  
5.6.2 Control Strain Example Microscopy 
Several different images of the same cells are shown in the results section.  Figure 5.17 shows an 
example montage of a strain with three fluorophores.   
 
    
A) B) C) D) 
Figure 5.17: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1, TRP1::pPEX3-
scPEX3-CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-scPEX3-YFP-ADH1t-pPEX19-scPEX19) A) 
RFP (mCherry)  B) CFP (Cerulean) C) YFP (mVenus) D) CFP-YFP overlay (Cerulean and 
mVenus).  These images show the example color system used with composite images. 
 
When showing the cell outlines and a single fluorophore, peroxisomes are shown in their 
fluorescent color (red, yellow or cyan).  When showing the cell outlines and two fluorophores, a 
false color red green image is displayed.  In this case, CFP (470 nm) will be shown in green and 
YFP (535 nm) in red.  Manipulating the colors was necessary to increase the contrast in the 
image to better show the difference between the two channels.   




5.7 Rescue Controls 
The basic outline for this section of the project was to show the strain information and images of 
the controls.  All cells in this section were grown in YEPD for 24 h, then grown in synthetic 
raffinose media for 24 h to induce peroxisomes.  All strains were paraformaldehyde fixed and 
stored at 4 oC until imaged, within a maximum period of 48 hours.  Each image is representative 
of the 4 – 7 that were acquired of the same cells on the slide.  As the image processing for 
quantitative data and the image processing for display requires slightly different protocols, not 
all images were processed for visualization, but all images were processed for data.   
5.7.1 Strain 1: KJY1 – RFP-PTS1 Peroxisome Function Control  
 
This strain is a control for both the RFP-PTS1 import construct and the endogenous 
peroxisomes.  The presence of peroxisomes indicates the strain is functionally capable of 
producing organelles without any modifications.  Observing peroxisomes indicates the RFP-
PTS1 construct is functional.   






Figure 5.18: (wt BY4741 MATa LEU2::pHIS3-RFP-RFP-PTS1) with 
RFP-PTS1 tagged peroxisomes (mCherry). The strain was grown in 
YPDA for 24 hours then washed in ddH2O and transferred to 
synthetic raffinose media to induce peroxisomes.   The cells were 
imaged fixed within 48 hours of fixation. 
 
Figure 5.18 shows how the peroxisomes look with the original PEX3 and PEX19 genes, before 
knocking out the endogenous copies of these genes.  The image shows presence of peroxisomes, 
indicating the strain already has the organelles, the construct is expressed and the RFP-PTS1 tag 
is functioning correctly.  This background strain is therefore able to express peroxisomes and 
import tagged proteins to demonstrate functionality.   
5.7.2 Strain 2: KJY2 – Pex3p Knockout Control 
 
KJY2 is the first of the knockout strains and is missing PEX3.  It has the RFP construct to show 
peroxisome import.  As PEX3 was knocked out, the RFP peroxisomes shown in the previous 
strain are no longer be present.      






Figure 5.19: (BY4741 MATa, pex3-Δ, URA2::pHIS3-RFP-RFP-
PTS1) Absence of peroxisomes with only cytoplasmic 
localization of RFP (mCherry). The strain was grown in YPDA for 
24 hours then washed in ddH2O and transferred to synthetic 
raffinose media to induce peroxisomes.   The cells were imaged 
fixed within 48 hours of fixation. 
 
Figure 5.19 shows only diffuse cytoplasmically localized RFP.  As this strain has the same RFP-
PTS1 construct shown to be functional in KJY1, it is clear PEX3 function has been lost.     
5.7.3 Strain 3: KJY3 – Pex19p Knockout Control 
 
This strain has the other essential peroxin, Pex19p, knocked out.  This strain has the RFP-PTS1 
construct to show peroxisome import function.  As PEX19 was knocked out, the RFP construct 
that would usually localize to the peroxisomes now appears diffused in the cytoplasm.    






Figure 5.20: (BY4741 MATa, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1) Absence 
of peroxisomes and cytoplasmic localization of RFP(mCherry). The strain 
was grown in YPDA for 24 hours then washed in ddH2O and transferred to 
synthetic raffinose media to induce peroxisomes.   The cells were imaged 
fixed within 48 hours of fixation. 
 
Figure 5.20, shows a lack of distinct peroxisomes, as was also seen in Figure 5.19.  From this 
similarity, we can conclude that the cells are unable to make functional peroxisomes when 
lacking PEX19.   
5.7.4 Strain 4: KJY4 – Yeast Pex3p Rescue Control 
 




The KJY4 strain uses the single PEX3 knockout to test the yeast PEX3 rescue function.  Two 
constructs were transformed into this strain.  The first is the RFP-PTS1 to verify peroxisome 
import function.  The second is the yeast PEX3-CFP construct.  As this was a PEX3 rescue 




Figure 5.21: (BY4741 MATa, pex3-Δ, LEU2::pHIS3-RFP-
RFP-PTS1, TRP1::pPEX3-scPEX3-CFP) A) RFP-PTS1 
peroxisomes (mCherry) B) KJY4 showing yeast PEX3-
CFP peroxisomes (Cerulean). The strain was grown in 
YPDA for 24 hours then washed in ddH2O and 
transferred to synthetic raffinose media to induce 
peroxisomes.   The cells were imaged fixed within 48 
hours of fixation. 
 
Figure 5.21 shows the KJY4 rescue strain.  Figure 5.21 A shows RFP peroxisomes, indicating 
that peroxisome import function has been rescued.  Figure 5.21 B shows CFP peroxisomes, with 
a near total overlap with the RFP ones in Figure 5.21 A.  This indicates the construct has rescued 
PEX3 function.  It also indicates that all peroxisomes are tagged with our yeast PEX3-CFP 
construct.   




5.7.5 Strain 5: KJY7 – Yeast Pex19p Rescue Control 
 
The KJY7 strain uses the single PEX19 knockout to test the yeast PEX19 rescue.  The yeast 
PEX19 construct rescues peroxisome function.  The RFP-PTS1 construct demonstrates 
peroxisome import function.  As this is a PEX19 rescue experiment, the original PEX3 was not 
deleted.   
 
 
Figure 5.22: (BY4741 MATa, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1 
TRP1::pPEX19-scPEX19) RFP-PTS1 peroxisomes (mCherry).  The strain 
was grown in YPDA for 24 hours then washed in ddH2O and 
transferred to synthetic raffinose media to induce peroxisomes.   The 
cells were imaged fixed within 48 hours of fixation. 
 
As indicated in the introduction to this section, Pex19p is untagged as it is a cytoplasmic peroxin 
(peroxisomal protein).  There is only one fluorophore in KJY7 which is shown as the RFP-PTS1 




construct in Figure 5.22.  Peroxisomes are visible, but there are clearly fewer than have been 
previously observed in the wild type and PEX3 rescue.  This version of PEX19 may not be 
expressed at the correct level, but the yeast can still produce functional peroxisomes.  This effect 
could be a function of the URA3 locus, but no further testing was conducted to verify this 
observation.   
5.7.6 Strain 6: KJY8 – Yeast Pex3p and Pex19p Rescue Control 
 
The KJY8 strain was constructed to test the rescue of the double PEX3 and PEX19 knockout.  It 
was transformed with two constructs, the RFP-PTS1 peroxisome function control and the yeast 
PEX3-CFP and PEX19.  Both PEX3 and PEX19 were built onto the same construct to save on 
the number of sequential transformations needed with each strain.   







Figure 5.23: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1, 
TRP1::pPEX3-scPEX3-CFP-ADH1t -pPEX19-scPEX19) A) RFP-PTS1 peroxisomes 
(mCherry) B) scPex3p-CFP (Cerulean) peroxisomes rescued by the yeast PEX3 
and Pex19p construct. The strain was grown in YPDA for 24 hours then washed 
in ddH2O and transferred to synthetic raffinose media to induce peroxisomes.   
The cells were imaged fixed within 48 hours of fixation. 
 
Figure 5.23 A shows functional peroxisomes with the RFP-PTS1 construct.  Figure 5.23 B 
shows CFP peroxisomes that have been rescued with the yeast Pex3p-CFP and Pex19p 
constructs.  These images demonstrate the successful rescue of peroxisome function when both 
essential genes have been removed.  They further show functional CFP yeast peroxisomes in 
greater numbers than with the previous control in Figure 5.22.   
5.7.7 Strain 7: KJY9 – Human Pex3p and Pex19p Rescue Control 
 
The KJY9 strain was constructed to test the rescue of the double PEX3 and PEX19 knockout 
using the human genes.  It was transformed with two constructs, the RFP-PTS1 control and the 




human Pex3p-YFP and Pex19p.  Both PEX3 and PEX19 were built onto the same construct to 




Figure 5.24: (BY4741 MATa, pex3-Δ, pex19-Δ LEU2::pHIS3-RFP-RFP-
PTS1, HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-scPEX19) A) RFP-
PTS1 peroxisomes (mCherry) B) KJY9 hsPex3p-YFP (mVenus) 
peroxisomes rescued by the human PEX3 and PEX19 construct.  The 
strain was grown in YPDA for 24 hours then washed in ddH2O and 
transferred to synthetic raffinose media to induce peroxisomes.   
The cells were imaged fixed within 48 hours of fixation. 
 
Figure 5.24 A shows functional peroxisomes with the RFP-PTS1 construct.  Figure 5.24 B 
shows YFP peroxisomes that were rescued with the human Pex3p-YFP and Pex19p constructs.  
These images demonstrate the successful rescue of peroxisome function using genes from 
another species when both essential genes have been removed.  This represents a novel 
experiment and has not been performed in yeast using human genes before.   
5.8 CFP-YFP Controls 
The previous control experiments demonstrated successfully tagged peroxisomes with the RFP-
PTS1 construct.  This construct is essential to demonstrate functionality, as the peroxisome 
import complex must be assembled and functional for import to be successful.  The second 
category of controls demonstrated successful deletion of yeast PEX3 and PEX19.  Further 
controls showed the ability to rescue both single knockouts and the PEX3 and PEX19 double 




knockout.  Both human and yeast functional peroxisomes were shown, allowing the project to 
progress to the next stage in development.  Furthermore, peroxisome function was rescued using 
human Pex3p and Pex19p, which has not been described in previous literature.  This section 
illustrates the three tri-channel fluorophore controls before showing the main experimental 
strain.   
5.8.1 Strain 9: KJY11 
 
KJY11 is the same as the main experimental strain minus the yeast PEX19.  This control aims to 
artificially create two populations of peroxisomes by introducing a bias in the way they are 
formed.   








Figure 5.25: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-
PTS1, TRP1::pPEX3-scPEX3-CFP, HIS1::pPEX3-hsPEX3-YFP-ADH1t-
pPEX19-scPEX19) A) RFP-PTS1 peroxisomes (mCherry) B) scPex3p-CFP 
peroxisomes (Cerulean) C) hsPex3p-YFP peroxisomes (mVenus) D) 
yeast and human false color overlay (Cerulean and mVenus) (CFP = 
green, YFP = red). The strain was grown in YPDA for 24 hours then 
washed in ddH2O and transferred to synthetic raffinose media to 
induce peroxisomes.   The cells were imaged fixed within 48 hours of 
fixation. 
 
Figure 5.25 A shows functional peroxisomes with the RFP-PTS1 construct.  Figure 5.25 B 
shows the yeast Pex3p-CFP construct.  Figure 5.25 C shows the human Pex3p-YFP 
peroxisomes.  Figure 5.25 D is a false color CFP-YFP image where CFP is green and YFP red.  
The KJY11 control was constructed to create a bias in the peroxisome populations be removing 
the yeast shuttle protein, Pex19p.  There is no observed difference in the CFP and YFP channels 
in B and C.  There is little color difference across the population in the false color overlay in D, a 
point that will be demonstrated numerically in the next chapter.   




5.8.2 Strain 10: KJY14 
 
KJY14 is a control strain where both CFP and YFP fluorophores are tagged to the yeast PEX3. 
Both yeast and human copies of PEX19 are present.  The aim of this control was to create two 
populations of peroxisomes with a bias on the yeast population due to the lack of the human 
tagged Pex3p.   
 








Figure 5.26: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-
PTS1, TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-hsPEX19, HIS1::pPEX3-
hsPEX3-YFP-ADH1t-pPEX19-scPEX19) A) KJY14 RFP-PTS1 peroxisomes 
(mCherry) B) scPex3p-CFP peroxisomes (Cerulean) C) scPex3p-YFP 
peroxisomes (mVenus) D) Pex3p false color overlay (Cerulean and 
mVenus) (CFP = green, YFP = red). The strain was grown in YPDA for 24 
hours then washed in ddH2O and transferred to synthetic raffinose 
media to induce peroxisomes.   The cells were imaged fixed within 48 
hours of fixation. 
 
Figure 5.26 A shows functional peroxisomes with the RFP-PTS1 construct. Figure 5.26 B shows 
correctly formed yeast Pex3p-CFP peroxisomes.  Figure 5.26 C shows some yeast Pex3p-YFP 
peroxisomes in some cells, but cytoplasmic localization in a small number of the yeast cells.  In 
the defective cells, no yeast-YFP peroxisomes are apparent.  This could be from Pex3p-YFP that 
remains bound to human Pex19p.  Part of the problem could also be a peroxisome inheritance 
issue between mother and daughter cells.  If the population is not homogenous and some of the 
mother cells do not form peroxisomes and pass this phenotype to their daughter cells, sporadic 
cytoplasmic localization of Pex3-YFP could occur.  Figure 5.26 D shows a false color CFP-YFP 
image where CFP is green and YFP red.  There is little overlap between the two colors and the 




cytoplasmic localization will interfere with the numerical analysis, as the problem is not present 
on the RFP channel.   
5.8.3 Strain 1: KJY15 
 
KJY15 is a control strain where both CFP and YFP fluorophores are driven by the yeast PEX3.  
This control aims to create a single, uniform population of mixed CFP and YFP peroxisomes as 
there is no copy of the human Pex19p.   








Figure 5.27: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-
PTS1, TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-scPEX19, 
HIS1::pPEX3-scPEX3-YFP-ADH1t-pPEX19-scPEX19) A) RFP-PTS1 
peroxisomes (mCherry) B) scPex3p-CFP peroxisomes (Cerulean) C) 
scPex3p-YFP peroxisomes (mVenus) D) yeast and yeast false color 
overlay (Cerulean and mVenus) (CFP = green, YFP = red). The strain 
was grown in YPDA for 24 hours then washed in ddH2O and 
transferred to synthetic raffinose media to induce peroxisomes.   
The cells were imaged fixed within 48 hours of fixation. 
 
Figure 5.27 A shows functional peroxisomes with the RFP-PTS1 construct.  Figure 5.27 B 
shows yeast Pex3p-CFP peroxisomes.  Figure 5.27 C shows yeast Pex3p-YFP peroxisomes.  
Figure 5.27 D is a false color CFP-YFP image where CFP is green and YFP red. The CFP and 
YFP channels in B and C appear to be closely correlated, but the peroxisomes are not a uniform 
yellow in D (which would represent a homogenous population of peroxisomes).  There is some 
difference in the CFP and YFP populations, but the images do not represent clear bimodality.  
The numerical analysis in chapter 7 describes the nature of this peroxisome population, which 
will be shown to be heterogeneous.   




5.9 Main Experimental Strain 
5.9.1 Strain 8: KJY10 
 
The KJY10 strain is the main experimental strain for the project.  It has been transformed with 
three constructs.  The first is the RFP-PTS1 to test for peroxisome import function.  The second 
is the yeast Pex3p-CFP and Pex19p construct, to induce yeast-CFP peroxisomes.  The third is 
the human Pex3p-YFP and Pex19p construct to induce human peroxisomes. 
 








Figure 5.28: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-
RFP-PTS1, TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-scPEX19, 
HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) A) A) RFP-
PTS1 (mCherry) peroxisomes, B) scPex3p-CFP peroxisomes 
(Cerulean) C) hsPex3p-YFP peroxisomes (mVenus) D) yeast and 
human false color overlay (mVenus and Cerulean) (CFP = green, 
YFP = red). The strain was grown in YPDA for 24 hours then 
washed in ddH2O and transferred to synthetic raffinose media 
to induce peroxisomes.   The cells were imaged fixed within 48 
hours of fixation. 
 
Figure 5.28 A shows the RFP-PTS1 construct and functional peroxisomes.  Figure 5.28 B shows 
the yeast Pex3p-CFP peroxisomes.  Figure 5.28 C shows the human Pex3p-YFP peroxisomes.  
Figure 5.28 D is the first false color composite CFP-YFP image.  As explained in the 
introduction to this Chapter, CFP is represented by green and YFP by red.  Yellow represents an 
overlap of the two colors.  These images show most of the peroxisomes appearing as 
yellow/light green indicating that there is little evidence of two species specific populations of 




peroxisomes.  Numerical analysis of these images in the following chapter shows the population 
of peroxisomes is a normal distribution.   
5.10 Conclusions 
When imaging, the acquisition times and brightness settings were calibrated based on the 
fluorophore.  CFP was generally imaged for longer than YFP and once the settings were chosen, 
up to 10 images were imaged using identical settings.  Z stacks were taken of the fluorescent 
channels, bright-field cells and a blank region on the slide to perform a background subtract.  
Once acquired, the Z-stacks were 3D deconvolved using AutoQuant X and processed using a 
script written for Image Pro 7.  This script identifies the peroxisomes and produces an Excel 
spreadsheet containing the CFP, YFP and RFP peroxisome data.   
 
Initial microscopy was performed on the KDY3-KX9-KX10-KX9_URA3 strain.  This was 
achieved and the dual color overlays indicate a bimodal population.  However, it was later 
discovered the xenon bulb was damaged and created an artificial bias in the image.  This image 
was discarded and microscopy was performed on the BY4741a strain collection.  The control 
strains were received, grown and imaged with the protocols described above.  The rescue 
controls all proved successful and neither the problem with cytoplasmic fluorescence nor the 
malfunctioning RFP-PTS1 were observed.  The new strain was deemed fit for the project and 
imaging could proceed with the key controls and main experimental strain.   
 
KJY11 was imaged and demonstrated both CFP and YFP peroxisomes.  KJY14 showed a 
problem as some peroxisomes were visible, but a lot of cytoplasmic localization was also 
observed.   KJY15 was imaged and visually showed a good CFP and YFP peroxisome overlap.  
Finally, KJY10 was successfully imaged and analyzed.  However, it did not show much visual 
difference between the CFP and YFP channels.  Numerical analysis of the results produced 
using the Image Pro analysis script is necessary to determine correlation between CFP and YFP 
for the three key controls and the main experimental strain.    This analysis will be conducted in 
the following Chapter. 
  




6 Numerical Analysis of the Peroxisome Experiments 
 
 
Images of the YPH500α and BY4741a strains were presented in the previous Chapter.  This 
Chapter describes methods used to collect and analyze the quantitative data captured from these 
images.  Data from the PSY1198-α strain are shown using the initial two channel Matlab 
processing script to highlight some of the issues with this analytical method.  The BY4741a 
strain analysis was conducted using a three channel normalization protocol based on functional 
peroxisome information in the RFP channel. 
 
Once the peroxisome data was captured with image manipulation scripts written in Image Pro 
7.0, it was analyzed in a quantitative manner.  The peroxisome average intensity was recorded 
for each peroxisome and used for the analysis.  This is a measure of the intensity of each pixel, 
averaged over the area of the peroxisome.  Before the images were analyzed, this average 
intensity was examined on an image to image basis using a simple moving average.  
6.1 Contributions to this Chapter 
The basis of the first Matlab script was written by Jake Wintermute.  The author wrote scripts for 
the more comprehensive two channel analysis and normalization and further three channel 
normalization and statistical analysis.  David Kelly wrote the initial image analysis scripts in 
Image Pro 7 according a protocol that was determined by the author.  The author made all 
further modifications and alterations to the Image Pro 7.0 analysis scripts.     
6.2 Matlab Processing 
The first Matlab script was initially written to visualize the relative intensity of CFP and YFP 
peroxisomes in a histogram as recorded by MetaMorph.  The code served as a basis for versions 
that were completely re-written by the author.  It was made as a simple way of viewing the CFP 
to YFP ratio.  The script starts by loading in the Excel data file from MetaMorph and assigning a 
channel to the CFP and YFP data.  This channel data is then parsed into a histogram by dividing 
CFP by YFP and plotting the log of the ratio.  A moving average of the CFP and YFP raw data 
were also plotted to examine the image to image variation across the data-set.  As each image 




has been individually thresholded by eye from the MetaMorph processing, examining this 
parameter is important for the integrity of the data.  The peroxisome number scale represents the 
intensity of every peroxisome in the series plotted sequentially and the intensity is a 
dimensionless measure of the grayscale value measured during the experiment.    
 
A) B) C) 
Figure 6.1: Matlab plots from the first pex processing script. A) Histogram of the YFP/CFP 
ratio against the frequency of the peroxisomes B) CFP image to image variation in 




Figure 6.1 shows the plots from the original Matlab script describing YPH500α.  The strain was 
grown to mid log phase in YEPD, then washed and transferred into YPGO with added adenine 
for 24 h.  The cells were paraformaldehyde fixed and imaged suspended in mounting media.  
The images were produced by acquiring a single best focus plane with a 2 second CFP exposure 
and a 1 second YFP exposure.  They were then analyzed using the MetaMorph protocol 
described in the previous section.   
 
Figure 6.1 A shows a histogram of the log of the YFP to CFP ratio.  This ratio gives an 
indication of how much CFP a peroxisome has relative to the amount of YFP.  In this case, the 
plot looks roughly like a normal distribution.  Figure 6.1 B and C show a moving average of the 
peroxisome average intensity.  The average intensity of each peroxisome is plotted in sequence.  
This parameter is necessary to visualize at an early stage as significant image to image 
fluctuations could be problematic when analyzing a ratio.  The purpose of these plots was to get 
a quick idea of the CFP/YFP ratio and to examine the image to image variation.  This was to test 




the image and data analysis and determine if and what changes were needed.  An in depth 




Figure 6.2: Photo-bleaching control A) CFP (Cerulean) image to image 
average intensity data.  B) YFP (mVenus) image to image average intensity 
data.  Green represents the first exposure while blue shows a second 
exposure of equal intensity and duration five seconds later Note: the y-
axis have not been normalized to highlight the relative difference 
between channels. 
 
Figure 6.2 shows the detail in the difference between the first and second images acquired during 
the photo bleaching experiment.  There is a shift in the scale of the intensity, but not the 
YFP/CFP ratio.  Photo bleaching was therefore not considered to be a significant hurdle in the 
progression of the project. 
6.3 Image Analysis Macro Evolution 
Several versions of the image analysis macro were created as the script evolved.  Version 4 
included an additional peroxisome identification step on the CFP and YFP channels.  This step 
creates duplicates of the CFP and YFP single plane images and applies the same image 
manipulation processes as performed on the RFP channel.  This process introduces an image to 
image bias due to the manual thresholding now being performed on all three channels.  
 




Macro V5 is an elaboration of V2 where peroxisome data are recorded for the RFP channel 
along with the CFP and YFP data.  This information was not recorded in previous versions as it 
was not deemed necessary.  The RFP regions were used to identify functional peroxisomes and 
these regions were reported from the CFP and YFP data.  Recording the additional RFP data 
allows a more thorough analysis to be conducted.  Initially, this RFP peroxisome data were to be 
used to normalize the CFP and YFP intensities on a peroxisome to peroxisome basis.  When this 
individual normalization was attempted, it removed much of the CFP/YFP resolution which was 
not acceptable.  The RFP channel will be used to normalize on an image to image basis.  A 
summary of the version progression can be seen in Table 6.1.   
 
Version Functions 
V1 Dual channel; only plots peroxisome data.   
V2 Dual channel image to image and population normalization.  
V4 Tri channel, image to image and population normalization, reports CFP and 
YFP peroxisome data.   
V5 Tri channel, image to image and population normalization, reports CFP, YFP 
and RFP peroxisome data.   
Table 6.1: Matlab analysis script progression 
6.4 Dual Channel Data Normalization 
Once the images were acquired and the data were processed using the ImPro analysis script, it 
was imported into Matlab for numerical analysis and normalization.  Several parameters were 
measured including: peroxisome area (per peroxisome, not averaged over the cell), average 
intensity per peroxisome, maximum intensity per peroxisome, the peroxisome origin and the 
channel (CFP, YFP or RFP).  The average intensity was chosen as the most important 
representation of the information contained within each peroxisome region and a script was 
written to normalize the data based on this parameter.  The CFP and YFP channels were 
normalized to each other based on the image to image average intensity and then the sample 
average.   
6.5 Data Acquisition using AutoQuant X and Image Pro 7 
Images for this project were processed using a set of software including Image Pro V7.0 
(ImPro), AutoQuant X and Matlab.  The images were captured in .dv format on the microscope 
and converted to .seq using ImPro.  They were then opened in AutoQuant X to perform a 3D 




deconvolution.  The .seq files contain all the information necessary for the deconvolution 
process (sensor pixel size, z-stack spacing, etc...) except for the objective magnification and the 
immersion media.  The images are always captured using a 100x objective with oil immersion 
and this information needs to be manually entered into the processing software.   
6.5.1 Image Pro analysis Macro 
The image analysis macro is presented in this Chapter.  A copy of this script is appended on 
page 197, Appendix 7: Image Pro 7.0 Macro V.5 script.  Once the images were deconvolved, 
they were processed to extract peroxisome data using a macro in ImPro.  Several versions of this 
script were developed as the analysis requirements evolved.   
 
The purpose of this script was parse out the peroxisome data from qualitative images into a 
quantitative format that can be numerically analyzed.  This was done with an emphasis on 
adding as little bias to the CFP/YFP ratio as possible.  It has a function to track each peroxisome 
to its cell of origin and will not measure any peroxisome intensity readings outside a cell.  This 
helps to cut down on false positive peroxisomes by eliminating any fluorescent contamination or 
minor image artifacts from the acquisition and deconvolution process.  The script can be broken 
down into three main modules: 
1- Creation of cell regions from the out-of-focus bright-field z-stack. 
2- Manipulation of the RFP image to identify user-defined peroxisome regions then 
reapplication of those regions to the CFP, YFP and unmanipulated RFP images. 
3- Excel spreadsheet output of peroxisome quantitative data. 
6.5.2 Image Pro Script Module 1 Details 
The first module of the script begins by subtracting a nominal numerical value from the blank z-
stack image.  Subtracting this value is essentially a trick to increase contrast on the important 
regions of interest in the next processing step.  To produce the blank, a region of the slide with 
no cells is imaged using the out-of-focus bright-field. 
 










Figure 6.3: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1, TRP1::pPEX3-
scPEX3-CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) 
A) out-of-focus bright-field z-stack B) out-of-focus bright-field z-stack after background 
subtract C) final cell regions after skeletonizing process.  Cells were imaged fixed. 
 
This is microscopy best practice as this blank can then be subtracted from the regions that 
contain cells as shown in Figure 6.3 A to remove any irregularities.  This blank is subtracted 
from the out-of-focus bright-field image containing the cells.  The result of this subtraction is a 
z-stack that contains half dark cells and half bright “halos” Figure 6.3 B.  The halo regions are 
selected for further processing and the other parts of the stack are deleted.  The halo stack 
(usually 10 – 20 images) is compressed into one frame and a smoothing filter is applied.  This 
single frame then has a sharpening “large spectral filter” applied to increase the contrast in the 
regions defined as the cell outlines.  Finally, a skeletonizing filter is run to create cell boundaries 
that are 1 pixel thick (Figure 6.3 C).  It is important to note that this processing technique does 
not give the exact size of the cells.  It also does not count 100% of the cells, as some of the cells 
present in Figure 6.3 A do not appear in C.  Algorithms to distinguish mother from bud and to 
ignore clumps several cells deep were not implemented.  The analysis can easily identify single 
cells but cannot always pick up grouped cells due to the smaller relative difference in contrast 
between the cell boundaries.  It gives a good indication of how many peroxisomes are in each 
cell and which peroxisomes come from which cell, but the areas defined as cell regions are 
larger than the actual cells are joined in regions of high cell density.  This effect can be seen in 
the control strains in Figure 5.19 and Figure 5.20 where the cytoplasmic localization of the cells 
does not exactly match up with the cell regions.  
 




In order to create regions around the cells, an embedded script is run within the first module.  To 
illustrate the non-trivial nature of the analysis, this script was written by the ImPro software 
developers specifically for this analytical situation.  The actual type of analysis is known as 
“fried egg analysis” as the program seeks to identify yolks (peroxisomes) within egg whites 
(cells) within a frying pan (the whole image).  The code uses the skeletonized cell regions to 
identify regions that are size selected for yeast cells.  As this technique only identifies regions of 
the correct size as cells, no fluorescent contamination appearing outside cells is falsely identified 
as a peroxisome.   
6.5.3 Image Pro Script Module 2 Details 
Once the first module was run, the second begins by creating a single image of the 50 images 






Figure 6.4: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1, 
TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-
pPEX19-hsPEX19) A) Single plane of the 3d deconvolved compressed Z-stack 
showing YFP peroxisomes (mVenus) B) Maximum brightness extended depth of field 
YFP image (mVenus).  Cells were imaged fixed. 
 
A maximum brightness “extended depth of field” operation is run to compress the maximum 
intensity pixels from the ~50 images into the same plane (Figure 6.4 B).  The CFP and YFP 
single plane images are not manipulated any further.  Any further modifications will result in 
variations to the YFP/CFP scaling information which could introduce bias. 





All further manipulations are performed on the RFP channel to identify the regions deemed 
peroxisomes in order to reapply and measure those areas on the CFP, YFP and original RFP 
images.  Using the RFP channel is necessary to prevent introducing bias on the CFP and YFP 
channels.  The RFP channel is used as these peroxisomes have been identified as functional by 
their import of the RFP-PTS1 marker.  Those functional peroxisome regions can then be applied 
back to the CFP, YFP and unmanipulated RFP image to get quantitative data.  Two copies of 
this RFP maximum intensity image are created and one is subject to a blurring large spectral 
filter operation to smooth out any fluorescence information that might not come from the 








Figure 6.5: (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1, TRP1::pPEX3-scPEX3-
CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-pPEX19-hsPEX19) A) Large 
spectral filter blurred image, B) Large spectral filter sharpened image, C) Binary mask.  Cells 
were imaged fixed. 
 
The blurred filtered image (Figure 6.5 A) is subtracted from the max intensity image to sharpen 
the peroxisomes.  A second sharpening large spectral filter is then run on this image to increase 
the contrast in the peroxisome regions as shown in Figure 6.5 B.  The image is manually 
thresholded to correspond to the expected peroxisome regions.  This technique does introduce 
some bias, but this bias exists only on an image to image basis.  These regions are transformed 
into a binary mask (Figure 6.5 C).  This binary mask is then inverted and subtracted from the 
CFP, YFP and original RFP images.  The resultant images only have signal on regions that the 
technique has identified as peroxisomes and everywhere else on the image has a zero value.  




Size filters are set to correspond with the maximum and minimum expected peroxisome size and 
the final module can then be applied.   
6.5.4 Image Pro Script Module 3 Details 
The last module in this macro takes information about the cell regions and creates data from the 
areas identified as peroxisomes, starting with the YFP image.  Each cell is individually called up 
and the intensity is examined based on the peroxisome image created from the RFP mask.  The 
size is applied to sort out some of the background signal.  Once a region has been identified as 
being a peroxisome of the correct size within a cell, its area, roundness, average brightness, 
maximum brightness and the cell number that it came from are written to an Excel spreadsheet.  
This process is then repeated for the CFP and RFP images.  This spreadsheet is manipulated in 
Excel or read into Matlab for analysis.   











2 2.42440 49611 23932.68 1 
2 2.04160 40558 23399.25 1 
2 2.04160 22080 13813.81 1 
2 1.53120 22706 15000.92 3 
2 1.40360 13090 9667.091 3 
2 2.04160 29420 16665.06 5 
2 1.53120 34499 21447.75 6 
2 1.53120 39999 24039.83 6 
Table 6.2: Example spreadsheet from peroxisome macro 
 
Table 6.2 shows an example of the spreadsheet generated from the ImPro process.  The 
fluorophore code identifies the peroxisome as RFP, CFP or YFP.  The area is the area (in um2) 
of the peroxisome.  Max intensity is the brightest pixel in the area and the average is calculated 
from all pixels in the peroxisome.  Finally, cell number tracks the cell of origin of the 
peroxisome.   
6.5.5 Image Pro Image Processing Summary Table 
Table 6.3 shows a summary table of the Image Pro processing script.  This is a summary of the 
techniques described in this Chapter on how the images are analysed and parsed for data capture.   




DeltaVision – Image Pro 7.0 Module: 
Run 3d deconvolution - 
Load out-of-focus brightfield Z-stack 1 
Subtract nominal value from out 
brightfield background stack 
1 
Compress half of stack into single focal 
plane 
1 
Use skeletonizing filter to select cell 
outlines 
1 
Load CFP, YFP and RFP Z-stacks 2 
Compress stacks to single images using a 
maximum intensity projection 
2 
Identify peroxisomes on RFP channel  2 
Threshold peroxisome regions on RFP 
channel  
2 
Create and invert binary mask on RFP 
channel 
2 
Subtract inverted binary mask from CFP 
and YFP channels 
2 
Read in peroxisome information in on 
CFP and YFP channels 
3 
Parse data into Excel spreadsheet 3 
Table 6.3: MM vs. ImPro image analysis comparison table. 
 
6.6 CFP-YFP Normalization and Image to Image Average Intensity 
This script was adequate for a first pass examination of the YFP/CFP ratio and a brief 
examination of the CFP and YFP image to image variation.  Due to the image to image 
variation, a normalization protocol was also included in the analysis.  This script starts by 
reading in the dual channel CFP-YFP data.  Each intensity measurement is the average of the 
peroxisome area measured on the CFP or YFP channel.  Each data point represents a CFP or 
YFP measure of a peroxisome.   





Figure 6.6: CFP (Cerulean) and YFP (mVenus) moving average and image to 
image average intensity. The left plot shows the raw image to image average 
intensity while the right plot shows the image to image average, represented by 
each plateau.  In this data-set there are 5 images, with a clear disparity on.   
 
Figure 6.6 shows a moving average of each peroxisome in the image variation in the first plot 
and the image average intensity in the second.  Each plateau represents the average intensity 
value of an image.  This representation now clearly shows that there is a significant drop in the 
average intensity in the second YFP image.   
 





Figure 6.7: CFP (Cerulean) and YFP (mVenus) image to image normalized moving 
average and image to image average normalized intensity. The left plot shows the first 
normalized image to image average intensity while the right plot shows the first 
normalized image to image average, represented by each plateau.    In the second plot, 
the CFP line is shown behind the YFP. 
 
Figure 6.7 shows the image to image average after it has been normalized.  The CFP amplitude 
has increased as it was offset by the relative change that was subject to both data-sets.   
 





Figure 6.8: CFP (Cerulean) and YFP (mVenus) image to image second normalized 
moving average and image to image average second normalized intensity. The left 
plot shows the second normalized image to image average intensity while the right 
plot shows the second normalized image to image average, represented by a flat 
line.  The second normalized plot shows two separate lines that are not 
superimposed.     
 
Figure 6.8 shows an attempt to normalize the CFP and YFP data to the same average.  The first 
plot shows the adjusted image values and the second, the image to image average.  This plot 
should show one line representing a normalized image to image average.  However, this 
normalization process required an iterative numerical solution to compare the CFP and YFP 
image to image average.  This solution was not possible to achieve in the time available for 
analysis and was deemed unnecessary as it would introduce a bias that could affect the CFP/YFP 
histogram.   
6.6.1 CFP-YFP Scatter Plot and Histogram Examination 
Figure 6.9 shows plots of the YFP vs. CFP scatter plot and the corresponding histogram.  The 
scatter plot shows areas of increased density in red and areas of low density, in blue.   





Figure 6.9:  YFP (mVenus) against CFP (Cerulean) raw average intensity scatter plot 
and YFP/CFP peroxisome average intensity histogram. 
 
This plot shows two areas of increased density, representing two populations of peroxisomes in 
the sample.  The second plot in the figure shows a histogram of a log of the YFP to CFP ratio.  
This histogram clearly shows two populations, corroborating the information in the scatter plot.    






Figure 6.10: CFP (Cerulean) against YFP (mVenus) first normalized average 
intensity scatter plot and first normalized YFP/CFP peroxisome average intensity 
histogram.   
 
The first normalization has changed the shape of the scatter plot, as there now only one area of 
high density is shown, relative to Figure 6.9.  It does not appear to have affected the shape of the 
histogram.   
 





Figure 6.11: (Cerulean) against YFP (mVenus) second normalized average intensity 
scatter plot and second normalized YFP/CFP peroxisome average intensity 
histogram. The scatter plot shows two areas of high density, while the histogram 
shows two peaks.   
 
Figure 6.11 shows the scatter plot and histogram for the second normalized (all image average) 
data.  The histogram shows very little change from Figure 6.10 and Figure 6.11.  However, the 
scatter plot shows a region of higher density towards the bottom of the plot, representing 
peroxisomes that are predominately CFP.  The normalization protocol took the CFP and YFP 
data and skewed the ratio towards CFP due to the normalization calculation lacking an iteration 
step.  This is entirely against the reason for normalizing the data.  It was assumed that changing 
the scale of the data proportionally by performing the same mathematical operations would 
preserve the YFP/CFP scaling.  This is not the case.  For this reason, the dual channel data was 
not considered during the analysis.   
6.7 Matlab Analysis of Tri-channel CFP-YFP-RFP Data 
Once the analysis of the dual channel data was determined to be insufficient, the script was 
adapted to analyze the images for quantitative RFP information along with CFP and YFP.  This 
script is in Appendix 8: Matlab image processing script.  The script was modified to perform the 
same analysis on RFP that was already performed on CFP and YFP.  The addition of a common 




reference frame in the form of the RFP data was used to normalize the CFP and YFP without 
changing the scaling information in favor of one channel or the other.  The normalization was 
first performed on an image to image basis and finally across the data-set as a whole.   
6.7.1 Example Analysis Strain: KJY15 
The script used in this section contains additional code to recorded quantitative data on the RFP 
peroxisomes.  These data were used as a common reference for the CFP and YFP.  The 
individual values of the CFP and YFP peroxisomes would only be changed relative to the scale 
of the RFP.  This process allowed the data to be examined without changing the scale of the 
individual peroxisomes.   
 
The first sample to be analyzed is the KJY15 strain that has been processed using macro V5.  As 
previously described, KJY15 was an ideal initial sample to examine as it has both CFP and YFP 
fluorophores where both are being driven by the yeast PEX3 promoter.  These data represent as 
close to a normal distribution as has been observed with the control samples.  Figure 6.12 
through Figure 6.17 illustrates the normalization protocol that has been written in Matlab.   
6.7.2 Image to Image Normalization  
This section details the normalization procedure in a similar way to the method presented for the 
CFP and YFP information.  A series of figures are presented where the left plot contains a 
smoothed image to image average and the right plot shows the changing image average 
intensity.   





Figure 6.12: CYR (Cerulean, mVenus and mCherry) raw data moving average and image to 
image average intensity. This data was acquired from 6 images of the KJY15 strain (pex3-Δ, 
pex19- Δ) then processed through scripts in Image Pro7 and Matlab.   
 
The first step in the normalization protocol was to examine a moving average of the CYR 
average intensity data.  This was shown in the first plot in Figure 6.12.  The second plot in the 
same figure shows the image to image average across the experiment.  In this case, there are 6 
plateaus, indicating that six image have been used in this analysis.   
 
This figure shows the RFP and CFP channels are on approximately the same scale but the YFP 
channel is much lower in intensity.  This phenomenon is dependent on the fluorescent proteins 
and is simply part of imaging biological samples.  Using a 16 bit camera with and EMCCD 
detector will also have an effect on the scale of the data.  The acquisition protocol was setup to 
capture information based on the maximum intensity peroxisome.  YFP is a stronger fluorophore 
than CFP but the YFP average is lower as the single greatest YFP value is much higher than the 
single greatest CFP value.  The result of this is effect is a higher CFP average despite CFP being 
a less sensitive fluorescent protein.   
 





Figure 6.13: CYR (Cerulean, mVenus and mCherry) first normalized moving average and image 
to image first normalized average intensity.  The image average intensity (Image AI) plot 
shows only one line, as the CFP and YFP image to image averages have been normalized to 
the RFP average.   
 
The first part of the normalization protocol adjusts the CFP and YFP image averages to the RFP 
average.  The first graph in Figure 6.13 shows the image to image moving average after this 
normalization has been performed.  The second plot in the figure illustrates how the image to 
image average now appears.  Note that the only line that appears is RFP as it is the final entry in 
the legend; it covers over the other two colors.   
 





Figure 6.14: CYR (Cerulean, mVenus and mCherry) second normalized moving average and 
image to image second normalized average intensity.  The second normalized average AI 
shows only one line, as the image to image average for the image-set has been normalized to 
the average of the RFP channel.    
 
Figure 6.14 illustrates the final step in the normalization protocol.  The image to image average 
is on the same scale across all images, as shown by the second plot in the figure.  The image to 
image average is now constant and the scale of the CFP and YFP values can now be compared.  
This normalization protocol has removed any channel specific bias that might have occurred 
during the imaging without changing the resolution of the data.   
6.7.3 Scatter-plot and Histogram Analysis  
The second part of the normalization script will show the scatter plot and histogram.  Three 
figures will be shown that highlight the changes in the shape of the histogram and the scatter plot 
with each stage of the normalization protocol.   





Figure 6.15: CFP vs. YFP average intensity scatter plot and YFP/CFP histogram.  
The scatter plot clearly shows a single area of higher intensity and the histogram 
also shows a single distribution. 
 
The first graph in Figure 6.15 shows a scatter plot of the raw YFP and CFP average intensity 
data.  The color bar shows the relative density of the points. The second plot in the figure is a 
histogram of the log of the YFP/CFP peroxisome average intensity raw data.  These two plots 
represent two different ways of looking at the same data.  The scatter plot shows how the two 
variables are related and the histogram shows the distribution of YFP/CFP ratio.   
 





Figure 6.16: CFP vs. YFP first normalized average intensity scatter plot and 
YFP/CFP first normalized histogram. 
 
Figure 6.16 shows the CFP vs. YFP scatter plot and the YFP/CFP histogram of the first 
normalized data.  The shape of the scatter plot and histogram may change a little in this 
intermediary normalization, but it is the final normalization that will be analyzed. 
 





Figure 6.17: CFP vs. YFP second normalized average intensity scatter plot and 
YFP/CFP second normalized histogram.  The shape of the scatter plot has 
changed relative to the raw data, but the plot still shows a single area of higher 
density.   
 
Figure 6.17 shows the second normalization of the CFP3 vs. YFP3 scatter plot and the log of the 
YFP/CFP histogram.  These data were analyzed to probe the relationship between YFP and CFP 
peroxisomes when normalized to the same scale.  Note the histogram in Figure 6.16 is identical 
to Figure 6.17 as the scaling element from the image to image normalization is already corrected 
with the YFP/CFP division.  There is a change in the scatter plot between Figure 6.16 and Figure 
6.17 because of the image population average normalization; hence the latter will be used for 
analysis.   
 
The script was also initially set to plot the R2 value for the three scatter plots.  After some initial 
investigation, it was clear that looking at R2 values for a scatter plot was insufficient as fitting a 
line to data that is distributed over an area was leading to analytical artifacts.  The scatter plot 
was chosen to be examined for multiple populations using a heat map, while the histogram was 
used for curve fitting analysis.   




6.8 Histogram Curve Fitting Analysis  
The histograms were analyzed using curve fitting algorithms in the Matlab statistical analysis 
toolbox.  Three distributions have been chosen: 
1) Normal distribution 
2) T-location scale  
3) Non-parametric  
 
These distributions were chosen to represent a good cross section of possible fits for the data.  
The normal distribution was chosen as the KJY15 strain would be expected to fall closest to this 
distribution.  The T-location scale distribution was used to model data with heavier tails or more 
outliers than a normal distribution.  Finally, the non-parametric distribution with a 0.25 
weighting was chosen to fit bimodal distributions.  This distribution calculates a probability 
density estimate of the sample based on weighted moving average.  If the weight is set to 1, the 
algorithm tries to fit the data to a normal distribution.  If this weight is changed a smoothed 
average can be plotted.  A weight of 0.25 was used as it gives enough resolution to show heavy 
tails and multiple modes in the data.   
6.8.1 Histogram Distribution Visualisation Fit Analysis 
Each distribution was fit to the CFP-YFP normalized histogram.  Matlab uses an iterative curve 
fitting algorithm to fit the chosen distribution as closely as possible to the data.  Once this fit was 
calculated, the plot was mapped as shown in Figure 6.18.   





Figure 6.18: KJY15 YFP/CFP histogram with fitted statistical distributions as 
calculated by Matlab.   
 
An initial visual inspection indicates that although the non-parametric fit appears the least 
compatible with the data, it was impossible to discern the best fit between the other distributions.  
A numerical analysis of the fit was conducted to assess which distribution most closely matches 
the data.   
6.8.2 Distribution Fit Analysis  
To assess the curve fit, the distribution was subtracted from the data and the sum of the squared 
residuals calculated.  In this case, a lower value indicated a better fit.  A value of 0 indicated that 
Matlab has perfectly matched the curve to the data although this outcome was not expected.   





A) B) C) 
Figure 6.19: Assessment of the normal, T location-scale and non-parametric fit when 
compared to the YFP/CFP histogram data.  The histogram has been re-plotted as a line graph 
for clarity, as represented by the green line.  The red line represents the distribution and the 
blue, the difference between the two.  A numerical assessment of distribution fit is assessed 
by calculating the square of the numerical value of the blue line.   
 
Figure 6.19 shows A the normal distribution, B the T-Location scale and C the Non-parametric 
curve fitting plots where the red line is the distribution, the green line is the histogram data 
plotted as a line graph and the blue line is the difference.  The histogram was replotted as a line 
graph to illustrate the residual analysis.  The blue line represents the difference between the fit 
and the histogram data and the square of the values for each point is calculated to assess the fit 
numerically.  The distributions superimposed on the histogram data were shown in Figure 6.18.  
As explained previously, the T-location scale distribution was used to model data with heavier 
tails or more outliers than a normal distribution and the non-parametric distribution was used to 
identify a bimodal distribution.   
 
 
Table 6.4: KJY15 strain distribution fitting numerical results 
 




Table 6.4 shows the sum of the residuals squared for the KJY15 strain.  The lowest value is the 
non-parametric fit.  It also indicates that the best fit for the YFP/CFP histogram was that of a 
bimodal distribution.   
6.8.3 Matlab Analysis Summary Table 
Table 6.4 shows a summary of the Matlab operations used to conduct the numerical analysis 
. 
Matlab analysis 
Load in Excel data 
Parse CFP, YFP and RFP channels 
Normalize CFP and YFP image to image 
intensity to RFP channel 
Normalize CFP and YFP images average 
intensity to population average 
Plot CFP vs. YFP scatter heat map of 
normalized average populations 
Plot log of CFP/YFP histogram of normalized 
data 
Fit distributions to histogram 
Assess distribution fit numerically and produce 
quantitative value of fit 
Table 6.5: Matlab comparison summary table 
6.9 BY4741a Scatter Plot and Histogram Analysis 
This numerical technique was written to compare two populations of peroxisomes that were 
normalized based on a third channel.  Using a third channel served two functions.  The first was 
to normalize that data on an external element different to both channels and the second was to 
normalize based on functional peroxisomes.  If the peroxisomes were deficient in the uptake of 
the tagged RFP molecule, they did not show up on the RFP image and hence were excluded 
from the analysis.  This technique only worked with samples that contain CFP, YFP and RFP.  
Only KJY11, KJY14, KJY15 and the KJY10 (main experimental strain) meet this criteria and 
were be analyzed for quantitative data.  The other control strains in the project served their 
purpose by demonstrating that the constructs worked and could rescue peroxisome deletions or 
by producing proof of concept images.    




6.9.1 Analysis: KJY11 
 
Figure 6.20: Normalized YFP/CFP scatter plot and histogram for the KJY11 control 
strain.  The scatter plot shows a few isolated points closer to the YFP axis, and 
the histogram shows tails offset from the main population that represent these 
points.   
 
The KJY11 control strain is missing yeast PEX19 and would therefore be expected to show a 
bias towards YFP-human peroxisomes.  The scatter plot heat distribution does not indicate the 
presence of two populations of peroxisomes.  The histogram shows one large peak with a small 
asymmetric tail. 
 





Figure 6.21: KJY11 YFP/CFP histogram with fitted distributions.  
 
 
Table 6.6: KJY11 strain distribution assessment. 
 
Figure 6.21 shows the distributions that have been fitted to the histogram and Table 6.6 shows 
the distribution summary.  Visually, the best distribution is the T location-scale fit, which is 
confirmed with the numerical fit assessment.  This distribution fits best to asymmetric data with 
long tails.     
 




6.9.2 Analysis: KJY14 
 
Figure 6.22: Normalized YFP/CFP scatter plot and histogram for the KJY14 control 
strain. 
 
Figure 6.22 shows the YFP/CFP scatter plot and histogram for the KJY14 control strain.  The 
scatter plot immediately shows little coherence or pattern to the peroxisome distribution.  It also 
indicates fewer peroxisomes than in the previous plot and the histogram is of lower resolution.  
This strain has CFP and YFP tagged to yeast Pex3p with human and yeast Pex19p.  This strain 
was expected to exhibit a histogram closely resembling a normal distribution.  Although the 
points are sparse, the scatter plot shows two different regions of higher density.   
 





Figure 6.23: KJY14 YFP/CFP histogram with fitted distributions.  Note the normal 
distribution was calculated but not plotted due to Matlab reaching the maximum 
number of iterations without producing a curve that could match the data. 
 
 
Table 6.7: KJY14 strain distribution assessment. 
 
Figure 6.23 shows the distributions fitted to the KJY14 control strain and Table 6.7, the 
numerical fit summary.  The first observation is that the normal distribution is missing from the 
plot.  This is due to the algorithm in Matlab being unable to fit a normal to the data within the 
standard number of iterations.  As the curve for this distribution was unable to be fitted to the 
plot, it will not be considered for analysis (although a numerical assessment of the fit will still be 
calculated).  Visually, the best distribution was the non-parametric fit as it maps the two major 




modes.  This was confirmed with the non-parametric fit being the lowest numerical result.  
However, the images for this strain contained a large degree of cytoplasmic localization, 
rendering numerical analysis difficult at best.   
6.9.3 Analysis: KJY15 
 
Figure 6.24: Normalized YFP/CFP scatter plot and histogram for the KJY15 control 
strain. 
 
Figure 6.24 shows the scatter plot and histogram for the KJY15 control.  This control has CFP 
and YFP both tagged to the yeast Pex3p and two copies of the yeast Pex19p.   
 





Figure 6.25: KJY15 YFP/CFP histogram with fitted distributions. 
 
 
Table 6.8: KJY15 strain distribution assessment. 
 
Figure 6.25 shows the fitted distributions for the KJY15 control and Table 6.8 gives a summary 
of the numerical fit assessment.  The non-parametric distribution was numerically calculated to 
be the best fit.  This strain was expected to exhibit the characteristics of a T-location scale 
distribution. 




6.9.4 Analysis: Main Experimental Strain KJY10 
 
Figure 6.26: Normalized YFP/CFP scatter plot and histogram for the KJY10/main 
experimental strain. 
 
Figure 6.26 shows the second normalized YFP/CFP scatter plot and histogram.  There is clearly 
only one area of points at high concentration as shown by the red color.  The histogram only 
shows one large main peak, although this will be analyzed by the curve fitting.   
 





Figure 6.27: KJY10 YFP/CFP histogram with fitted distributions. 
 
 
Table 6.9: KJY10 strain distribution. 
 
Figure 6.27 shows the YFP/CFP histogram data and fitted distributions and Table 6.9 gives the 
numerical fit summary.  The KJY10 strain contains the human Pex3p tagged with CFP and the 
yeast Pex3p tagged with YFP.  One of two results was expected from this experiment.  This 
strain was expected to either show two separate populations of human and yeast peroxisomes in 
the cell, or one homogenous population of hybrid peroxisomes.  The scatter plot shows only one 
population and the best distribution to fit the data is the normal distribution.  These data suggest 
the experiment produced a single population of human-yeast hybrid peroxisomes.   




6.9.5 Numerical Summary Table 
The previous section presented the histogram distribution and scatter plot analysis.  This section 
compares the numerical results of the four distributions for the three control strains and the 
experimental strain.   
 
Table 6.10: Matlab data summary. 
 
Table 6.10 shows a summary of the distribution analysis.  The best fit distributions are 
highlighted in yellow.  As was explained earlier in the Chapter, the yellow boxes represent the 
closest fit.  KJY15 was expected to be a normal distribution as this strain had two copies of the 
yeast Pex3p, one tagged with CFP and the other with YFP.  The other point of interest in this 
table is the KJY10 strain data fitting a normal distribution.   
6.10 Chapter Conclusions 
This Chapter presented image and numerical analysis of the peroxisomes using scripts written in 
Matlab to produce scatter plots and YFP/CFP histograms.  The dual channel data was analyzed 
and a normalization script was written to normalize the data from image to image, then across 
the data set.  This protocol required an iterative numerical solution to complete the second 
normalization which was deemed too complex for this analysis.  The scatter plot and histograms 
were examined and the technique deemed insufficient due to the change in the YFP to CFP 
scaling ratio.   
 




The dual channel data using YPH500α was then examined and a flaw in the original technique 
discovered.  This flaw was theorized to come from an observer introduced bias in the data 
capture.  The dual channel images were therefore removed from the analysis. 
 
The tri-channel data was analyzed using a similar normalization protocol that made use of the 
additional RFP image.  This script normalized the CFP and YFP channels to the RFP channel, 
then normalized the images across the data-set.   The second normalized histogram was then 
analyzed using the curve fitting algorithm in Matlab.  Three distributions were chosen to 
represent the possible situations: normal, T-location and non-parametric.   
 
The three key control strains and the main experimental strain were analyzed and the second 
normalized log of the YFP/CFP histogram fitted to these distributions.  The KJY14 strain fit the 
non-parametric distribution the best.  This distribution is used to fit bimodal distributions.  The 
main experimental strain KJY10, was matched the closest to a normal distribution.  This strain 
was expected to either have a bimodal distribution if two populations of peroxisomes were 
present or a normal distribution if this population was homogenous.  This was corroborated by 
the scatter plot showing no evidence of two populations.  It is therefore possible to conclude that 
the human and yeast Pex3p work closely in tandem, producing a uniform population of yeast-
human hybrid peroxisomes.   




7 Discussion and Further Work 
 
 
The aims of this Thesis were to develop a standard to measure the activity of E. coli promoters 
and compare results to those of other labs using an in vivo reference standard, to develop and 
build a set yeast strains capable of expressing human and yeast peroxisomes, to image these 
yeast strains, to validate the nature of the peroxisome population through numerical analysis, and 
finally, to investigate the creation of heterologous (or artificial) peroxisomes.   
 
An in vivo reference standard to measure E. coli promoter activity was created using BioBricks 
from the Registry of Standard Biological Parts.  This standard was called the Relative Promoter 
Unit (RPU) and was based on comparing the activity of a reference promoter BBa_J23101 to 
other promoters under the same conditions.  This standard was used to measure the activity of a 
collection of promoters that were distributed to multiple labs at six different institutions.  The 
results showed a less than two-fold range across the three promoters measured by the labs, when 
standardized to the reference promoter.  This activity shows that a lack of standardized 
equipment and calibrations does not inhibit recording standard measures of promoter activity 
when using a reference standard and protocol.  Labs can now standardize promoter measurement 
by simply adhering to a measurement protocol and using a reference strain.   
 
The aim of the yeast promoter experiments was to assess the promoter activity of a strain 
collection in several different media compositions by applying knowledge gained from the E. 
coli measurement experiments.  Further work needs to be conducted to measure the promoter 
collection strains with single constructs, in a standard glucose media.  Using the Kelly method 
with only the YFP fluorophores could result in a more robust, reliable comparative measure for 
yeast promoters where the ADH1 promoter could be used as the reference standard.   
 
A collection of yeast strains was built in an attempt to create artificial peroxisomes.  Background 
strains (BY4741a and YPH500α) were selected and the key peroxisome biogenesis proteins 
(Pex3p and Pex19p) were knocked out.  BioBrick constructs were assembled from yeast and 




human genomic DNA to rescue the function of these peroxisomes.  These constructs were built 
and assembled in E. coli and then transformed into yeast to create a collection of control strains 
and a master experimental strain.  The BY4741 strain eventually proved more successful and 
was used to collect data.  Once all the controls and the main experimental strain had been 
constructed, the imaging and analysis was conducted.   
 
This Chapter highlights the key findings from the results and analysis Chapters.  The E. coli and 
S. cerevisiae promoter measurement work is discussed, followed by the peroxisome project.  
Key microscope setup information, images and numerical results are interpreted and discussed in 
the greater context of the work.  Chapter 5 presented images of the peroxisome strains.  Chapter 
6 showed the results of the numerical Matlab analysis.  Finally, this work will be discussed in 
the greater context of the scientific community.   
7.1 E. coli and S. cerevisiae Promoter Measurement Discussion  
A method to measure the promoter activity in E. coli across multiple labs using a standardized 
reference promoter was presented.  Construct BBa_I20260 (promoter only part: BBa_J23101) 
was chosen as the constitutive E. coli reference promoter.  Results from the multi-institution 
experiments were shown, indicating that using a relative standard and measurement protocol can 
produce close results across labs with non-standard equipment.  This method built on previous 
work by Miller by allowing promoter measurement to be compared between labs on different 
days (Miller and Zipser 1977).  It was hoped researchers will adopt this method to increase the 
body of knowledge associated with the characterization of biological parts.  To this end, a 
measurement kit was developed and distributed to the iGEM teams during the 2008 competition 
and discussions with teams who used the kit reported that it worked well.   
 
The aims of the yeast promoter experiments were to assess the promoter activity of a strain 
collection in different media compositions by applying knowledge gained from the E. coli 
measurement experiments and to investigate a yeast reference promoter.  This work indicated 
that the ADH1 promoter could be used as a reference promoter.  Selecting this promoter must, 
however, come with the caveat of acquiring measurements during mid-log phase when the strain 
is grown in glucose.  The promoter is known to be repressed as the concentration of ethanol in 
the medium increases which will change the nature of the measurements.  The protocol specified 




glucose as the carbon source in the media.  This promoter should be tested and characterized 
relative to other suitable candidates such as HXT1, HXT2, HIS3 and potentially PGK1 in order to 
select the correct standard promoter in yeast.  HXT1 and HXT2 regulate hexose transport, 
allowing yeast to grow on glucose (Reifenberger, Freidel et al. 1995).  They are responsive to 
different concentrations of glucose, therefore, further testing would be required to assess which 
of the two promoters would be better suited to measurements over time.  HIS3 is involved in 
histidine biosynthesis, so using it as a measurement standard would require standard growth 
conditions to regulate the quantity of histidine in the media.  PGK1 is involved in ATP 
biosynthesis.  It is highly expressed, the mRNA is highly stable and has been thoroughly studied 
by the yeast community (Chambers, Tsang et al. 1989; Packham, Graham et al. 1996).    The 
ideal solution would be a synthetic promoter that expressed the same protein irrespective of 
growth media, conditions or growth phase and potentially organism. However, designing this 
promoter would present a significant technical challenge, irrespective of whether this feat is 
actually possible.   
 
The first step in assessing these promoters would be to test how their expression levels change 
over time during different phases of yeast growth, which reflect dynamic changes in nutrient 
availability as culture medium is progressively depleted.  If they express protein at a constant 
rate during mid-log phase, then protocols from the Kelly method could be employed.  If not, 
they may not be suitable to use as a standardized promoter for yeast.  Further work is required to 
measure the promoter collection strains with single constructs.  YFP measurements were 
ultimately not reported in conditions other than SD.  Using the Kelly method with only the YFP 
fluorophores could result in a more robust, reliable comparative measure for yeast promoters.    
7.2 Synthetic Hybrid Peroxisome Discussion 
The KJY14 control strain produced images with cytoplasmic localization in the YFP channel, a 
result that was unexpected (genotype: BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-
RFP-PTS1, TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-hsPEX19, HIS1::pPEX3-scPEX3-
YFP-ADH1t-pPEX19-scPEX19).  The yeast Pex3p-YFP construct was locating to the cytoplasm 
in some cases (approx. less than 20% of cells).  This strain possessed both human and yeast 
copies of Pex19p, so interference could be hypothesized to come from the human Pex19p.  If the 
human Pex19p docked to yeast Pex3p and did not undock the cargo, there could be an 




accumulation of Pex3p proteins docked to human Pex19p in the cell, which might appear as 
cytoplasmic localization.  This problem could be assessed and monitored if time-lapse videos, 
cell tracking and peroxisome tracking had been implemented.   
 
The KJY10 strain (BY4741 MATa, pex3-Δ, pex19-Δ, LEU2::pHIS3-RFP-RFP-PTS1, 
TRP1::pPEX3-scPEX3-CFP-ADH1t-pPEX19-scPEX19, HIS1::pPEX3-hsPEX3-YFP-ADH1t-
pPEX19-hsPEX19) was the main experimental strain for the work conducted on the 
DeltaVision.  It was transformed with three constructs.  The first was the RFP-PTS1 to test for 
peroxisome function.  The second is the yeast Pex3p-CFP and Pex19p construct, to induce yeast-
CFP peroxisomes.  The third is the human Pex3p-YFP and Pex19p construct to induce human 
peroxisomes.  Figure 5.28 A) shows the RFP-PTS1 construct and functional peroxisomes.  
Figure 5.28 B) shows the yeast Pex3p-CFP peroxisomes.  Figure 5.28 C) shows the human 
Pex3p-YFP peroxisomes.  Figure 5.28 D) is the first false color composite CFP-YFP image.  As 
explained in the introduction to this Chapter, CFP is represented by green and YFP by red with 
yellow being the overlap of the two colors.  This image shows most of the peroxisomes 
appearing as yellow/light green indicating that there is little evidence of two species specific 
populations of peroxisomes.  Figure 5.28 D shows a very close correlation to both Figure 5.28 B 
(Cerulean) and Figure 5.28 C (mVenus) upon visual inspection.  This information has been 
obtained using a much better suited microscopy setup, an observer bias free image analysis 
technique and a superior 3d-deconvolution process.  Images from the DeltaVision are better 
representations of the actual depth of grey scale.   
 
Automated image analysis of peroxisomes has been previously described (Niemisto, Selinummi 
et al. 2006).   This analysis was furthered by comparing two populations of peroxisomes based 
on a common marker for peroxisome function (RFP-PTS1) in search of bimodality. Figure 6.26 
shows the second normalized YFP/CFP scatter plot and the log of CFP/YFP histogram.  On the 
scatter plot, there is clearly only one area of high density points as shown by the red color.  This 
denotes a single population of peroxisomes with uniform characteristics.  Figure 6.27 shows the 
YFP/CFP histogram data and fitted distributions.  The normal distribution was found to have the 
best fit by calculating the sum of the residuals squared.  This strain was expected to either have a 
bimodal distribution if two populations of peroxisomes were present or a normal distribution if 




this population was homogenous.  A normal distribution was observed indicating a lack of 
bimodality which was corroborated by the scatter plot also showing no evidence of two 
populations of peroxisomes.   
 
The script to analyze the image data collected using the Nikon microscope was flawed due to an 
error in the observer thresholding bias.  This error was introduced due to the lack of third 
channel (RFP) to allow for normalization.  The error introduced a significant bias on the 
bimodality due to the image to image variation.  When spurious images were removed from the 
data-set, the bimodality disappeared, leading to the knowledge that this analysis technique was 
insufficient.  This applied to all dual channel data that was processed with this technique.  The 
DeltaVision analysis technique starts with an image to image normalization process as has been 
explained in Chapter 6.  This process results in a change to the relative scaling of the quantified 
data, leaving the only comparison metric to be the shape and nature of the distribution on the 
histogram and the pattern of the scatter plot.  The relative scale of the data cannot be compared 
as it has been normalized on an image to image basis.  As the important quantities are the 
distribution of the CFP/YFP histogram and the shape of the scatter plot, this was not deemed a 
problem.   
 
When investigating such a phenomenon in the future, several important questions first need to be 
asked.  The first is whether the microscopy setup is correct and sufficiently sensitive for the 
expected phenomenon?  Does the camera capture all the observed phenomena, i.e. can the sensor 
be saturated without using unreasonably long exposure times and extreme levels of brightness?  
When examining the analysis, what are the most important points relative to the data needed to 
demonstrate the phenomena under investigation?  What factors will make this analysis more or 
less robust and what factors is it most sensitive to?  Contemplating and answering these 
questions in future projects would likely make data capture and analysis more robust and reliable 
at the stage in the project where changes are easy to make.   
7.3 Conclusions 
Previous research has been conducted to investigate the construction of artificial organelles.  
One such group sought to recreate the function of the Golgi apparatus in vitro using 
microfluidics, magnetic particles and recombinant enzymes (Martin, Gupta et al. 2009).  Another 




group created artificial organelles in vivo using polymers that were internalized and remained 
stable in macrophage cells for up to 48 hours (Ben-Haim, Broz et al. 2008).  The 2007 UCSF 
iGEM team set out to make an artificial organelle by expressing a higher eukaryote lipid 
phosphatase MTM in S. cerevisiae.  They were successful in their attempts and produced 
fluorescence images of GFP tagged synthetic organelles in yeast (Chen 2007).   However, none 
of the groups mentioned have looked at using peroxisomes as a base for organelle engineering.  
We built a yeast strain that produced novel functional peroxisomes in S. cerevisiae using Human 
Pex3p and Pex19p.  This project builds on previous work by constructing a human-yeast hybrid 
organelle in vivo.  Human Pex19p has previously been shown to bind to yeast Pex3p (Fransen, 
Wylin et al. 2001; Fransen, Brees et al. 2002).  Although the human Pex19p – yeast Pex3p 
interaction has previously been shown, we are unaware of any literature demonstrating the 
creation of peroxisomes functional in the import of PTS-tagged proteins using human Pex3p and 
Pex19p in yeast.   
 
The analysis script output an Excel data file that was normalized and analyzed using Matlab.  
The result of this numerical analysis was a scatter heat map of the YFP vs. CFP peroxisome 
intensity and a histogram of the log of the CFP to YFP ratio.  The curve fitting toolbox was used 
to fit distributions to this histogram to analyze the dynamics of the populations.  The sum of the 
square of the residuals was calculated to assess the quality of the fitted distributions.  The four 
tri-channel control strains were analyzed using Matlab and the scatter heat map and the 
distribution fit analysis were compared and discussed relative to the microscopy images.  The 
control strains were KJY11, KJY14 and KJY15.  From the control strains, KJY14 showed the 
most interesting results.  The strain showed two populations in the scatter heat map and although 
the data were sparse, it showed a bimodal distribution in the histogram.  When looking at the 
images to confirm this analysis, cytoplasmic localization can be clearly seen leading to these 
results being not a true representation of the actual situation.   
 
The main experimental strain KJY10 showed a single population of peroxisomes on the 
normalized scatter heat map.  The distribution that best fitted the histogram was a normal 
distribution, indicating a complete lack of bimodality.  The microscopy images were then 
reviewed and by visual inspection showed no evidence of two populations of peroxisomes.  This 




experiment therefore produced no evidence of bimodality when examining the interactions of 
human and yeast Pex3p and Pex19p peroxins.  The four proteins have been shown to cooperate 
to produce a single population of chimeric human-yeast peroxisomes.  The project was 
successful in creating a yeast strain that produced peroxisomes in yeast using human Pex3p and 
Pex19p.   
 
The author was also involved in continuing work on the arsenic biosensor first described during 
the iGEM competition (Aleksic, Bizzari et al. 2007).  The continuation of this work involved 
designing high-throughput colorimetric pH assay system that was used to quantify arsenic 
concentrations in groundwater analogs.  The publication, entitled “A pH-based biosensor for 
detection of arsenic in drinking water” was submitted, peer-reviewed and at the time of 
publication of this Thesis, was being prepared for re-submission.  This publication can be found 
in Appendix 3: ABC paper on page 169.  A complete list of the author‟s publications can be 
found on page 152.  
7.4 Further Work  
The promoter measurement work in E. coli could be continued by examining inducible 
promoters and promoters that use other sigma factors to affect transcription.  A method would 
need to be designed so that standard measures of, for example IPTG, could be reliably and 
repeatedly used to induce promoters to the same level of activity.  This could then be further 
developed as a method to measure the activity of promoters inducible by the presence of biotic 
or abiotic factors.  This work could also be applied to other organisms such as B. subtilis or S. 
elongatus, where a reference promoter would need to be defined.  Future promoter measurement 
work in S. cerevisiae could continue the experiments to demonstrate suitability of the ADH1 
promoter as the yeast reference promoter and establish a standard measurement protocol and 
media conditions.  Another project could investigate finding in nature or designing a promoter 
that responds in a universal manner to all media conditions and investigating how to measure 
inducible promoters.  This promoter would probably need to be engineered as it is unlikely to 
exist in current biology.   
 
With the initial results indicating no bimodality, the door remains open to further experiments to 
create an artificial population of peroxisomes.  The necessity of having two populations of 




peroxisomes is a matter of debate as yeast could survive without endogenous peroxisomes, 
rendering bimodality in the peroxisome population unnecessary if synthetic peroxisomes are the 
intended outcome.  A system could be developed to create temporary bimodality by putting key 
proteins such as Pex3p and Pex19p under control of inducible promoters.  The PEX genes are 
induced using oleic acid and raffinose.  Constructs could be made to express the key peroxins 
under the control of promoters induced by IPTG for a peroxisome on/off switch or constitutively 
expressed using the hexose transport (HXT) genes.  These genes would include PEX3 and 
PEX19 but also a series of other genes.   
 
Protein engineering would be a viable option to further the work on creating artificial organelles.  
If the binding domains of the human and yeast Pex3p-Pex19p interaction could be re-designed to 
be sufficiently different from each other, then bimodality might be observed.  As the protein 
structures have now been resolved for Pex3p and Pex19p, this is now a more realistic possibility 
(Schmidt, Treiber et al. 2010; Schueller, Holton et al. 2010).  This could be done by using 
binding domains from another species that have no similar motifs in yeast.   
 
One option for further work with the current data-set would be to investigate the stochasticity 
regarding the number of peroxisomes per cell.  The cell of origin information was captured, but 
not analysed so the data are present.  Literature quotes cells as having one or two peroxisomes 
when the cells are growing under normal conditions (YEDP/YPDA).  What makes a cell create a 
single peroxisome or several peroxisomes in a population of yeast cells?  Is this behavior 
deterministic or random?  In the context of the human and yeast peroxisome strain, does this 
behavior change from generation to generation and over time, does the population prioritize a 
specific species? 
 
Following up on this question, the stochasticity could be investigated from generation to 
generation using time lapse fluorescence microscopy.  An experiment could be setup to monitor 
the population over a period of 24 hours.  Software would need to be written to track the cell of 
origin during the imaging and to assess the nature of the peroxisomes during the experiment.  If 
a cell has solely yeast or human peroxisomes, what characterizes the daughter cell?  Does it 
show the same characteristics as the mother cell, a homogenous population of peroxisomes or 




the exact opposite?   If these cells are tracked over time, is there any way to change the 
population composition by changing the media type or by modifying other external factors?   
7.5 Perspective on Synthetic Biology 
One of the greatest achievements in science was the sequencing of the human genome.  Since 
the completion of the project, another 10 people have had their genomes sequenced and projects 
are in place to sequence hundreds and even thousands of individual genomes in an attempt to 
understand medicine at a genetic level.  As sequencing capacity has increased exponentially, 
costs have fallen proportionately.  Although DNA synthesis costs are still high relative to 
sequencing, the costs and error rates are eventually expected to fall, paving the way to a new 
world of digital biology.  However, building new synthetic genes, proteins, pathways and 
eventually new organisms is not as simple as entering a genetic sequence into a web form and 
pressing the “order” button.   
 
Many major challenges are still facing the field.  One concerns part characterization and 
function.  Parts can be defined as single genes, promoters, terminators, assemblies of parts and 
even entire metabolic networks could be built onto a single plasmid or integration vector.  How 
are these parts characterized?  Will libraries of parts be necessary for each organism?  How will 
characterization differ across organisms?  Another of the issues is standardization.  How do you 
standardize protein function?  How accurate do the measurements need to be?  What are the 
tolerances on these measurements and how far out of the specification can these parts be before 
biological malfunction will crash the system?  This information will likely be highly context 
specific; in terms of building a simple system to express GFP, the system will likely be robust to 
fluctuations in promoter expression levels.  When engineering a metabolic pathway to produce 
pharmaceuticals or chemicals, flux of different intermediaries will be subject to much tighter 
control, both in terms of the robustness of the system to external perturbations and of the 
financial viability of the industrial process.  More protein-protein interactions are also needed to 
further the field of Synthetic Biology.  The ideal situation would be to write a coding region of 
DNA and be able to predict the functional structure.  This problem has been described as being 
as difficult as accurately predicting the weather, so the challenge is not insignificant.  Knowing 
the context in which the protein will function and other structures necessary for it to form will be 
key to this development, but in the mean time being able to reliably engineer functional protein 




domains in constructs would be of immense value.  There are parts for this purpose in the 
Registry of Standard Biological Parts, but they are generally not heavily used or well 
characterized.   
 
These challenges are great, but are being addressed as the field of Synthetic Biology continues to 
develop.  The field of biology is at a turning point.  Progress made with single cell organisms 
will apply in other areas.  Techniques will be developed to allow reliable specific integration of 
genetic material into mammalian cells.  Genetic modifications will begin to move beyond the lab 
and into people‟s daily lives.  A large part of the coming synthetic world of biology will involve 
cheaper, faster and better production of commercially valuable biological molecules such as 
drugs and fuels.  Moving beyond commercial production, cells will be modified to fight cancer 
and cure human diseases in ways that pharmaceuticals will never be capable.  The final stage of 
the synthetic world could be the advent of synthetic organisms, designed to solve problems far 
and beyond the capabilities of existing technology.  This synthetic world will be ushered starting 
with small steps, designing custom organelles and measuring simple genetic regulatory function, 
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Appendix 2: Supplemental Protocols 
 
Methods Specific to the E. coli Promoter Measurement Project 
A cell growth and measurement protocol was to suit the multi-institution measurements.  The 
aim of the protocol design was to establish something easy enough to allow an iGEM team to 
take the measurements with little or no specialized training.  No attempts were made to 
standardize the equipment across the testing institutions.   
E. coli Culture Protocol 
The multi-institution protocol was developed and tested using a flow cytometer (Kelly 2008): 
1) Streak LB + Kan plates of the 5 test strains and an LB (no antibiotic) for TOP10  
2) For each test construct add 5ml of supplemented M9-glycerol medium and Kanamycin 
(20 µg/ml) to three 14 ml test tubes (15 tubes total). Add 5 ml of supplemented M9 
medium (w/glycerol) with no antibiotic for the TOP10 negative control cells to three 14 
ml test tubes.  
3) Inoculate media by picking single colonies from plates using tips. Grow cultures for 20 
hrs at 37 °C with aeration at 200 rpm.  
4) In the morning dilute 100x into 5ml of pre-warmed (37 oC) fresh media to get cells back 
into log phase and let grow for 4hrs under same conditions as overnight  
5) The cultures should be at an OD of 0.2 - 0.4 after 4hrs.  
Live Cell E. coli Flow Cytometry Procedure 
Cells were collected at two time points while the cultures were in exponential phase.  The GFP 
channel was measured once the flow cytometer had been calibrated (Kelly 2008): 
1) When the 5 ml culture reaches OD600 ~ 0.300, pellet the cells by centrifuging 1ml of 
each culture in an Eppendorf at 3000 g at room temperature for 5 minutes.  
2) Remove the supernatant.  
3) Resuspend the cell pellet in 1 ml PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Sodium 





4) Add 250 µl washed cells through the cell strainer lid into a 5 ml polystyrene tube. To get 
the solution to pass through the strainer, apply slight pressure to the strainer lid with the 
pipette tip as dispensing the cell solution.  
5) Add 250 µl PBS through the cell strainer lid into the 5 ml polystyrene tube.  
6) Place cells on ice.  
7) Analyze cells by flow cytometry using 488 nm excitation as quickly as possible.  
S. cerevisiae growth protocol  
This protocol was developed for use with the BD LSD-II flow cytometer as used with the E. coli 
promoter measurement experiments.  It was adapted to work with yeast, and with a greater 
number of samples. 
1) Fill a 96 well deep-well plate with 750 µl of YEPD media per well 
2) Inoculate using a 96 head pin tool from the frozen glycerol stock plate 
3) Grow the plate overnight to saturation in a shaking incubator at 30 oC and 1000 rpm.   
The high rpm was achieved in an Appropriate Technical Resources (ATR) Multitron 2 
4) Fill a 96 well U-bottom plate with 200 µl of SD or S-KAc media per well 
5) Inoculate the 96 well deep-well plate using 50 µl of culture (to an OD of ~0.1 at 600 
nm) and place in shaking incubator for 3-4 h 
6) Spin down the plate and extract media with vacuum line/multi-head pipette 
7) Wash cells using ddH20 twice 
8) Re-suspend cells in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Sodium Phosphate 
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Appendix 7: Image Pro 7.0 Macro V.5 script 
 
Public BlueId As Integer, YellowId As Integer, RedId As Integer 
Public BlankId As Integer, YeastId As Integer, ProcessedYeast As 
Integer 
Public DoughnutId As Integer, ProcessedYellow As Integer, 
InvertMask As Integer, ProcessedBlue As Integer, ProcessedRed As 
Integer 
 





    ret = MsgBox("This is Version 5 of the macro (uses RFP image 








 ret = MsgBox("Move data from YFP to sheet 2 in Excel as 
sheets one will be overwritten") 
 Step1CreateOutlines 
 MeasureRFP 
 ret = MsgBox("Move data from CFP to sheet 2 in Excel as 
sheets one will be overwritten") 
 Step1CreateOutlines 
 ret = IpAoiManager(AOIDELETE,"")'delete all AOIs 




Dim x As Integer 
 ret = MsgBox("Open Files in the order CFP, YFP, RFP") 
 'Open and max intensity composite 3 images 
 ret = IpTemplateMode(1) 
 For x = 0 To 2 
  'ret = 
IpWsLoad("\\129.215.237.150\s0129661\Microscopy\10_S7_1_R3D - 
470 nm.seq","seq") 
  'ret = IpWsLoad("E:\Kim_test\10-25-09_1-





  'ret = 
IpWsLoad("G:\Kim_IMPro_processing\7_24h\10_S7_1_R3D - 470 
nm.seq","seq") 
  ret = IpWsLoad("E:\Kim_test\12-01-09\ - 470 nm - 470 
nm.seq","seq") 
 
 Next x 
 
BlueId = 3 
YellowId =4 
RedId = 5 
 
'BlueId = 0 
'YellowId =1 
'RedId = 2 
 
ret = IpBlbShow(1) 
 For x = 0 To 2 
  ret = IpEDFAdd(x) 
  ret = IpEDFNew(x) 
  ret = IpEDFSet(EDF_NORMALIZE, 0, 0) 
  ret = IpEDFSet(EDF_CRITERIA, EDF_MAX_INTENSITY, 0) 
  ret = IpEDFSet(EDF_ORDER, EDF_BOTTOMUP, 0) 
  ret = IpEDFCreate(EDF_COMPOSITE) 
 Next x 
 ret = IpTemplateMode(0) 
 For x = 0 To 2 
  ret = IpAppSelectDoc(x) 
  ret = IpDocClose() 
 Next x 
 
 'Open and prepare Blank Image 
 ret = MsgBox("Open Blank Image") 
 ret = IpTemplateMode(1) 
 'ret = 
IpWsLoad("\\129.215.237.150\s0129661\Microscopy\10_S7_1_R3D - 
470 nm.seq","seq") 
    'ret = IpWsLoad("E:\Kim_test\10-25-09_1-3h\10_S7_1_R3D - 470 
nm.seq","seq") 
 'ret = IpWsLoad("G:\Kim_IMPro_processing\7_24h\10_S7_1_R3D 
- 470 nm.seq","seq") 
 ret = IpWsLoad("E:\Kim_test\12-01-09\10_S5-CYR_1_R3D\ - 470 
nm - 470 nm.seq","seq") 
 ret = IpTemplateMode(0) 
 ret = IpDocGet(GETACTDOC, 0, BlankId) 
 ret = MsgBox("Open yeast image") 





 'ret = 
IpWsLoad("\\129.215.237.150\s0129661\Microscopy\10_S7_1_R3D - 
470 nm.seq","seq") 
 'ret = IpWsLoad("E:\Kim_test\10-25-09_1-3h\10_S7_1_R3D - 
470 nm.seq","seq") 
 'ret = IpWsLoad("G:\Kim_IMPro_processing\7_24h\10_S7_1_R3D 
- 470 nm.seq","seq") 
    ret = IpWsLoad("E:\Kim_test\12-01-09\10_S5-CYR_1_R3D\ - 470 
nm - 470 nm.seq","seq") 
 ret = IpTemplateMode(0) 






 ret = IpAppSelectDoc(BlankId) 
 'ret = IpOpNumberArithmetics(3000.0, OPA_SUB, 0) 
 ret = IpOpNumberArithmetics(1500.0, OPA_SUB, 0) 'This is 
the line that changes the numerical subtract from the background 
 ret = IpAppSelectDoc(YeastId) 
 ret = IpOpShow(1) 
 ret = IpOpImageArithmetics(BlankId, 0.0, OPA_SUB, 1) 
 ret = IpOpShow(0) 
 ret = IpDocGet(GETACTDOC, 0, ProcessedYeast) 
 ret = IpAppSelectDoc(YeastId) 
 ret = IpDocClose() 
 ret = IpAppSelectDoc(BlankId) 
 ret = IpDocClose() 
 
 ret = IpAppSelectDoc(BlankId) 
 ret = MsgBox("Select part of stack to best show doughnuts") 
 ret = IpEDFAdd(ProcessedYeast) 
 ret = IpEDFNew(ProcessedYeast) 
 ret = IpEDFSet(EDF_NORMALIZE, 0, 0) 
 ret = IpEDFSet(EDF_CRITERIA, EDF_MAX_INTENSITY, 0) 
 ret = IpEDFSet(EDF_ORDER, EDF_BOTTOMUP, 0) 
 ret = IpEDFCreate(EDF_COMPOSITE) 
 ret = IpDocGet(GETACTDOC, 0, DoughnutId) 
 
 ret = IpAppSelectDoc(ProcessedYeast) 
 ret = IpDocClose() 
 
 ret = IpAppSelectDoc(DoughnutId) 
 ret = IpFltLoPass(3, 10, 5) 
 ret = IpSegSetRange(0, 2048, 65535) 






 ret = IpBlbSetFilterRange(BLBM_AREA, 307.0921021, 
30709.21094) 
 ret = IpBlbCount() 
 ret = IpBlbUpdate(0) 





 '**      FILTERING SECTION 
    ** 
 '**********************************************************
*** 
 ret = IpLSFltApply(LF_HIPASS,10,10,2,1) 'Large Spectral 
HighPass 
 'ret = MsgBox("Manually Threshold images to select halos") 
 'ret = IpBlbCount() 
 'ret = IpBlbUpdate(0) 
 'ret = IpBlbCreateMask() 
 ret = IpFltClose(MORPHO_2x2SQUARE, 3)  'Close Filter 
 ret = IpFltDilate(MORPHO_2x2SQUARE, 3) 'Dilate Filter 
 ret = IpFltErode(MORPHO_2x2SQUARE, 3) 'Erode Filter 




 '**    END OF FILTERING SECTION  




 'Produce Yeast cell AOI 
 ret = IpBlbSetFilterRange(BLBM_AREA, 153.5460510, 
2456.736816)  ' Area filter range of 2.5 - 40 
 'ret = IpBlbSetAttr(BLOB_BRIGHTOBJ, 0) 'Turn on 
measure dark objects 
 ret = MsgBox("Select Automatic Dark Objects") 
 ret = IpBlbCount()       ' 
Count dark objects 
 ret = IpBlbUpdate(0) 
 ret = 
IpBlbSaveOutline("\\129.215.237.150\s0129661\Microscopy\Outlines
_Temp\Outlines.scl") 'Save resulting cell outlines 
 
 ret = IpDocClose() 
 ret = IpAppSelectDoc(DoughnutId) 







 Sub MeasureYFP 
  Dim RedIdDup As Integer, RedIdSub As Integer 
 
 ret = IpAppSelectDoc(RedId) 'Select RFP image 
 ret = IpWsDuplicate()  'Duplicate RFP image (one for 
low pass filtering 
 ret = IpDocGet(GETACTDOC, 0, RedIdDup) 
 ret = IpLSFltApply(LF_LOPASS,10,10,2,1) 'Large Spectral 
HighPass 
 ret = IpAppSelectDoc(RedId) 
 ret = IpOpImageArithmetics(RedIdDup, 0.0, OPA_SUB, 1)
 'Subtract LoPassed duplicate image from original RFP image 
 ret = IpDocGet(GETACTDOC, 0, RedIdSub) 
 ret = IpAppSelectDoc(RedIdSub)   'Select 
subtracted RFP image 
 ret = IpLSFltApply(LF_HIPASS,10,10,2,1) 'Apply highpass 
filter 
 'ret = IpBlbSetFilterRange(BLBM_AREA, 6.141842365, 
12.28368473) 'Set area measurement filters 0.1 -0.2 
 'ret = IpBlbSetFilterRange(BLBM_AREA, 9.212763786, 
73.70211029) 'Set area measurement filters 0.15 - 1.2 
 'ret = IpBlbSetFilterRange(BLBM_AREA,  5.86, 46.92) 
    ret = IpBlbSetFilterRange(BLBM_AREA, 10, 70) 'Set area 
measurement filters ~0.15 - 1.2 
 ret = IpSegShow(1) 
 ret = IpSegSetRange(0, 2048, 65535) 
 ret = MsgBox("Set Threshold Values") 
 ret = IpBlbCount()   'Count Objects in image 
 ret = IpBlbUpdate(0) 
 ret = IpBlbCreateMask()  'Make mask of counted 
objects 
 ret = IpLutSetAttr(LUT_CONTRAST, -2)    'Invert Mask 
 ret = IpDocGet(GETACTDOC, 0, InvertMask) 
 ret = IpAppSelectDoc(YellowId) 'Select the YFP image 
 ret = IpOpImageArithmetics(InvertMask, 0.0, OPA_SUB, 1) 
 ret = IpDocGet(GETACTDOC, 0, ProcessedYellow) 
 ret = IpSegSetRange(0, 257, 65535) 
 ret = IpSegPreview(CURRENT_C_T) 
 ipICal(0) = 257 
 ipICal(1) = 65535 
 ret = IpBlbMultiRanges(ipICal(0), 1) 
 
 'ret = IpAppSelectDoc(RedId) 
 'ret = IpDocClose() 
 ret = IpAppSelectDoc(RedIdSub) 









 ret = IpAppSelectDoc(BlueId) 'Select the CFP image 
 ret = IpOpImageArithmetics(InvertMask, 0.0, OPA_SUB, 1) 
 ret = IpDocGet(GETACTDOC, 0, ProcessedBlue) 
 ret = IpSegSetRange(0, 257, 65535) 
 ret = IpSegPreview(CURRENT_C_T) 
 ipICal(0) = 257 
 ipICal(1) = 65535 




 ret = IpAppSelectDoc(RedId) 'Select the RFP image 
 ret = IpOpImageArithmetics(InvertMask, 0.0, OPA_SUB, 1) 
 ret = IpDocGet(GETACTDOC, 0, ProcessedRed) 
 ret = IpSegSetRange(0, 257, 65535) 
 ret = IpSegPreview(CURRENT_C_T) 
 ipICal(0) = 257 
 ipICal(1) = 65535 
 ret = IpBlbMultiRanges(ipICal(0), 1) 
End Sub 
 
'Count objects on image 1 and then execute the macro 
Sub Step1CreateOutlines 
 ret = IpMacroStop("Count objects on image 1 . Click 
Continue to save the outlines of every object to AOI manager. 
Then go to step 2.", 0) 
 If ret=2 Then Exit Sub    'cancel 
 ReDim blbpts(1000) As POINTAPI 
 Dim numpoints As Integer, numobj As Integer 
 Dim status As Integer, i As Integer 
 ' get the total number of objects, in-range and out-of-
range, 
 ' hidden and visible. 
 
'ret = IpAppSelectDoc(ProcessedYellow) 





 ret = IpBlbGet(GETNUMOBJEX, 0, 0, numobj) 
 IpAoiManager(AOIDELETE,"")'delete all AOIs 
 For i = 0 To numobj - 1 





    If numpoints > 0 Then 
         ' create AOI out of the object outline and XOR it. 
         ret = IpAoiCreateIrregular(blbpts(0), numpoints) 
   ret = IpAoiManager(AOIADD, "Polygon" & Str(i+1)) 
    End If 
 Next i 
 IpIniFile(INICMD_SETINT,"NumberOfAOIs",numobj) 





 ret = IpMacroStop("Set threshold and count/size parameters 
on image 2 and click Continue to measure object parameters 
withing saved on step 1outlines .", 0) 
 If ret=2 Then Exit Sub'cancel 
 Dim i As Integer, numobj As Integer, status As Integer, 
numeasure As Integer, x As Integer 
Dim FirstCol As String, SecondCol As String, ThirdCol As String, 
FourthCol As String, FifthCol As String 
Dim Row As Integer 
 
 ret=IpIniFile(INICMD_GETINT,"NumberOfAOIs",numobj) 
 ' Open communication with sheet1 of Excel 
 ret = IpDde(DDE_OPEN, "Excel", "sheet1") 
 ret = IpDde(DDE_PUT, "R1C1", "Area") 
 ret = IpDde(DDE_PUT, "R1C2", "Roundness") 
 ret = IpDde(DDE_PUT, "R1C3", "Max Intensity") 
 ret = IpDde(DDE_PUT, "R1C4", "Average Intensity") 
 ret = IpDde(DDE_PUT, "R1C5", "Cell Number") 
 
 'set append data to the bottom 
 ret = IpDde(DDE_SET, "row", "3") 
 'ret = IpDde(DDE_SET, "append", "1") 
 ret = IpDde(DDE_SET, "row", "1") 
 Row = 2 
ret = IpBlbEnableMeas(BLBM_DENSITY, 1) 
ret = IpBlbEnableMeas(BLBM_DENSMAX, 1) 
ret = IpBlbEnableMeas(BLBM_ROUNDNESS, 1) 
'ret = IpBlbSetFilterRange(BLBM_AREA, 6.141842365, 12.28368473) 
ret = IpBlbSetFilterRange(BLBM_AREA, 10, 70) 'Set area 
measurement filters ~0.15 - 1.2 
For i=0 To numobj-1 
 ret = IpAoiManager(AOISET, "Polygon" & Str(i+1)) 
 ret = IpBlbCount()'count within AOI 
 ret = IpBlbUpdate(0) 
 'export data to Excel appending the data to the bottom 











   ret = IpBlbGet(GETNUMOBJEX, 0, 0, numeasure) 
   Dim PutVal As Single 
   For x = 0 To numeasure -1 
    ret = IpBlbGet(GETSTATUS, x, 0, status) 
 
    ' Put values into cell on appropriate row 
and column. 
 
   If status >= 0 Then 
    FirstCol = "R" + CStr(Row) + "C1" 
    ret = IpBlbData(BLBM_AREA, x, x, PutVal) 
    ret = IpDde(DDE_PUT, FirstCol, 
Str(PutVal)) 
 
    SecondCol = "R" + CStr(Row) + "C2" 
    ret = IpBlbData(BLBM_ROUNDNESS, x, x, 
PutVal) 
    ret = IpDde(DDE_PUT, SecondCol, 
Str(PutVal)) 
 
    ThirdCol = "R" + CStr(Row) + "C3" 
    ret = IpBlbData(BLBM_DENSMAX, x, x, 
PutVal) 
    ret = IpDde(DDE_PUT, ThirdCol, 
Str(PutVal)) 
 
    FourthCol = "R" + CStr(Row) + "C4" 
    ret = IpBlbData(BLBM_DENSITY, x, x, 
PutVal) 
    ret = IpDde(DDE_PUT, FourthCol, 
Str(PutVal)) 
 
    FifthCol = "R" + CStr(Row) + "C5" 
    ret = IpDde(DDE_PUT, FifthCol, Str(i)) 
    Row = Row + 1 
   End If 
  Next x 
  'ret = IpBlbSaveData("",  S_Y_AXIS+S_DDE)'the rest 
without headers 















Appendix 8: Matlab image processing script 
 
% This script is for processing Macro V5 spreadsheets 
% Scripts needed to run MacroV5: 
% 
%   Labelmaker 
%   Structuremaker 
%   XLParse 
%   Structuremaker2 
%   CYRStructuremaker 
%   Plot_figure1 
%   Plot_figure2 
%   KJY15_Fit 






% File to load 
  
%FileName = '2-12-09_KJY15_Macro_V5.xls'; 
%FileName = 'KJY10_MacroV5_12-01-09';  %Works!  
FileName = 'KJY11_MacroV5_12-01-09';  %Works! 
%FileName = 'KJY14_MacroV5_12-01-09_2'; %Works minus one image 
%FileName = 'KJY15_MacroV5_12-01-09'; %Works! 
  
Data = []; 




Labels = []; 
Labels.YFPlabel = 1;  
Labels.CFPlabel = 2;  
Labels.RFPlabel = 3; 
  
[XLnum XLtxt] = xlsread(FileName); 
  
Labels.ChannelNameCol = 1; 
Data.ChannelLabels = XLnum(:, Labels.ChannelNameCol); 
  
Labels.AreaCol = 2;  
Data.Areas = XLnum(:, Labels.AreaCol); 
  
Labels.RoundnessCol = 3; 






Labels.MaxIntensityCol = 4;  
Data.MI = XLnum(:, Labels.MaxIntensityCol); 
  
Labels.AverageIntensityCol = 5;  
Data.AI = XLnum(:, Labels.AverageIntensityCol); 
  
Labels.CellNumberCol = 6; 
Data.CellNumber = XLnum(:, Labels.CellNumberCol); 
%----------------------------------------------------------------------
---- 
% %Parse out YFP, CFP and RFP Channels; 
  





YFP.AI = []; 
CFP.AI = []; 
RFP.AI = []; 
YFP.Areas = []; 
CFP.Areas = []; 
RFP.Areas = []; 
YFP.Roundness = []; 
CFP.Roundness = []; 
RFP.Roundness = []; 
YFP.MI = []; 
CFP.MI = []; 
RFP.MI = []; 
YFP.CellNumber = []; 
CFP.CellNumber = []; 
RFP.CellNumber = []; 
YFP.ImageAverage = []; 
CFP.ImageAverage = []; 
RFP.ImageAverage = []; 
YFP.ImageMultiplier = []; 
CFP.ImageMultiplier = []; 
YFP.ImageAdjust = []; 
CFP.ImageAdjust = []; 
YFP.ImageNorm1 = []; 
CFP.ImageNorm1 = []; 
CFP.AIMean = []; 
YFP.AIMean = []; 
RFP.AIMean = []; 
CFP.AIMeanArray = []; 
YFP.AIMeanArray = []; 
RFP.AIMeanArray = []; 
CFP.AINormmean = []; 
YFP.AINormmean = []; 
RFP.AIMean2 = []; 





YFP.AIMean2 = []; 
RFP.AINorm2 = []; 
CFP.AINorm2 = []; 
YFP.AINorm2 = []; 
CFP.CFP2 = []; 
YFP.YFP2 = []; 
RFP.RFP2 = []; 
CFP.CFP3 = []; 
YFP.YFP3 = []; 
RFP.RFP3 = []; 
CFP.CFP4 = []; 
YFP.YFP4 = []; 
RFP.RFP4 = []; 
  




% This section writes the Excel YFP, CFP and RFP data to the structures 
%----------------------------------------------------------------------
---- 
% This .m file is part of the MacroV5 parse script.  It writes the 
XLnum data  
%into the correct locations in the (X)FP.structure.  It was made into a 
% separate file to reduce the length of MacroV5.   
  
for i = 1:length(Data.AI); 
  
   if isnan(Data.AI(i)) 
       i; 
    
       continue 
   end 
     
   if Labels.YFPlabel == Data.ChannelLabels(i); 
       YFP.AI = [YFP.AI Data.AI(i)]; 
       YFP.Areas = [YFP.Areas Data.Areas(i)]; 
       YFP.Roundness = [YFP.Roundness Data.Roundness(i)]; 
       YFP.MI = [YFP.MI Data.MI(i)]; 
       YFP.CellNumber = [YFP.CellNumber Data.CellNumber(i)]; 
   end 
    
   if Labels.CFPlabel == Data.ChannelLabels(i); 
       CFP.AI = [CFP.AI Data.AI(i)]; 
       CFP.Areas = [CFP.Areas Data.Areas(i)]; 
       CFP.Roundness = [CFP.Roundness Data.Roundness(i)]; 
       CFP.MI = [CFP.MI Data.MI(i)]; 
       CFP.CellNumber = [CFP.CellNumber Data.CellNumber(i)]; 
   end 
    





       RFP.AI = [RFP.AI Data.AI(i)]; 
       RFP.Areas = [RFP.Areas Data.Areas(i)]; 
       RFP.Roundness = [RFP.Roundness Data.Roundness(i)]; 
       RFP.MI = [RFP.MI Data.MI(i)]; 
       RFP.CellNumber = [RFP.CellNumber Data.CellNumber(i)]; 
   end 
    
    if Labels.YFPlabel ~= Data.ChannelLabels(i) | Labels.CFPlabel ~= 
Data.ChannelLabels(i) | Labels.RFPlabel ~= Data.ChannelLabels(i); 
        %i; "~=" is the NOT EQUALS operator 
    end 






BadData = 1; 
BadData = []; 
BadData = union(BadData, find(log(YFP.AI ./ CFP.AI) < -3)); 
BadData = union(BadData, find(YFP.AI == 0)); 
  
CFP.AI(BadData) = []; 
YFP.AI(BadData) = []; 
CFP.Areas(BadData) = []; 
YFP.Areas(BadData) = []; 
  
%This section is about normalizing the CFP and the YFP data to the 
image to 
%image average and uses the RangeN array 
  
StartPos = 1; 
ImageNumber = 1; 
RangeN = []; 
  
for i = 1:length(Data.AI); 
  
   if isnan(Data.AI(i)) 
       i; 
    
       FinPos=i-1; 
       RangeN = [RangeN; StartPos,... 
                 FinPos,... 
                 (FinPos - StartPos+1),... 
                 Data.CellNumber(FinPos),... 
                 mean(Data.AI(StartPos:FinPos))]; 
       XLnum(StartPos:FinPos, 7) = RangeN(ImageNumber, 5); 
       StartPos=i+1; 
       ImageNumber=ImageNumber+1; 
       continue 







%Writing the ImageAverage data to the XLnum array 
Labels.ImageAverageCol = 7; 
Data.ImageAverage = XLnum(:, Labels.ImageAverageCol); 
  






for i = 1:length(Data.AI); 
  
   if isnan(Data.AI(i)) 
       i; 
    
       continue 
   end 
     
   if Labels.YFPlabel == Data.ChannelLabels(i); 
       YFP.ImageAverage = [YFP.ImageAverage Data.ImageAverage(i)]; 
   end 
    
   if Labels.CFPlabel == Data.ChannelLabels(i); 
       CFP.ImageAverage = [CFP.ImageAverage Data.ImageAverage(i)]; 
   end 
    
   if Labels.RFPlabel == Data.ChannelLabels(i); 
       RFP.ImageAverage = [RFP.ImageAverage Data.ImageAverage(i)]; 
   end 
    
    if Labels.YFPlabel ~= Data.ChannelLabels(i) | Labels.CFPlabel ~= 
Data.ChannelLabels(i) | Labels.RFPlabel ~= Data.ChannelLabels(i); 
        %i; "~=" is the NOT EQUALS operator 






%This section takes previously made structures and normalizes them 
based on 
%the image to image average and the RFP channel 
CFP.AIMean = mean(CFP.AI); 
YFP.AIMean = mean(YFP.AI); 
RFP.AIMean = mean(RFP.AI); 
  
YFP.ImageMultiplier = YFP.ImageAverage ./ RFP.ImageAverage; 





YFP.ImageAdjust = YFP.ImageAverage ./ YFP.ImageMultiplier; 
CFP.ImageAdjust = CFP.ImageAverage ./ CFP.ImageMultiplier; 
  
% This is the normaliztion protocol for AImean 
if CFP.AIMean/RFP.AIMean >= 0 
    CFP.ImageNorm1 = CFP.AI ./ CFP.ImageMultiplier; 
elseif CFP.AImean/RFP.AIMean <= 0 
    CFP.ImageNorm1 = CFP.AI .* CFP.ImageMultiplier; 
end 
  
if YFP.AIMean/RFP.AIMean >= 0 
    YFP.ImageNorm1 = YFP.AI ./ YFP.ImageMultiplier; 
elseif YFP.AImean/RFP.AIMean <= 0 
    YFP.ImageNorm1 = YFP.AI .* YFP.ImageMultiplier; 
end 
  
CFP.AINormmean = mean(CFP.ImageNorm1); 
YFP.AINormmean = mean(YFP.ImageNorm1); 
  
RFP.AIMean2 = RFP.ImageAverage ./ mean(RFP.AI); 
CFP.AIMean2 = CFP.ImageAverage ./ mean(RFP.AI); 
YFP.AIMean2 = YFP.ImageAverage ./ mean(RFP.AI); 
  
%Creates the CYR.Norm2structures 
if RFP.ImageAverage/RFP.AIMean >= 1 
    RFP.AINorm2 = RFP.AI .* RFP.AIMean2; 
elseif RFP.AIMean/RFP.AIMean <= 1 
    RFP.AINorm2 = RFP.AI ./ RFP.AIMean2; 
end 
  
if CFP.ImageAverage/CFP.AINormmean >= 0 
    CFP.AINorm2 = CFP.AI ./ CFP.AIMean2; 
elseif CFP.AIMean/CFP.AINormmean <= 0 
    CFP.AINorm2 = CFP.AI .* CFP.AIMean2; 
end 
  
if YFP.ImageAverage/YFP.AINormmean >= 0 
    YFP.AINorm2 = YFP.AI ./ YFP.AIMean2; 
elseif YFP.AIMean/YFP.AINormmean <= 0 







%This  section calculates RFP2, RFP3 and RFP4 
  
    CFP.CFP2=zeros(size(CFP.AI,1)-windowsize); 





        CFP.CFP2(ii)=mean(CFP.AI(ii:ii+windowsize)); 
    end 
    YFP.YFP2=zeros(size(YFP.AI,1)-windowsize); 
    for ii=1:size(YFP.AI,2)-windowsize 
        YFP.YFP2(ii)=mean(YFP.AI(ii:ii+windowsize)); 
    end 
    RFP.RFP2=zeros(size(RFP.AI,1)-windowsize); 
    for ii=1:size(RFP.AI,2)-windowsize 
        RFP.RFP2(ii)=mean(RFP.AI(ii:ii+windowsize)); 
    end 
  
    CFP.CFP3=zeros(size(CFP.ImageNorm1,1)-windowsize); 
    for ii=1:size(CFP.ImageNorm1,2)-windowsize 
        CFP.CFP3(ii)=mean(CFP.ImageNorm1(ii:ii+windowsize)); 
    end 
    YFP.YFP3=zeros(size(YFP.ImageNorm1,1)-windowsize); 
    for ii=1:size(YFP.ImageNorm1,2)-windowsize 
        YFP.YFP3(ii)=mean(YFP.ImageNorm1(ii:ii+windowsize)); 
    end 
    RFP.RFP3=zeros(size(RFP.AI,1)-windowsize); 
    for ii=1:size(RFP.AI,2)-windowsize 
        RFP.RFP3(ii)=mean(RFP.AI(ii:ii+windowsize)); 
    end     
     
    RFP.RFP4=zeros(size(RFP.AINorm2,1)-windowsize); 
    for ii=1:size(RFP.AINorm2,2)-windowsize 
        RFP.RFP4(ii)=mean(RFP.AINorm2(ii:ii+windowsize)); 
    end 
    CFP.CFP4=zeros(size(CFP.AINorm2,1)-windowsize); 
    for ii=1:size(CFP.AINorm2,2)-windowsize 
        CFP.CFP4(ii)=mean(CFP.AINorm2(ii:ii+windowsize)); 
    end 
    YFP.YFP4=zeros(size(YFP.AINorm2,1)-windowsize); 
    for ii=1:size(YFP.AINorm2,2)-windowsize 
        YFP.YFP4(ii)=mean(YFP.AINorm2(ii:ii+windowsize)); 










     
% Calculating results and numerical cell/peroxisomes statistics 
  
ResultsTable = []; 
% Total number of peroxisomes in all images calculation 





% Total number of cells in all images calculation 
ResultsTable(2 , 2) = sum((RangeN(:,4))/3); 
% Peroxisome/Cell ratio calculation 
ResultsTable(3 , 2) = (ResultsTable(1 , 2)/ResultsTable(2 , 2)); 
% Number of images in this data set calculation 
ResultsTable(4 , 2) = (length(RangeN(:,1))/3); 
  





for i = 1:3 
  a(:,i) = polyfit(x(:,i),y(:,i),1); 
end 
  
% Calculate the sum of the squares of the residuals 
% First calculate the values y_hat lying on the fitted straight line 
and 
% the corresponding residuals  
  
for i = 1:3; 
     y_hat(:,i) = polyval(a(:,i),x(:,i)); 
     residual(:,i) = y_hat(:,i)-y(:,i); 
     residual_sq(:,i) = residual(:,i).*residual(:,i); 
     Results.sum_sq_res(i) = sum(residual_sq(:,i));  
     R_12 = corrcoef(x(:,i),y(:,i)); 
     Results.r_squared(i) = R_12(1,2)^2; 
end 
  
% Write the values for the slopes 
Results.slope=a(1,:); 
%disp(' ') 
%fprintf('%s %d', 'The values for the slope are:', a(1,:)) 
% Write the values for the intercepts 
Results.intercept=a(2,:); 
%disp(' ') 
%fprintf('%s %d', 'The values for the intercepts are:', a(2,:)) 
% calculate the mean of the x and y values 
Results.mean_x = mean(x); 
%disp(' ') 
%fprintf('%s %d', 'The means of the x values are:', mean(x)) 
Results.mean_y = mean(y); 
%disp(' ') 
%fprintf('%s %d', 'The means of the y values are:', mean(y)) 
  
%Prints data from the RangeN array 
disp(' '); 
fprintf('%s %d', 'Total number of peroxisomes in all images:', 






fprintf('%s %d', 'Total number of cells in all images:', 
round(ResultsTable(2 , 2))) 
disp(' '); 
fprintf('%s %d', 'Peroxisome/Cell ratio:', ResultsTable(3 , 2)) 
disp(' '); 







%This part of the plot produces the scatterplot 
  
figure    
% %This gives an indication of the image to image variation in CFP 
subplot(1,2,1)   
    plot ((1:length(CFP.CFP2)),CFP.CFP2,'c',... 
          (1:length(YFP.YFP2)),YFP.YFP2,'y',... 
          
(1:length(RFP.RFP2)),RFP.RFP2,'r','LineWidth',2,'LineStyle','-') 
%Syntax is (x1,y1,s1,x2,y2,s2,x3,y3,s3,...) 
    title(['CYR Moving Average AI';'']); 
    %title syntax: title(['First line';'Second line']) 
  
    xlabel('Peroxisome Number') 
    ylabel('Average Intensity') 
    legend('CFP','YFP','RFP','Location','SouthOutside') 
    axis square 
%     mTextBox = uicontrol('style','text') 
%     set(mTextBox,'String','Hello World') 
   
   %set('LineWidth',3,'LineStyle',':') 
     
% This plot shows the image to image average 
subplot(1,2,2)     
    plot (1:length(CFP.ImageAverage),CFP.ImageAverage,'c',... 
          1:length(YFP.ImageAverage),YFP.ImageAverage,'y',... 
          
1:length(RFP.ImageAverage),RFP.ImageAverage,'r','LineWidth',2,'LineStyl
e','-') 
    title({'CYR Image to Image AI';'']); 
    xlabel('Peroxisome Number') 
    ylabel('Image Mean Intensity') 
    legend('CFP','YFP', 'RFP','Location','SouthOutside') 
    axis square 
     
figure 
%This is a test plot of the image to image variation on all 3 channels 
subplot(1,2,1)   





          (1:length(YFP.YFP2)),YFP.YFP3,'y',... 
          
(1:length(RFP.RFP2)),RFP.RFP3,'r','LineWidth',2,'LineStyle','-') 
%Syntax is (x1,y1,s1,x2,y2,s2,x3,y3,s3,...) 
    title(['CYR 1st Normalized Moving AI';'']); 
    xlabel('Peroxisome Number') 
    ylabel('1st Normalized AI') 
    legend('CFP','YFP','RFP','Location','SouthOutside') 
    axis square 
  
%This is a test plot of the image to image variation on all 3 channels 
subplot(1,2,2)     
    plot (1:length(CFP.ImageAdjust),CFP.ImageAdjust,'c',... 
          1:length(YFP.ImageAdjust),YFP.ImageAdjust,'y',... 
          
1:length(RFP.ImageAverage),RFP.ImageAverage,'r','LineWidth',2,'LineStyl
e','-') 
    title(['CYR 1st Normalized Image AI';'']); 
    xlabel('Peroxisome Number') 
    ylabel('Image Mean 1st Normalized AI') 
    legend('CFP','YFP', 'RFP','Location','SouthOutside') 
    axis square 
        
figure  
% This plot shows the image to image corrected  
subplot(1,2,1)   
     plot((1:length(CFP.CFP4)),CFP.CFP4,'c-',... 
          (1:length(YFP.YFP4)),YFP.YFP4,'y-',... 
          (1:length(RFP.RFP4)),RFP.RFP4,'r-
','LineWidth',2,'LineStyle','-') %Syntax is 
(x1,y1,s1,x2,y2,s2,x3,y3,s3,...) 
    title(['CYR 2nd Normalized Moving AI';'']); 
    xlabel('Peroxisome Number') 
    ylabel('2nd Normalized AI') 
    legend('CFP','YFP','RFP','Location','SouthOutside') 
    axis square 
     
subplot(1,2,2)     
    plot(1:length(CFP.AIMeanArray),CFP.AIMeanArray,'c-',... 
         1:length(YFP.AIMeanArray),YFP.AIMeanArray,'-y',... 
         1:length(RFP.AIMeanArray),RFP.AIMeanArray,'r-
','LineWidth',2,'LineStyle','-'); 
    title(['CYR 2nd Normalized Image AI';'']); 
    xlabel('Peroxisome Number') 
    ylabel('Image Mean 2nd Normalized AI') 
    legend('CFP','YFP','RFP','Location','SouthOutside') 
    axis square 
     
%----------------------------------------------------------------------
---- 








myplot = figure(4) 
%figure(4) = figure('PaperSize',[20.98 29.68]); 
  
subplot(1,2,1)   
    %plot(CFP.AI,YFP.AI,'o',CFP.AI,y_hat(:,1),'-') 
    hold on 
    dscatter(CFP.AI', YFP.AI') 
    %dscatter(CFP.AI',(YFP.AI'),'plottype','contour') 
    hold off 
    %plot(x(:,1),y(:,1),'o',x(:,1),y_hat(:,1)) 
    title(['CFP vs YFP Scatterplot';'']); 
    %xlim([0 100]) 
    %ylim([0 100]) 
    xlabel('CFP relative values') 
    ylabel('YFP relative values') 
    colorbar('Location','Southoutside','XTickLabel',... 
             ['Lower Density',' ',' ','Higher Density']) 
    %set(get(cbar_handle,'ylabel'),'string','My Title','fontsize',16) 
    %legend('CFP/YFP','contours','Location','SouthOutside') 
    %set(myplot,'Position',[100,100,500,500]) 
    axis square 
    %[n,xout] = hist(CFP.AI, YFP.AI,40);     
  
    %set(myPlot1,'Position',[100,100,500,500]) 
  
     
%This plots a histogram of the CFP/YFP ratio 
subplot(1,2,2)     
    hist (log(YFP.AI ./ CFP.AI), 50);  
    title(['YFP/CFP histogram';'']); 
    xlabel('Log of YFP/CFP') 
    ylabel('Frequency') 
    %set(myplot,'Position',[600,100,500,500]) 
    %legend('Data','Location','SouthOutside') 
    %colorbar ('Location','Westoutside') 
    axis square 
     
figure(5) 
subplot(1,2,1)   
  
    
%plot(CFP.ImageNorm1,YFP.ImageNorm1,'o',CFP.ImageNorm1,y_hat(:,2),'-') 
    hold on 
    dscatter(CFP.ImageNorm1', YFP.ImageNorm1') 
    %dscatter(CFP.ImageNorm1',(YFP.ImageNorm1'),'plottype','contour') 
    hold off 
    title(['CFP2 vs YFP2 1st Normalized Scatterplot';'']); 





    %ylim([0 100]) 
    xlabel('CFP2 relative values') 
    ylabel('YFP2 relative values') 
    colorbar('Location','Southoutside','XTickLabel',... 
            ['Lower Density',' ',' ',' ','Higher Density']) 
    %legend('Norm1','contours','Location','SouthOutside') 
    axis square 
     
%This plots a histogram of the CFP/YFP ratio 
subplot(1,2,2)     
    hist (log(YFP.ImageNorm1 ./ CFP.ImageNorm1), 50);  
    title(['YFP2/CFP2 1s Normalized Histogram';'']); 
    xlabel('Log of CFP2/YFP2') 
    ylabel('Frequency') 
    axis square 
  
figure(6) 
subplot(1,2,1)     
    % plot(CFP.AINorm2,YFP.AINorm2,'o',CFP.AINorm2,y_hat(:,3),'-') 
    hold on 
    dscatter(CFP.AINorm2', YFP.AINorm2') 
    %dscatter(CFP.AINorm2',(YFP.AINorm2'),'plottype','contour') 
    hold off 
    title(['CFP3 vs YFP3 2nd Normalized Scatterplot';'']); 
    %xlim([0 100]) 
    %ylim([0 100]) 
    xlabel('CFP3 relative values') 
    ylabel('YFP3 relative values') 
    colorbar('Location','Southoutside','XTickLabel',... 
            ['Lower Density',' ',' ','Higher Density'])     
    %legend('Norm2','contours','Location','SouthOutside') 
    axis square 
     
%This plots a histogram of the CFP/YFP ratio 
subplot(1,2,2) 
    hist (log(YFP.AINorm2 ./ CFP.AINorm2), 50);  
    title(['CFP3/YFP3 2nd Normalized Histogram';'']); 
    xlabel('Log of CFP3/YFP3') 
    ylabel('Frequency') 
    axis square 
     
%----------------------------------------------------------------------
---- 
[n,AINorm2] = hist(log(YFP.AINorm2 ./ CFP.AINorm2), 50); 
%This is the curve fitting part of  
%----------------------------------------------------------------------
---- 









%function [output_parameter_list] = function_name(input_parameter_list) 
  
%KJY15_FIT2    Create plot of datasets and fits 
%   KJY15_FIT2(AINORM2,N) 
%   Creates a plot, similar to the plot in the main distribution 
fitting 
%   window, using the data that you provide as input.  You can 
%   apply this function to the same data you used with dfittool 
%   or with different data.  You may want to edit the function to 
%   customize the code and this help message. 
% 
%   Number of datasets:  1 
%   Number of fits:  4 
  
% This function was automatically generated on 27-Apr-2010 12:20:00 
% AINorm2 = []; 
% n = []; 
%  
% AINORM2 = AINorm2(:); 
% n = n(:) 
  
% Data from dataset "AINorm2 data (2 )": 
%    Y = AINorm2 
%    Frequency = n 
%   
 PlotData = []; 
 %n = n/max(n); 
  
% Force all inputs to be column vectors 
  
% Set up figure to receive datasets and fits 
f_ = []; 
figure(7); 
set(f_,'Units','Pixels','Position',[309 241 824 578.5]); 
legh_ = []; legt_ = [];   % handles and text for legend 




% --- Plot data originally in dataset "AINorm2 data (2 )" 
t_ = ~isnan(AINorm2) & ~isnan(n); 
Data_ = AINorm2(t_); 
Freq_ = n(t_); 
[F_,X_] = ecdf(Data_,'Function','cdf'... 
               ,'freq',Freq_... 
              );  % compute empirical cdf 
Bin_.rule = 3; 
Bin_.nbins = 50; 
[C_,E_] = dfswitchyard('dfhistbins',Data_,[],Freq_,Bin_,F_,X_); 





h_ = bar(C_,N_,'hist'); 
set(h_,'FaceColor','none','EdgeColor',[0.333333 0 0.666667],... 
       'LineStyle','-', 'LineWidth',1); 
xlabel('Data'); 
ylabel('Density') 
legh_(end+1) = h_; 
legt_[end+1] = 'YFP/CFP Histogram Data'; 
  
% Nudge axis limits beyond data limits 
xlim_ = get(ax_,'XLim'); 
if all(isfinite(xlim_)) 
   xlim_ = xlim_ + [-1 1] * 0.01 * diff(xlim_); 
   set(ax_,'XLim',xlim_) 
end 
  
x_ = linspace(xlim_(1),xlim_(2),100); 
  
% --- Create fit "fit 1" 
  
% Fit this distribution to get parameter values 
t_ = ~isnan(AINorm2) & ~isnan(n); 
Data_ = AINorm2(t_); 
Freq_ = n(t_); 
% To use parameter estimates from the original fit: 
%     p_ = [ -0.04612222664033, 0.377542133208]; 
pargs_ = cell(1,2); 
[pargs_[:]] = normfit(Data_, 0.05, [], Freq_); 
p_ = [pargs_[:]]; 
y_ = normpdf(x_,p_(1), p_(2)); 
h_ = plot(x_,y_,'Color',[1 0 0],... 
          'LineStyle','-', 'LineWidth',2,... 
          'Marker','none', 'MarkerSize',6); 
legh_(end+1) = h_; 
legt_[end+1] = 'Normal Distribution'; 
  
PlotData.x1 = reshape(x_, 2, 50); 
PlotData.y1 = reshape(y_, 2, 50); 
  
% --- Create fit "fit 3" 
  
%Fit this distribution to get parameter values 
t_ = ~isnan(AINorm2) & ~isnan(n); 
Data_ = AINorm2(t_); 
Freq_ = n(t_); 
%   To use parameter estimates from the original fit: 
%     p_ = [ -0.05227557744762, 0.3571478053621, 19.1096594856]; 
p_ = mle(Data_, 'dist','tlocationscale', 'alpha',0.05, 'cens',[], 
'freq',Freq_);  % Fit t location-scale distribution 
y_ = pdf('tlocationscale',x_,p_(1), p_(2), p_(3)); 
h_ = plot(x_,y_,'Color',[0.666667 0.333333 0],... 





          'Marker','none', 'MarkerSize',6); 
legh_(end+1) = h_; 
legt_[end+1] = 'T Location-Scale Fit'; 
  
PlotData.x3 = reshape(x_, 2, 50); 
PlotData.y3 = reshape(y_, 2, 50); 
  
% --- Create fit "fit 4" 
  
t_ = ~isnan(Freq_) & ~isnan(n); 
Data_ = AINorm2(t_); 
Freq_ = n(t_); 
y_ = ksdensity(Data_,x_,'kernel','normal',... 
               'cens',[],'weight',Freq_,... 
               'support','unbounded',... 
               'width',0.25,... 
               'function','pdf'); 
h_ = plot(x_,y_,'Color',[0.333333 0.333333 0.333333],... 
          'LineStyle','-', 'LineWidth',2,... 
          'Marker','none', 'MarkerSize',6); 
legh_(end+1) = h_; 
legt_[end+1] = 'Non-Parametric Fit'; 
  
hold off; 
leginfo_ = ['Orientation', 'vertical', 'Location', 'SouthOutside'];  
h_ = legend(ax_,legh_,legt_,leginfo_[:]);  % create legend 
title(['YFP/CFP histogram data with fitted distributions';'']); 
set(h_,'Interpreter','none'); 
  
PlotData.x4 = reshape(x_, 2, 50); 
PlotData.y4 = reshape(y_, 2, 50); 
%----------------------------------------------------------------------
---- 
% This is the curve fitting graphs 
%----------------------------------------------------------------------
---- 
%This is a  
  
%This is a temporary command as the KJY15_Fit run needs to be run for 
this 




% PlotData.x = reshape(x_, 2, 50); 
% PlotData.y = reshape(y_, 2, 50); 
  
%This command removes the second row from the resized distribution 
curves 
PlotData.x1(2,:) = [];  





%PlotData.x2(2,:) = [];  
%PlotData.y2(2,:) = [];  
PlotData.x3(2,:) = [];  
PlotData.y3(2,:) = [];  
PlotData.x4(2,:) = []; 
PlotData.y4(2,:) = [];  
  
%This command isn't quite finished. Need to have a better expression of 
the 
%scaling of the Freq_ array. 
  
%PlotData.Freq_ = (Freq_ / max(Freq_)); 
 PlotData.Freq_ = ((Freq_ / max(Freq_)) * max(N_));  
 PlotData.Freq_ = PlotData.Freq_'; 
  
PlotData.r1 = PlotData.y1 - PlotData.Freq_'; 
%PlotData.r2 = PlotData.y2 - PlotData.Freq_'; 
PlotData.r3 = PlotData.y3 - PlotData.Freq_'; 
PlotData.r4 = PlotData.y4 - PlotData.Freq_'; 
  
figure(8) 
%figure(8) = figure('PaperSize',[20.98 29.68]); 
%= figure('PaperSize',[20.98 29.68]); 
subplot 131 
plot (PlotData.x1(1,:),abs(PlotData.r1(1,:)),'-',... 
      PlotData.x1(1,:),PlotData.Freq_,'-g',... 
      PlotData.x1(1,:),PlotData.y1(1,:),'-
r','LineWidth',2,'LineStyle','-.') 
  legend('Normal Distribution','Histogram 
data','Difference','location','SouthOutside') 
    title(['Normal Distribution';'']); 
    xlabel('Data') 
    ylabel('Scaled Intensity') 
axis square 
  
%Line style example txt: ('Marker, symbol, Color') For example, 
plot(x,y,'-.or') 
  
% subplot 122 
% plot (PlotData.x2(1,:),PlotData.y2(1,:),'-',...   
%       PlotData.x2(1,:),PlotData.Freq_,'-',... %Histogram data in life 
format 
%       
PlotData.x2(1,:),abs(PlotData.r2(1,:)),'LineWidth',2,'LineStyle','-') 
%   legend('Generalized Extreme Value','Histogram 
data','Difference','location','SouthOutside') 
%     title(['Generalized Extreme Value';'']); 
%     xlabel('Data') 
%     ylabel('Scaled Intensity') 
%  





   
%     (PlotData.x1(1,:),abs(PlotData.r1(1,:)),'-',... 
%      PlotData.x1(1,:),PlotData.Freq_,'-g',... 






      PlotData.x3(1,:),PlotData.Freq_,'-g',... 
      PlotData.x3(1,:),abs(PlotData.r3(1,:)),'-
b','LineWidth',2,'LineStyle','-.') 
  legend('T Location-Scale Fit','Histogram 
data','Difference','location','SouthOutside') 
    title(['T Location-Scale Fit';'']); 
    xlabel('Data') 
    ylabel('Scaled Intensity') 
  axis square 
   
subplot 133 
plot (PlotData.x4(1,:),abs(PlotData.y4(1,:)),'-r',... 
      PlotData.x4(1,:),PlotData.Freq_,'-g',... 
      PlotData.x4(1,:),abs(PlotData.r4(1,:)),'-
b','LineWidth',2,'LineStyle','-.') 
  legend('Non-Parametric Fit','Histogram 
data','Difference','location','SouthOutside') 
    title(['Non-Parametric Fit';'']); 
    xlabel('Data') 
    ylabel('Scaled Intensity') 
  axis square 
     
%This needs to be better as the best fitting distribution should 
%numerically be the first one.   
PlotData.R21 = sum(PlotData.r1.*PlotData.r1); 
%PlotData.R22 = sum(PlotData.r2.*PlotData.r2); 
PlotData.R23 = sum(PlotData.r3.*PlotData.r3); 
PlotData.R24 = sum(PlotData.r4.*PlotData.r4); 
  
PlotData.Results(1 , 1) = PlotData.R21;  
%PlotData.Results(1 , 2) = PlotData.R22;  
PlotData.Results(1 , 3) = PlotData.R23;  
PlotData.Results(1 , 4) = PlotData.R24;  
  
disp(' '); 
fprintf('Sum of the squares of the residuals from the curve fitting =') 
disp(' '); 











%This script will make the cell reference that displays all the 
information 
%about a processed datasheet into an Excel file 
  
ResultsTable2 = []; 
  
%ResultsTable2[1,1] = []; 
ResultsTable2[2,1] = 'Matlab summary script'; 
ResultsTable2[3,1] = 'File Name:'; 
ResultsTable2[3,2] = FileName; 
  
%ResultsTable2[3,1] = []; 
ResultsTable2[4,1] = 'The number of peroxisomes in all images ='; 
ResultsTable2[5,1] = 'The number of cells in all images ='; 
ResultsTable2[6,1] = 'Peroxisome/Cell ratio ='; 
ResultsTable2[7,1] = 'Number of images in this data set ='; 
ResultsTable2[4,2] = ResultsTable (1,2); 
ResultsTable2[5,2] = ResultsTable (2,2); 
ResultsTable2[6,2] = ResultsTable (3,2); 
ResultsTable2[7,2] = ResultsTable (4,2); 
  
ResultsTable2[8,1] = 'Sum of the squares of the residuals from the 
curve fitting'; 
ResultsTable2[9,1] = 'Normal Distribution'; 
ResultsTable2[10,1] = 'Generalized Extreme Value'; 
ResultsTable2[11,1] = 'T Location-Scale Fit'; 
ResultsTable2[12,1] = 'Non-Parametric Fit'; 
  
ResultsTable2[9,2] = PlotData.Results(1,1); 
ResultsTable2[10,2] = PlotData.Results(1,2); 
ResultsTable2[11,2] = PlotData.Results(1,3); 
ResultsTable2[12,2] = PlotData.Results(1,4); 
  
%This part writes a summary Excel spreadsheet 
a = FileName; 
b = '_XLSheet'; 





% %This is the curve fitting tool 
 %dfittool 
%  
 
